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Dedicated to the lung transplant patients 
 
 
 
 
Hope is the thing with feathers 
Hope is the thing with feathers 
That perches in the soul, 
And sings the tune without the words, 
And never stops at all, 
 
And sweetest in the gale is heard; 
And sore must be the storm 
That could abash the little bird 
That kept so many warm. 
 
I've heard it in the chillest land, 
And on the strangest sea; 
Yet, never, in extremity, 
It asked a crumb of me. 
 
 
Emily Dickinson, 1861 
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I 
Abstract 
Lung transplantation (LTx) is an effective treatment for end-stage lung failure. Despite great 
advances in transplant medicine over the last few decades, LTx does not result in complete 
recovery of health, as transplant recipients continue to be confronted by various health 
problems that must be psychologically processed and overcome. Many suffer from frequent 
emotional distress and psychological disorders that can negatively influence their ability to 
cope with their new organ, negatively impacting both their adherence to immunosuppressive 
therapy and health-related quality of life (HRQoL). Therefore, it is both clinically and 
scientifically relevant to assess the postoperative HRQoL and mental health of LTx recipients 
to identify those at risk for poor post-transplant outcomes and to improve patients’ symptom 
experience.  
This manuscript consists of three studies that review psychological adjustment to lung 
transplantation in terms of HRQoL and psychosocial outcomes via three different 
approaches. Study 1 is a systematic review of the literature to compile and interpret the 
evidence on measures to assess HRQoL and psychological outcomes following LTx, 
summarizing psychological outcomes in studies published between 1994 and 2013. Of 371 
articles, 63 studies were selected for final review. Considerable heterogeneity was found in 
methodology, operational concepts and applied outcome measures in the existing literature 
on HRQoL and psychological outcomes after LTx. Nevertheless, eligible studies generally 
point to significant improvements in both mental health and HRQoL post-transplant. A huge 
opportunity for future research lies in the development of guidelines to aid in the selection of 
outcome measures to assess psychological outcomes of lung transplant recipients. 
   
 
 
II 
The second study investigated the psychosocial outcome trajectories of 40 lung transplant 
recipients related to psychological distress and HRQoL over their first six months post-
transplant. Three distinctive clusters were identified: (1) patients with optimal postoperative 
trajectories (35%); (2) patients with good postoperative trajectories (42%); and (3) patients 
with poor postoperative trajectories (23%). The last group tended to be older, to suffer from 
more severe disease, to have more co-morbid conditions, and to have had a prolonged ICU 
and/or hospital stay. Disease severity, length of stay, and HRQoL two weeks post-transplant 
were strong predictors of psychological distress and impaired HRQoL at six months of 
follow-up. The results underscore the psychosocial needs of patients with poor post-
transplant trajectories.  
The third study qualitatively analyzed patient experiences with transplantation and 
their adjustment to normal life within the first six months post-transplant. ‘Physical benefits’, 
‘fear of rejection’, ‘gratitude towards the donor’, and ‘side effects’ were the most frequently 
named themes with respect to the transplantation process, new lungs, donor and medication 
regimen. Most themes remained unchanged over time. While comments about ‘intensive care 
unit delirium’ and ‘worries regarding donated organ quality’ diminished significantly over 
time, mentions of ‘restrictions in everyday life’ increased significantly. Gender comparison 
revealed only marginal differences in the response categories. Improvements in physical 
function during the early postoperative phase may be limited by the onset of clinical 
complications, fear of rejection and infections, medication side effects, and restrictions in 
everyday life. 
Generally, studies on HRQoL and psychological outcomes after lung transplantation 
have been limited by lost to follow-up, cross-sectional designs, small sample sizes and, great 
variability in the use of validated and non-validated outcome measures, such that 
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comparisons between different studies are difficult. One area of future research is the 
development of consensus guidelines to aid in the selection of outcome measures to assess 
HRQoL and psychological outcomes among LTx patients. In addition, longitudinal studies, 
including pre- vs. post-transplant assessment with adequately-sized samples are needed to 
further investigate outcome profiles and identify additional outcome predictors in these 
patients.  
   
 
 
IV 
Zusammenfassung 
Die Lungentransplantation ist eine effektive Therapiemethode für Patienten mit 
fortgeschrittenen Lungenerkrankungen im Endstadium. Trotz den unbestreitbaren 
medizinischen Fortschritten, die in den letzten Jahren stattgefunden haben, führt eine 
Lungentransplantation nicht zu einer vollständigen gesundheitlichen Genesung. 
Lungentransplantierte Patienten bleiben weiterhin mit verschiedenen gesundheitlichen 
Problemen konfrontiert, die sie psychisch verarbeiten und bewältigen müssen. Viele 
lungentransplantierte Patienten leiden unter anhaltendem emotionalen Distress oder sogar an 
psychischen Störungen, die den Umgang mit dem neuen Organ erschweren und die 
Therapieadhärenz für die notwendigen immunsupressiven Medikamente und die 
Lebensqualität beeinträchtigen können. Es ist deshalb von klinischer und wissenschaftlicher 
Relevanz, die Lebensqualität und psychische Gesundheit von lungentransplantierten 
Patienten zu untersuchen, um Patienten mit schlechten post-operativen Verläufen rechtzeitig 
identifizieren und die psychischen Beschwerden behandeln zu können.  
Dieses Manuskript umfasst drei Studien, welche die psychische Verarbeitung einer 
Lungentransplantation im Sinne von Lebensqualität und psychosozialen Aspekten anhand 
von drei unterschiedlichen Ansätzen untersuchen. Die erste Studie umfasst einen 
systematischen Review, welcher die verwendeten psychometrischen Instrumente zur 
Untersuchung der gesundheitsbezogenen Lebensqualität und der psychischen Gesundheit 
nach einer Lungentransplantation bewertet. Der Artikel fasst Studien zusammen, die 
zwischen 1995 und 2013 veröffentlich wurden. Von 371 Artikeln wurden 63 Studien in die 
Übersichtsarbeit eingeschlossen. In der vorhandenen Literatur über Lebensqualität und 
psychische Gesundheit nach einer Lungentransplantation wurde eine beträchtliche 
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Heterogenität in der Methodik, operationalen Konzepten und angewendeten 
psychometrischen Instrumenten gefunden. Die eingeschlossenen Studien weisen jedoch 
einheitlich auf eine signifikante Verbesserung der psychischen Gesundheit und der 
Lebensqualität nach einer Lungentransplantation hin. Ein künftiger Forschungsbereich liegt 
in der Entwicklung von Richtlinien hinsichtlich der Auswahl von psychometrischen 
Testinstrumenten zur Beurteilung der psychologischen Outcomes nach einer Lungen 
Transplantation.  
Die zweite Studie untersuchte bei 40 lungentransplantierten Patienten postoperative 
Verläufe hinsichtlich psychischen Distress und Lebensqualität während den ersten sechs 
Monaten nach der Transplantation. Es konnten drei unterschiedliche Clustertypen 
identifiziert werden: Patienten mit 1) ausserordentlich guten postoperativen Verläufen (35%), 
2) guten postoperativen Verläufen (42%) und 3) schlechten postoperativen Verläufen (23%). 
Patienten mit schlechten postoperativen Verläufen waren typischerweise älter, schwerer 
erkrankt, litten unter mehr Komorbiditäten und wiesen eine längere Hospitalisation sowohl 
auf der Intensivstation als auch auf der Normalstation auf. Der Schweregrad der Erkrankung, 
die Länge der Hospitalisation und die gesundheitsbezogenen Lebensqualität zwei Wochen 
nach der Transplantation waren wichtige Prädiktoren für psychischen Distress und 
Lebensqualität 6 Monaten nach der Transplantation. Unsere Resultate unterstreichen den 
psychosozialen Behandlungsbedarf von Patienten mit schlechten postoperativen Verläufen.  
Die dritte Studie untersuchte mittels einer qualitativen Datenanalyse die subjektive 
Wahrnehmung einer Lungentransplantation und die Rückkehr in den Alltag innert der ersten 
sechs Monate nach der Transplantation. ‚Verbesserung der körperlichen Belastbarkeit’, 
‚Angst vor Abstossung’, ‚Dankbarkeit dem Spender gegenüber’, und ‚Nebenwirkungen’ 
waren die häufigsten genannten Themen hinsichtlich der Transplantation, der neuen Lunge, 
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dem Spender und der Medikamente. Die meisten Themen blieben über die  Zeit unverändert. 
Während Aussagen bezüglich Delirium auf der Intensivstation und Sorgen bezüglich Qualität 
des neuen Organs über die Zeit abnahmen, nahmen Äusserungen hinsichtlich 
Einschränkungen im Alltag über die Zeit signifikant zu. Geschlechtsvergleichende Analysen 
zeigten nur marginale Unterschiede in Bezug auf die Antwortkategorien. Die Verbesserung 
des körperlichen Wohlbefindens nach einer Lungentransplantation kann durch das Auftreten 
von medizinischen Komplikationen, Angst vor Abstossung und Infektionen, 
Nebenwirkungen der Medikamente und Einschränkungen im Alltag beeinträchtigt sein.  
Bisherige Studien zur Untersuchung der Lebensqualität und psychischen Gesundheit 
von lungentransplantierten Patienten sind häufig durch methodische Schwächen wie lost to 
follow-up, Querschnittstudiendesigns, kleine Stichprobengrössen und eine hohe Variabilität 
der verwendeten Testinstrumente, die den Vergleich zwischen den Studien erschwert, 
limitiert. Künftige Studien sollten auf die Entwicklung von Richtlinien, die eine Auswahl von 
Testinstrumenten zur Erfassung der Lebensqualität und psychischen Gesundheit nach einer 
Lungentransplantation vereinfachen, fokussieren. Zudem sind weitere Längsschnittstudien 
mit prä- versus postoperativen Untersuchungen und genügend grossen Stichproben 
notwendig, um postoperative Verläufe und Verlaufsprädiktoren zuverlässig identifizieren zu 
können.  
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1 
1 Introduction  
Lung transplantation (LTx) has become an established therapeutic option to extend survival, 
reduce disability and improve health-related quality of life (HRQoL) in selected patients with 
end-stage pulmonary diseases of different etiologies (Dierich et al., 2013). Although survival 
rates among adult lung transplant recipients have increased remarkably over the years, due to 
enhanced surgical techniques and postoperative care, long-term rates are still inferior to those 
achieved with other solid organ transplants (Krueger, Berutto, & Aubert, 2011). Acute and 
chronic allograft rejection and infections involving a transplanted graft that is in direct 
contact with open air constitute the main postoperative challenges (Inci, Schuurmans, 
Boehler, & Weder, 2013).  
Traditionally, the main outcome of interest with any lung transplant procedure has 
been patient survival. With improved survival rates, however, post-transplant health-related 
quality of life (HRQoL) has become an important component of any evaluation of benefits 
(Anyanwu, McGuire, Rogers, & Murday, 2001). Furthermore, lung transplant recipients 
represent a heterogeneous group, and therefore do not necessarily experience the same 
survival benefits or exhibit the same post-transplant trajectories. Moreover, throughout the 
transplant process, lung transplant patients undergo complex physical and psychological 
changes that can cause a range of psychosocial issues that affect physical function, mental 
health, social roles and relationships, as well as adherence to medication (Rosenberger, Dew, 
DiMartini, DeVito Dabbs, & Yusen, 2012).  
Psychological aspects of transplantation have been investigated and documented 
extensively, commonly addressing HRQoL, mental health, social functioning and symptom 
experiences. Results from previous research generally demonstrate considerably improved 
HRQoL and psychological function in lung transplant recipients relative to their pre-
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transplant period (Kugler et al., 2005; Limbos, Joyce, Chan, & Kesten, 2000; Santana, Feeny, 
Jackson, Weinkauf, & Lien, 2009). However, numerous methodological problems limit the 
reliability and generalizability of findings in the literature and affect the ability to draw well-
supported conclusions regarding the effect of lung transplantation on HRQoL. These 
limitations include the use of small cohorts, retrospective data collection, cross-sectional 
study designs, survivor bias, and the heterogeneous use of psychometric instruments to assess 
psychological outcomes after LTx (Finlen Copeland, Vock, Pieper, Mark, & Palmer, 2013). 
Prospective studies with large enough samples are few in the field of lung transplantation, 
and data obtained in larger studies often included cohorts with different organ transplants that 
potentially obscure results among lung transplant recipients.  
To address these limitations, this thesis contributes the existing literature by 
presenting 1) a systematic review of the application of psychometric instruments to assess 
health-related quality of life and psychological outcomes following lung transplantation; 2) a 
six-month observational study investigating psychological distress and quality of life; and 3) 
a qualitative analysis exploring patients’ experience with their transplant and adjustment to 
normal life over the first six months post-transplant. 
 
2 Theoretical framework 
This chapter first summarizes the most important cornerstones in the development of 
transplant medicine. Secondly, medical and ethical issues relating to lung transplantation are 
outlined; and thirdly, the most important psychosocial consequences of lung transplantation 
are highlighted.  
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2.1 History of lung transplantation 
The first contribution to organ transplant history was made by Vladimir Petrovich Demikhov 
(1916 – 1998), a Russian scientist who, by means of animal experiments in the 1930s through 
1950s, demonstrated that transplantation procedures were technically feasible (Blumenstock 
& Lewis, 1993). The next major breakthrough was made by James Hardy at the University of 
Mississippi in 1963. He performed the first human lung transplant; however, his patient 
survived for only 18 days after transplantation, rapidly succumbing to renal failure (Hardy, 
Webb, Dalton, & Walker, 1963). Over the following twenty years, multiple further attempts 
at lung transplantation failed due to infection, acute rejection and the excessive toxicity of 
inadequately immunosuppressive drugs (Lynch & Ross, 2006). In 1972, however, a new 
immunosuppressant drug called cyclosporine was developed and found to be a promising 
means to attenuate allograft rejection (Borel, Feurer, Magnee, & Stahelin, 1977). 
Subsequently, in 1983, the Toronto Lung Transplant Group performed the first successful 
long-term single lung transplant in a patient with pulmonary fibrosis. Twenty-six months 
after transplantation, the patient was reported to be in good health, leading a normal life and 
working regularly. That patient eventually died of renal failure seven years after 
transplantation. This successful case report demonstrated that unilateral lung transplantation 
was possible in selected patients with end-stage lung disease (Toronto Lung Transplant 
Group, 1986).  
In summary, over the past sixty years, remarkable advances have been made in the 
field of transplant medicine. What started in the early twentieth century as animal 
experiments has progressed to effective high-tech clinical practice (De Perrot et al., 2004). 
Today, lung transplantation is regarded worldwide as a mainstay of therapy for many patients 
with life-threatening pulmonary disease (Banner, Polak, & Yacoub, 2003). 
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2.2 Lung transplantation in Switzerland 
2.2.1 Facts and figures of lung transplantation  
To date, more than 47’000 adult lung transplants have been reported worldwide to the 
Registry of the International Society for Heart and Lung Transplantation (ISHLT) (Yusen et 
al., 2014). Meanwhile, in Switzerland since 1992, more than 700 lung transplants have been 
performed (Swisstransplant, 2015a). In Switzerland, there are two transplant centers, which 
perform lung transplantation. One is located at the University Hospital of Zurich, the other 
one at the University Hospital of Lausanne. Overall patient survival has progressively 
improved, such that today, one-, three-, and five-year survival rates of 87%, 75% and 69%, 
respectively, have been achieved at the University Hospital of Zurich, rates comparable to 
those achieved at high-volume programs internationally (Inci et al., 2013). One of the key 
challenges in lung transplantation is the limited availability of donor organs for lung 
transplantation. Switzerland has one of the lowest post mortem donation rates among 
European countries, and as a consequences, many patients die while awaiting organ 
transplant (Immer, 2015). Background data on the lung transplant-related characteristics of 
Swiss patients are presented for the year 2014 in Table 1.  
 
Table 1. Key data regarding lung transplantation in Switzerland 
Lung transplant-related characteristics [d] 
Number of patients on lung waiting-list 122 
Number of lung transplanted patients 56 
Average time on waiting-list 465 
Deceased patients on waiting-list 6.6% 
Nr. of imported lungs organs 8 
Note: Data provided by the 2014 Annual Report of the Swiss National Foundation for Organ Donation and 
Transplantation (Swisstransplant, 2015b).  
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2.2.2 Organ procurement for lung transplantation  
In Switzerland, most organs donated for lung transplantation are retrieved from primary or 
secondary brain-dead donors with sustained circulation (heart-beating donors). Donation after 
brain death (DBD) is possible when cerebral functions are totally and irreversibly abolished 
due to some lesion or injury affecting the brain (Spaight, Weiss, Keel, & Immer, 2013). 
Furthermore, since 2011, organ donation after circulatory determination of death (DCD or 
non-heart-beating donors) is being increasingly accepted in Switzerland to partly compensate 
for the general shortage of organs suitable for transplantation. In Switzerland, the procuring 
of organs from DCD donors is strictly regulated and only permitted, if cardiocirculatory 
arrest occurs within 60 minutes after cessation of life-sustaining treatment, followed by brain 
death diagnosis after 10 minutes of documented circulatory arrest. However, organ 
procurement from DCD donors is a demanding procedure and only performed in highly 
specialized centers, so that the number of DCD donors remains relatively low. The diagnosis 
of death in view of organ donation is strictly regulated by the Swiss Academy of Medical 
Sciences (SAMS) and governed by the Swiss Transplantation Law (Immer, 2015). 
 
2.2.3 Ethical aspects of lung transplantation  
Over the past few decades, technological accomplishments in the understanding of 
immunologic responses to foreign tissues, the technology of organ preservation, immune 
suppression and surgical procedures, have opened up further possibilities for organ 
transplantation, resulting in an ever-increasing need for transplantable organs (Mahoney, 
2001). However, rapid developments in transplant medicine have raised many ethical, moral 
and policy concerns. Among the many questions raised have been whether the criterion of 
‘brain death’ is an ethically-acceptable definition of death; how best to procure more organs; 
how to fairly distribute limited resources; where to set medical limits; what kind of medical 
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conditions should be treated and which should not, despite the medical possibilities; and 
whether all transplants should be covered by public funds (Shelton & Balint, 2001). 
Today, the shortage of available organs and the distribution of limited sources 
constitute the main ethical problems for cadaveric organ transplantation, causing heated 
discussions over what measures ought to be taken to increase the available supply (Quante & 
Wiedebusch, 2006). Explanations for the organ shortage can be divided into two categories: 
the complexity of the medical system and individuals’ willingness for organ donation. 
Results from previous studies demonstrated that countries with established organ donor 
centers that outreach to larger population groups perform a greater number of transplants 
(Horton & Horton, 1991; Matesanz & Dominguez-Gil, 2007). However, willingness to 
donate also depends on individual attitudes, social structures, cultural practices and religious 
beliefs (McGlade & Pierscionek, 2013). It has been suggested that unusually high fear and 
anxiety concerning one’s own death can deter people from behaviors that confront them with 
their own mortality (Lester, 2005). Furthermore, there is evidence that serious doubts about 
the criteria used to determine death dissuade people from becoming organ donors (DuBois & 
Anderson, 2006). Moreover, the concept of brain death, which constitutes the legal definition 
of death, has been frequently misunderstood in the population. This misconception holds 
people back from considering organ donation (Anker & Feeley, 2010; Siminoff, Mercer, & 
Arnold, 2003).  
In summary, doubts associated with organ transplantation based on misinformation, 
misunderstandings, and mistrust can decrease organ donation rates (Dubois, 2010). Despite 
major public campaigns among medical personnel and the general public, the supply of 
organs for transplantation remains far short of demand. Consequently, in Switzerland, a 
nationwide intense debate about possible incentives to encourage individuals to donate has 
been ignited. Different solutions have been discussed. Among them is to treat individuals 
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willing to donate preferentially when it comes to receiving a transplant; to offer gifts when 
someone fills out a donor card; and providing monetary reimbursement in cases of living 
donation. To date, none of the named possibilities have come into force (BAG, 2015). 
Further improving knowledge regarding organ donation, the methods available for 
registration, and the regulations that govern the process of organ donation could help to 
remove significant barriers and encourage more individuals to donate their organs (McGlade 
& Pierscionek, 2013). 
 
2.2.4 Transplantation act 
In Switzerland, organ transplantation is bound by medical-ethical guidelines, which 
determine under which conditions organ, tissues and cells can be used for transplantation. 
These guidelines have been established to prevent the improper handling of organs in the 
context of human transplantation medicine, and to protect human dignity, privacy and health. 
The most important regulations stated in the Federal Council Decree 2007 are the following 
(The Federal Assembly of the Swiss Confederation, 2014, pp. 3-18):  
 
- Criteria for death and determination of death: “a person is dead if the functions of his or 
her brain, including the brain stem, have ceased irreversibly” (by definition: brain death) 
(Art. 9). 
- Organ transplantation is free of charge and therefore, trade involving human tissues is 
prohibited (Art. 6 and 7). 
- Switzerland practices a soft opt-in solution: utilizing the organs of a deceased person is 
only allowed “if the person has consented before his or her death to their removal” or if 
the person’s relatives have expressed agreement (Art. 8). 
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- Allocation of organs is followed by principles of equality and fairness (Art. 17) in 
consideration of four criteria: 1) the medical urgency of transplantation; 2) the medical 
benefits of transplantation; 3) the waiting time; and 4) equal opportunity (in particular for 
individuals reliant on a graft with rare physiological characteristics (Art 18).  
- Confidentiality of data: confidentiality merits protection. “The data must accordingly be 
treated confidentially” by assuring anonymity of the recipient to (the relatives of) the 
donor and of the donor to the recipient (Art 57 and 58). 
 
2.2.5 Swiss organ allocation system 
In Switzerland, the allocation of organs is navigated by a web-based computer program 
called the Swiss Organ Allocation System (SOAS), which contains relevant data on potential 
recipients on the Swiss waiting list, as well as data on all available donors. By means of these 
provided data, the system prioritizes registered transplant candidates based on the following 
criteria: 1) medical urgency, 2) domicile in Switzerland, 3) medical purpose, and 4) priority 
(e.g. blood group), 5) waiting time (Swisstransplant, 2015a).  
 
2.2.6 The Swiss Transplant Cohort Study 
Similar to other national or international transplant registries (e.g. the Scientific Registry of 
Transplant Recipients (SRTR) in the US; the Heidelberg-based Collaborative Transplant 
Study (CTS) in Europe; the Australian and New Zealand Dialysis and Transplant 
(ANZDATA) registry, the Swiss Transplant Cohort Study (STCS) aims at systematically 
monitor transplant outcomes of solid organ transplantation (e.g. heart, lung, liver, kidney) in 
Switzerland to evaluate the quality, effectiveness and efficiency of transplantation. The STCS 
is a multi-center cohort study, which has collected prospectively data from all, transplant 
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centers in Switzerland since 01.05.2008. The main objectives of the STCS are the followings 
(STCS, 2015): 
 
- To improve knowledge about the progress and complications following transplantation in 
all Swiss transplant centers and of all transplanted organs. 
- To identify efficacy and side effects of the treatment. 
- To study the relationship with concomitant disease, psychological and social factors. 
- To analyze the influence of genetic factors on the progress after transplantation. 
- To examine the response to treatment and the occurrence of side effects. 
 
All transplant patients who got transplanted in Switzerland and have given their consent are 
considered to be eligible for inclusion. Data are collected longitudinally, before 
transplantation, 6 months and 12 months after transplantation and thereafter yearly. The study 
period is indefinite (STCS, 2015).   
 
2.3 Referral for lung transplantation 
Today, lung transplantation is accepted as a viable treatment option for selected patients with 
diverse end-stage pulmonary disorders, who either are not or are no longer responding to 
maximal medical therapy, or for whom no effective medical therapy exists. According to the 
most recent Registry Report of the International Society for Heart and Lung Transplantation 
(ISHLT) (Yusen et al., 2014), the main indications for lung transplantation between 1995 and 
2013 were chronic obstructive pulmonary disease (COPD, 33%); followed by interstitial lung 
disease (ILD, 24%), which includes idiopathic pulmonary fibrosis (IPF); and cystic fibrosis 
(CF, 16%). Referral for lung transplantation assessment is warranted when patients have less 
than 50% two- to three-year predicted survival. As the demand for donor lungs far exceeds 
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the supply, the waiting time for a suitable donor organ is steadily increasing. Survival on a 
waiting list depends on the waiting time, the underlying diagnosis, and donor availability. 
Waiting times tend to be longer for small candidates and for recipients with a blood group 
other than AB (Orens et al., 2006). 
 
2.3.1 Absolute and relative contraindications 
Potential candidates need to be well-informed regarding the procedure and its health 
implications, and they must demonstrate adequate health behaviors and willingness to adhere 
to guidelines from healthcare professionals. To screen for contraindications, prior to active 
listing potential candidates are sent for complex medical and psychosocial assessments 
performed by a multidisciplinary team to determine whether they meet the selection criteria 
for lung transplantation. This screening process helps to identify factors in a person's life that 
could cause difficulties for them during the waiting period, during recovery, and/or 
postoperatively (Hook & Lederer, 2012). The psychosocial assessment screens potential 
candidates for mental and psychosocial health issues, their use and abuse of alcohol, and their 
decisional capacity, motivation for transplantation, and coping skills for dealing with chronic 
disease (Lanuza & McCabe, 2001). If a patient successfully meets the selection criteria, he or 
she is added to the transplant waiting list. Absolute and relative contraindications are listed in 
Figure 2. Single relative contraindications are seldom considered prohibitive. Someone with 
multiple relative contraindications is generally rejected for transplantation (Inci et al., 2013).  
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Absolute contraindications to transplant  
! Malignancy in the last 2 years. In general, a 5-year disease-free interval is prudent 
! Untreatable advanced dysfunction of another major organ system (e.g. heart, liver or kidney) 
! Acute medical instability including, but not limited to, acute sepsis, myocardial infarction, and liver 
failure 
! Incurable chronic extrapulmonary infection including chronic active viral hepatitis B, hepatitis C and 
human immunodeficiency virus 
! Class II or III obesity (body mass index [BMI] ≥ 35.0 kg/m2) 
! Significant chest wall/ spinal deformity 
! Documented nonadherence or inability to follow through with medical therapy 
! Absence of an adequate or reliable social support system 
! Substance addiction (e.g. alcohol, tobacco or narcotics) that is either active or within the last 6 months 
Relative contraindications to transplant 
! Age older than 65 years 
! Class I obesity (body mass index [BMI] exceeding 30kg/m2) 
! Severe or symptomatic osteoporosis 
! Extensive prior chest surgery with lung resection 
! Critical or unstable clinical condition (e.g. shock, mechanical ventilation or extracorporeal membrane 
oxygenation) 
! Colonization with highly resistant or highly virulent bacterial, fungi or mycobacteria 
! Other medical conditions that have not resulted in end-stage organ damage (e.g. diabetes mellitus, 
systemic hypertension, epilepsy, central venous obstruction, peptic ulcer disease, or gastroesophageal 
reflux) 
Figure 1. Absolute and relative contraindications to lung transplantation adapted by Weill et al. (2015, pp. 3-4). 
The list is not intended to include all possible clinical scenarios but rather to highlight common areas of 
concern.  
 
2.3.2 Chronic obstructive pulmonary disease 
Chronic obstructive pulmonary disease (COPD) is characterized by chronically-poor airflow. 
Main symptoms include shortness of breath, cough, and excessive sputum production. 
Typically, airflow limitation is progressive. The most common cause of COPD is tobacco 
smoking, together with numerous other factors like air pollution and genetic determinants 
(Decramer, Janssens, & Miravitlles, 2012). Presently, COPD is the fourth leading cause of 
death worldwide, but the World Health Organization (WHO) predicts that this disease will 
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become the third leading cause by 2030 unless urgent action is taken to reduce underlying 
risk factors, in particular tobacco use (WHO, 2015). Referral for transplantation for COPD 
should only be considered when patients continue to deteriorate even with optimal medical 
and surgical therapy, including smoking cessation, maximal bronchodilator treatment, 
rehabilitation, long-term oxygen therapy, and endoscopic or surgical lung volume reduction 
(Orens et al., 2006). Compared to other end-stage lung diseases, COPD patients have a 
relatively good transplant prognosis (Inci et al., 2013). 
 
2.3.3 Interstitial lung disease 
Interstitial lung disease (ILD) refers to a diverse group of lung diseases that involve 
inflammation and fibrosis of the alveoli, distal airways and septal interstitium of the lungs. 
The term idiopathic pulmonary fibrosis is used to describe an interstitial lung disease for 
which no obvious cause can be identified (hence, idiopathic) (Raghu et al., 2011). Inhaled 
substances such as dust or other particles in the air, and exposure to molds, gases or fumes, 
but also autoimmune diseases can be responsible for some types of ILD (King, 2005). 
Typically, the patient suffers from progressive breathlessness, lung crackles, and a diffusely-
abnormal chest radiograph (Raghu et al., 2011). Prolonged ILD may result in idiopathic 
pulmonary fibrosis (IPF). IPF results from scarring of lung tissue and is characterized by a 
progressive decline in lung function and worsening dyspnea. IPF patients have a poor 
prognosis and experience the highest mortality rate while on the waiting list (Christie et al., 
2012). 
 
2.3.4 Cystic fibrosis 
Cystic fibrosis (CF) is a genetic disorder that primarily affects the lungs, but also the 
pancreas, liver, kidneys and intestine. Long-term complications include difficulties with 
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breathing and coughing up sputum as a consequence of frequent lung infections. Other 
symptoms include, among others, sinus infections, poor growth, clubbing of fingers and toes, 
and infertility in males (O'Sullivan & Freedman, 2009). Interestingly, cystic fibrosis is most 
common among residents of northern Europe, among whom the disease occurs in 
approximately 1 in 3’000 newborns (Walters & Mehta, 2007). As there is no cure for cystic 
fibrosis, lung infections are treated with antibiotics (Hofer et al., 2009). Ultimately, lung 
transplantation is the only treatment option that allows advanced CF patients to obtain normal 
respiratory health. Good post-transplant outcomes, in terms of prolonged survival and 
improved health-related quality of life, have been reported worldwide (Meachery et al., 
2008).  
 
2.4 Diathesis-stress model as an explanation for the development of distress 
in lung transplant recipients 
Current research in psychosocial transplant medicine seeks to assess the relationship between 
illness and distress and what variables may influence this association. Specific questions that 
have been addressed are what factors are associated with distress and with the individual’s 
ability to cope and adapt successfully with lung transplantation and whether distress has an 
impact on outcomes following transplantation (Dew et al., 2012; Phillips, Burker, & White, 
2011).  
One theoretical model that may explain the development of distress in lung transplant 
patients, is the diathesis-stress model (Zubin & Spring, 1977). This model assumes that 
specific types of psychopathology arise from a combination of vulnerability (diathesis) in the 
context of life stress (Monroe & Simons, 1991). The term diathesis derives from the Greek 
and is conceptualized as a disposition or vulnerability, including genetic, psychological, 
biological or situational factors (Ingram & Luxton, 2005). Stress can be defined as a 
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significant life event that disrupts the equilibrium of a person’s life (Lazarus & Folkman, 
1984). The diathesis-stress model describes a dose-response relationship, suggesting that if 
the combination of the diathesis and the stress exceeds a threshold, the person is likely to 
develop a disorder. This model is also useful for the purpose to describe why some 
individuals who go through stressful live events are more vulnerable to develop a disorder 
than others (Ingram & Luxton, 2005). Protective factors are critical when considering the 
interaction of diatheses and stress because they can mitigate major stressors. Examples of 
protective factors include particular personal traits, a supportive peer network, and individual 
and social competences (Ingram & Price, 2001). Translating this model to the experience of a 
lung transplantation, the diathesis includes predispositional factors, such as genetic, 
biological, cognitive or interpersonal variables, while stress refers to the transplant 
evaluation, waiting period, perioperative recovery and adjustment to life as a transplant 
recipient. 
In the following, the diathesis-stress model is used as a conceptual framework to 
understand patients’ response to lung transplantation and relative adaptation to life as a lung 
transplant recipient.  
 
2.5 The waiting period for lung transplantation 
2.5.1 Mental health of lung transplant candidates 
Transplant candidates and recipients are confronted with a great number of stressors 
throughout the process of transplant evaluation, the waiting period, the period of peri-
operative recovery, and both early and long-term after transplantation (Figure 2), all of which 
can adversely affect global quality of life, mental health, social roles, relationships, and 
health maintenance behaviors (Rosenberger, Dew, DiMartini, et al., 2012). Waiting for a 
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transplant can be an intensely agonizing and stressful time for both patients and caregivers 
(Naef & Bournes, 2009; Yelle, Stevens, & Lanuza, 2013).  
 
Transplant-specific 
events 
Periods Health Issues Psychosocial Issues Interventions 
Evaluation for 
transplant 
Waiting for donor 
lung 
- Continued 
deterioration of lung 
function 
- Acute health crisis 
- Hospitalizations 
- Treatment for end 
stage lung disease 
and sequelae 
- Stress of transplant 
evaluation 
- Stage of acceptance 
of need for 
transplant 
- Uncertainty about 
waitlist outcome 
- Quality of life 
decrements 
- Psychological 
distress 
- Cognitive-
behavioral therapy 
to improve quality 
of life and reduce 
psychological 
distress 
Transplant surgery 
Perioperative 
recovery 
- Improvements in 
lung function 
- Sequelae of major 
surgery 
- Hospital stay 
obscures realistic 
expectations of 
caregiving 
 
 
 
Hospital discharge 
Adjustment to life 
as a transplant 
recipient 
- New medications 
side effects 
 
- Optimism of post-
operative 
‘honeymoon’ 
obscures 
participation in self-
care regimen 
 
 
First anniversary 
Early years post-
transplant 
- Acute graft 
rejection 
- Infection 
- Re-hospitalization 
- Physical 
rehabilitation 
- Chronic post-
operative pain 
- Disappointment 
about slower pace 
of functional 
improvement 
- Changing family 
dynamics 
- Quality of life 
improvements 
- Adherence to self-
care regimen 
- Psychological 
distress 
- Caregiver burden 
- Physical activity 
rehabilitation to 
improve physical 
functioning and 
quality of life 
- Self-monitoring and 
decision support aid 
to improve 
adherence and 
communication 
with transplant 
team 
Five-year 
anniversary 
 
 
 
 
 
 
Ten-year anniversary 
Long-term post-
transplant 
- Chronic graft 
rejection 
- New health 
problems 
- Sequelae of long-
term 
immunosuppression 
 
- Burden of 
additional health 
problems 
- Quality of life 
changes 
- Return to work 
- Caregiver burden 
 
- Mindfulness-based 
stress reduction to 
reduce 
psychological 
distress 
 
Figure 2. Examples of events and stressors that contribute to different phases of the transplantation experience 
as well as interventions that have demonstrated efficacy in reducing the impact of these stressors (Rosenberger, 
Dew, DiMartini, et al., 2012, pp. 519). 
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Usually, lung transplant candidates are in a highly-critical state of physical health, associated 
with a marked reduction in their vitality and quality of life (Chen et al., 2011). Shortness of 
breath, limited physical fitness, frequent hospitalizations, and oxygen dependency are the 
most distressing symptoms reported by end-stage respiratory patients, which in turn, can 
cause severe psychological distress (Lanuza et al., 2012). Stressors associated with the 
transplant procedure include fear of surgery, worry about changes to future life plans, 
financial strains, and ambivalent feelings with respect to treatment options (Rosenberger, 
Dew, DiMartini, et al., 2012). 
Adjustment disorders with anxiety and mood disturbances and simultaneously 
reduced HRQoL relative to norms are common among candidates awaiting surgery, 
presumably due to their poor underlying medical condition, including their symptoms of 
dyspnea, hyperventilation and feebleness that can trigger anxiety and distress (Feltrim et al., 
2008; Limbos et al., 2000). Prevalence rates for anxiety and mental disorders are high, 
reportedly ranging from 21% to 55% (Chen et al., 2011; Craven, 1990; Najafizadeh et al., 
2009). Consequently, it is not surprisingly that lung transplant candidates often are in need of 
medical and psychosocial support. Fortunately, favorable results have been achieved using 
cognitive behavioral interventions aimed at improving coping skills, quality of life, mood 
symptoms and relationships with caregivers (Rodrigue, Baz, Widows, & Ehlers, 2005). 
 
2.5.2 The lived experience of waiting 
Most challenging for transplant candidates and their caregivers might be the balancing act 
between being in a life-threatening situation, accompanied by feelings of uncertainty and 
ambiguity, and the hope that their well-being will improve and suffering dissipate 
(Rosenberger, Dew, DiMartini, et al., 2012). Patients on a waiting list for organ 
transplantation describe their situation as uncomfortable, unpleasant, irritating, frustrating 
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and threatening: ”It’s like living with a time bomb and watching the sand in the hourglass run 
out” (Bunzel, Wollenek, & Grundbock, 1992). Thoughts about death became prominent as 
people became more ill: ”God, if I don’t get the transplant, I wonder how long I can 
survive?” (Flynn, Daiches, Malpus, Yonan, & Sanchez, 2013). One patient waiting for lung 
transplantation described being on a waiting list as living from day to day, feeling both 
miserable and yet hopeful, always wondering when “the phone call” is going to come, and 
making plans for “after the operation” (Thomsen & Jensen, 2009). Another lung transplant 
candidate reported that “I have no choice, but to accept that my family and I must simply put 
our lives on hold until after the transplant surgery” (Naef & Bournes, 2009).  
 
2.6 The early years after lung transplant 
Most patients experience a rapid change in health soon after transplantation. Because of the 
transplantation, patients transition quickly from life with minimal lung function and maximal 
restrictions to life with normal lung function, no dyspnea, and more energy (Rosenberger, 
Dew, DiMartini, et al., 2012). Notwithstanding, it usually takes several years for patients to 
fully adjust to their new life situation after their transplant (Langer, 2015). 
 
2.6.1 Health-related quality of life of lung transplant recipients 
Health-related quality of life is an important outcome measure to assess the effectiveness of 
lung transplantation. The World Health Organization (WHO) defines quality of life as 
“individuals perception of their position in life in the context of the culture and value systems 
in which they live and in relation to their goals, expectations, standards and concerns. It is a 
broad ranging concept affected in a complex way by the person’s physical health, 
psychological state, level of independence, social relationships, personal beliefs and their 
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relationship to salient features of their environment” (WHO, 1997, pp. 1). The term ‘health-
related quality of life’ (HRQoL) is a multidimensional construct and reflects the health and 
disease-related aspects of quality of life. The concept of HRQoL incorporates domains that 
include physical, psychological, and social functioning (WHOQOL group, 1993). HRQoL 
measurement quantifies the impact of disease and treatments on daily life and well-being in a 
formal and standardized way (Yusen, 2009). 
Within transplant medicine, a considerable number of outcome studies have 
demonstrated significant improvements in HRQoL following lung transplantation relative to 
the pre-transplant period (Gerbase, Spiliopoulos, Rochat, Archinard, & Nicod, 2005; 
Kunsebeck et al., 2007; Vermeulen et al., 2004). Quality of life benefits can already be 
observed within the first six months of a transplant and appear to remain stable for a period of 
three to five years (Limbos et al., 2000; Santana et al., 2009). This improvement in HRQoL 
after LTx are primarily related to considerably better physical function, increased vitality, 
fewer restrictions in social and leisure activities, more energy, and less pain and discomfort 
relative to pre-transplant levels (Lanuza et al., 2012; Vermeulen et al., 2003). Only few 
authors have investigated predictors of HRQoL outcomes after transplantation. Predictors for 
poor post-transplant HRQoL outcomes included a single lung transplant, older age at the time 
of transplantation, and recurrent infections (Kugler et al., 2005). The onset of bronchiolitis 
obliterans syndrome (BOS) (Santana, Feeny, Ghosh, & Lien, 2012), side effects from 
immunosuppressant medication (Smeritschnig et al., 2005), and pain (Girard et al., 2006) also 
significantly reduced post-transplant HRQoL. In contrast, results on other potential outcome 
predictors, including gender, psychiatric history, longer waiting times for transplantation, 
haven been contradictory and were supported only by single studies (Dew et al., 2012; 
Gerbase et al., 2005). Further research is warranted to investigate predictions of postoperative 
complications and reduced post-transplant HRQoL.  
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2.6.2 Mental health of lung transplant recipients 
During the early postoperative phase, delirium is common among lung transplant candidates, 
mostly due to hypoxia (Hafliger, 2005). However, its prevalence and prognostic significance 
have not been systematically investigated. There are only few studies indicating that the 
occurrence of delirium in lung transplant recipients was associated with poorer pre-transplant 
cognitive functioning and longer hospital stays (Smith et al., 2014; Smith et al., 2015). 
Although lung transplant recipients report significantly better mental health than transplant 
candidates, anxiety, depression and adjustment disorders occur frequently in patients within 
the first year after transplantation with prevalence rates up to 30% (Dew et al., 2012; Kugler 
et al., 2013). Evidence also supports associations between pre-transplant risk factors and 
post-transplant mental health, including female gender, a longer wait for transplantation, and 
having poor caregiver support as major risk factors for the onset of anxiety and depression 
post-transplant (Dew et al., 2012). However, surprisingly few studies exist that investigated 
onset rates and risk factors for psychiatric disorders in lung transplant recipients. This is an 
important research gab as studies on other solid organ transplantation indicated psychiatric 
morbidity as a predictor for negative long-term outcomes (DiMartini et al., 2011; 
Rosenberger, Dew, Crone, & DiMartini, 2012). The impact of psychiatric conditions on the 
morbidity and mortality of lung transplant recipients remains inconclusive and further 
research is warranted to investigate these associations among a broader range of psychiatric 
predictors.  
 
2.6.3 Adherence to medication regimen in lung transplant recipients 
Non-adherence to immunosuppressive therapy is a common problem in the treatment of solid 
organ transplant recipients, with severe consequences for the patient’s health, including acute 
rejection and mortality. Adherence is defined as “the extent to which a person’s behavior – 
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taking medication, following a diet, and/ or executing lifestyle changes – corresponds with 
agreed recommendations from a health care provider” (WHO, 2003). The prevalence of non-
adherence reported in the context of organ transplantation ranges widely, between 20% and 
50% (Chisholm, 2002; Dew et al., 2007; Germani et al., 2011). Furthermore, pre-transplant 
medication non-adherence is predictive of post-transplant non-adherence with 
immunosuppressives (De Geest et al., 2014), and post-transplant non-adherence increases 
over time (Dew et al., 2007; Germani et al., 2011). However, non-adherence rates differ 
greatly between different organ groups. In lung transplant recipients, non-adherence to 
immunosuppressive therapy is comparable to that observed among heart transplant patients, 
and superior to what is seen among liver or kidney transplant patients (De Geest et al., 2014; 
Dew et al., 2008; Goetzmann et al., 2008).  
The World Health Organization (WHO, 2003) proposes five interacting dimensions 
affecting medication adherence: 1) social/economic factors; 2) the health-care system; 3) 
condition-related factors; 4) therapy-related factors; and 5) patient-related factors. These five 
dimensions of adherence are summarized in Figure 3. In one literature review (Dew et al., 
2007), non-Caucasian ethnicity, poorer social support, and poorer perceived health were the 
most consistently-observed determinants of non-adherence to medical regimens after solid 
organ transplantation. Further psychosocial variables that appear to influence 
immunosuppressive non-adherence in organ recipients are younger age (Bosma, Vermeulen, 
Verschuuren, Erasmus, & van der Bij, 2011), poor social and family support (Chisholm, 
2002; Hugon et al., 2014), social isolation (Germani et al., 2011), a low internal locus of 
control (Burker, Evon, Galanko, & Egan, 2005), and a difficult doctor-patient relationship 
(Dew et al., 2007). Non-adherent transplant patients also tend to have lower perceptions 
about the necessity of medications, weaker beliefs that their medication will prevent rejection 
and greater concerns about potential harm resulting from their medication than adherers 
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(Kung, Koschwanez, Painter, Honeyman, & Broadbent, 2012). Given the negative 
consequences of non-adherence to medical regimens on clinical outcomes, the behavioral 
dimension of transplant patient management deserves increased attention, both in research 
and clinical practice. Efforts to implement adherence-enhancing interventions to encourage 
proper medication-taking behavior are an important component of post-transplant care (De 
Geest, Dobbels, Fluri, Paris, & Troosters, 2005). 
 
Social/ economic 
factors  
Health-care system Condition-related 
factors 
Therapy-related 
factors 
Patient-related 
factors 
Young age 
 
Low educational 
level 
 
Lack of social 
support 
 
Unstable living 
conditions 
 
High medication cost 
 
Difficult provider-
patient relationship 
 
Poor provider’s 
communication skills 
 
Disparity between 
health beliefs of the 
health care provider 
and patient 
 
Lack of positive 
reinforcement from 
the health care 
provider 
 
Incomprehensible 
patient information 
materials 
Chronic disease 
 
Symptom severity 
 
Psychiatric disorders 
(e.g. depression, 
anxiety) 
 
Mental retardation 
 
 
Complexity of 
medication regime 
(dose, mastery of 
techniques) 
 
Duration of therapy 
 
Lack of immediate 
benefit of therapy 
 
Actual or perceived 
unpleasant side 
effects 
 
Treatment interferes 
with lifestyle/ 
requires sign. 
behavioral changes 
Lack of knowledge 
about the disease 
 
Insufficient 
understanding why 
medication is needed 
 
No perceived benefits 
of treatment 
 
Lack of motivation 
 
Fear of possible 
averse effects/ 
dependence 
 
Frustration with 
health care provider 
 
Stress, anxiety, 
depression 
substance abuse 
Figure 3. Five dimension of adherence to long-term therapies according to WHO (WHO, 2003, pp. 27-30). 
 
2.7 Long-term outcomes after lung transplantation 
In subsequent years following transplantation, patients tend to become more stable and secure 
dealing with medical and psychosocial issues and usually shift their focus towards 
reestablishing normalcy in everyday life. Yet, lung transplant recipients often remain 
chronically ill and the risk of medical complications remains (Goetzmann et al., 2010). Major 
long-term complications that survivors of lung transplantation develop include chronic 
rejection and medical complications that arise as a consequence of immunosuppressive 
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therapy, like renal failure, diabetes, cardiovascular complications like hypertension and 
atherosclerosis, osteoporosis, and malignancies like skin cancer and lympho-proliferative 
disorders (Yusen et al., 2014). Only few longitudinal studies have investigated long-term 
outcomes of HRQoL after lung transplantation. Based upon these results, it appears that, 
beyond 5 years after transplantation, HRQoL outcomes become less predictable. There are 
many lung transplant recipients who ultimately start to experience a decline across several 
dimensions of HRQoL, largely due to an increase in co-morbid conditions and the onset of 
chronic rejection reaction (Rutherford et al., 2005; Vermeulen et al., 2003). Besides, these 
long-term post-transplant complications are associated with an increased risk of emotional 
distress and reduced social function (Rutherford et al., 2005). Future investigations may 
address these limitations of prior research by examining determinants of post-transplant 
HRQoL through prospective longitudinal study designs.    
 
2.8 Mental processing of lung transplantation 
2.8.1 Theoretical concepts  
Despite the potential of lung transplantation to prolong life and to improve health-related 
quality of life, the psychological processes associated with solid organ transplantations 
largely remain unknown. To date, only a few studies have been published investigating the 
mental processing of organ transplants. Most of these studies have relied on psychoanalytic 
concepts to explain what goes on psychologically in patients after they receive their new 
organ. Since the early nineteen seventies, which is when the first successful organ 
transplantations occurred, some investigators have utilized psychoanalytic methods to study 
the psychological implications of organ transplantation in depth, though this has primarily 
been among kidney transplant recipients (Lefebvre, Crombez, & LeBeuf, 1973; Muslin, 
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1971, 1972). In this context, organ integration refers to the mental process of experiencing 
the transplanted organ as part of the person’s self and not as part of the deceased donor or as 
a foreign object (Boothe, Boehler, & Goetzmann, 2013). In postmortem donation, as is the 
case in lung transplantation, the psychological processing includes not only the incorporation 
of an organ extracted from someone else’s body, but also the fact that the organ was donated 
by someone who is now deceased; in other words, for lung transplant recipients to live, 
someone else had to die. In this sense, lung transplantation becomes an extreme experience 
that raises philosophical questions regarding one’s identity of self and the meaning of life 
(Quintin, 2013).  
In accordance with the psychoanalytic conceptualizations of organ integration 
proposed by Muslin (1972) and Lefebvre et al. (1973), Neukom, Corti, Boothe, Boehler, and 
Goetzmann (2012) introduced a psychodynamic model to describe the psychological 
processes that occur in lung transplant patients relative to their organ donor. This proposed 
model has three stages. In the first, called the foreign body stage, self-representation is 
consistent with donor representation, while the lung remains externalized. In this initial phase 
of mental processing, the recipient identifies subconsciously with the unknown donor. In the 
second stage, the transitional stage, the donor and the lung become transitional; i.e., both the 
lung and donor can be experienced simultaneously as both foreign and part of the recipient. 
This means that the lung is perceived to belong to both the donor and the recipient. In the 
final stage, which is called the stage of complete internalization, the graft becomes 
progressively integrated into the patient’s own body image, and thus is gradually accepted as 
part of the patient’s self. In contrast, the donor is moved progressively into an external 
position and is increasingly represented as foreign and distinct from oneself.  
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2.8.2 Empirical findings 
To date, only a few authors have empirically examined the mental processing of lung 
transplant patients. For instance, Goetzmann et al. (2009) reported that 90% of 76 lung 
transplant patients viewed their new lungs as a part of themselves, while 66% mentioned 
frequently thinking about their lung donor, but fewer than 20% believed that they had 
adopted any of the donor’s characteristics. Complementarily, Neukom et al. (2012) examined 
the relationship between lung transplant recipients and their unknown deceased donors. 
Almost all of the study subjects expressed concern over the questions of whether and how 
they were connected with their donor; but only a minority (20%) admitted to having latent 
feelings of guilt related to the deceased donor. Furthermore, Goetzmann et al. (2009) found 
that poor organ integration predicted low rates of adherence to treatment and strong feelings 
of guilt, and that high ratings of donor identification predicted higher levels of psychological 
distress. In addition, patients’ worries concerning the transplant were significantly associated 
with patient feelings of distress (Goetzmann et al., 2010). Conversely, mental processing of 
the transplant was found to be favorable when the graft was perceived as part of the patient’s 
own body (Goetzmann et al., 2009), and when the patient managed to view the donor as 
external (Boothe et al., 2013).  
In conclusion, the findings briefly outlined above suggest that undergoing 
transplantation represents a physical and psychological challenge that can essentially 
modulate a patient’s self-concept and body image. Although these psychological theories 
regarding the processing of a lung transplant are preliminary and few in numbers, they 
contribute to a deeper understanding of the transplant experience. Further investigation is 
needed, however, to confirm and elaborate on these theories. Employing qualitative methods 
could generate further insights into the psychological adjustments to life that occur in lung 
transplant recipients, and the emotional difficulties they face.  
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2.9 Rationale  
Lung transplantation is the only available therapy for patients with end-stage pulmonary 
diseases of different etiologies when other alternative treatment options are no longer 
effective (Hofer et al., 2009). The shortage of suitable donor organs in Switzerland demands 
that patients are selected for lung transplantation only if they are likely to experience a 
survival benefit of the procedure (Hook & Lederer, 2012). However, approximately 20% of 
lung transplant recipients die within the first year after lung transplantation (Inci et al., 2013), 
indicating, that the patient evaluation and selection criteria for lung transplantation failed to 
identify those at high risk for severe early complications. Although the majority of patients 
experience considerably improved psychological well-being and quality of life after 
transplantation, a small proportion of patients experience no significant improvement in their 
health-related quality of life (Yusen, 2011). Typically, most investigators have looked at 
post-transplant outcomes of the entire study group and subgroup analysis for detecting 
patients with poor post-transplant outcomes have rarely been performed. Lastly, the lung 
transplant procedure is associated with complex ongoing medical and psychological 
challenges for patients that start prior to surgery and continue long beyond the first year of 
survival (Rosenberger, Dew, DiMartini, et al., 2012). In this perspective, ongoing research of 
long-term post-transplant outcomes after lung transplantation is both of clinical and scientific 
relevance to evaluate outcomes of lung transplantation, to identify those patients with poor 
post-transplant HRQoL-trajectories, to determine factors that are predictive for postoperative 
complications and to sustain and increase gains related to this procedure by providing 
psychosocial interventions. 
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3 Empirical work 
3.1 Aims and hypotheses 
The overall aims of this thesis were to evaluate health-related quality of life (HRQoL) and 
psychological outcomes after lung transplantation and to investigate psychological 
adjustment to lung transplantation within the first six months post-transplant. To achieve this, 
three separate but related studies were conducted using three distinct methodological 
approaches. The first study was a systematic review of the literature analyzing HRQoL 
outcomes of lung transplantation and the study designs and methodology adopted; the second 
and third were a prospective longitudinal study identifying patients at risk for poor 
postoperative outcomes and a longitudinal qualitative study examining the patients’ 
experience with their transplant and adjustment to normal life, respectively. In the following 
section, the three studies are introduced briefly, together with each study’s rationale and 
aims. 
 
3.1.1 A systematic review of health-related quality of life and psychological outcomes 
following lung transplantation  
The issues of health-related quality of life (HRQoL) and psychological outcomes following 
lung transplantation have been investigated in a number of outcome studies. A variety of 
assessment instruments have been suggested for measuring psychological health outcomes 
after transplantation, but only a small number of investigators have systematically evaluated 
the strengths and limitations of these measures. Moreover, the interpretation of quality of life 
outcomes related to transplantation is often affected by methodological limitations, such as 
bias and unmeasured confounding that might hinder the generalizability of results. We 
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addressed this knowledge gap via a systematic literature review focusing on empirical 
research articles assessing HRQoL and psychological outcomes in adult lung transplant 
recipients. The objectives of this review were 1) to determine which validated self-report 
instruments are being used in the literature to assess HRQoL and psychological outcomes 
after lung transplantation; 2) to explore the study designs and methodology used; 3) to review 
the instruments and outcomes that have been utilized most frequently; and 4) to provide 
recommendations for selecting appropriate outcome measures. By systematically analyzing 
post-transplant outcomes regarding HRQoL and psychological outcomes, identifying 
understudied thematic areas and knowledge gaps for future research, this study provided an 
important bases for the following two empirical work.   
 
3.1.2 Psychological distress and quality of life in lung transplant patients. A six months 
observational study 
Lung transplantation aims not merely to prolong recipients’ lives and reduce disability, but 
also to improve health-related quality of life (HRQoL). However, lung transplant recipients 
are a heterogeneous group, and do not necessarily experience the same improvements in 
health status. In the medical literature, the post-transplant HRQoL trajectories of lung 
transplant recipients and predictors of post-transplant HRQoL are not well described. An 
improved understanding of the magnitude and durability of HRQoL following lung 
transplantation has important clinical and research implications. To bridge the existing 
research gaps, the aims of this study were threefold: 1) to assess psychosocial outcome 
trajectories in lung transplant recipients related to psychological distress and HRQoL over the 
first six months post-transplant, 2) to identify patients with poor post-transplant trajectories, 
and 3) to determine potential predictors of psychological distress and poor HRQoL at six 
months post-transplant. It was hypothesized that HRQoL will improve within the first six  
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months post-transplant but that not all patients will show the same degree of HRQoL 
improvements after lung transplantation.  
 
3.1.3 Early postoperative adjustment to lung transplantation. A longitudinal qualitative study 
While several published studies have focused on the quantitative assessment of post-
transplant HRQoL, only a few have qualitatively examined the experience of transplantation 
and the impact this procedure has on patients’ everyday lives. Qualitative data analysis is 
generally considered a powerful tool for studying the complexities of human experiences 
within a specific research field (Anderson, 2010). Our aim in this last study was, therefore, to 
delve deeper into patients’ experiences with their transplant and adjustment to normal life 
within the first six months of the procedure utilizing a qualitative approach. We used semi-
structured interviews to specifically explore the thoughts, feelings and attitudes of lung 
transplant recipients with respect to the transplantation process, their new lungs, the organ 
donor, and their medication regimen over their first six months post-transplant. A more 
comprehensive understanding of the issues that patients consider important in the early 
postoperative phase could improve clinical decision-making and interventions. It was 
hypothesized that the frequency of comments of most codes will diminish within the first six 
months post-transplant and that gender differences in response rate can be observed.  
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4.1 Abstract 
Background: Lung transplantation (LTx) aims to reduce physical disability and mental 
distress, extend survival, and improve health-related quality of life (HRQoL). This systematic 
review aimed 1) to augment evidence regarding measures to assess HRQoL and 
psychological outcomes following lung transplantation (LTx), and 2) to summarize HRQoL 
and psychological outcomes after LTx.  
Methods: Validated and standardized instruments with well-known psychometric properties 
used for assessing HRQoL and psychological outcomes after LTx were identified by means 
of comprehensive literature searches of Psychinfo and Medline/PubMed, up through March 
2014, using the following search terms in various combinations: lung transplantation, 
physical functioning, symptom experience, mental health, anxiety, depression, distress, social 
functioning, life satisfaction, and health-related quality of life. 
Results: The search strategy identified 371 titles and abstracts. Of these, 279 were retrieved 
for further assessment and 63 papers selected for final review. Thirty-nine studies were found 
for HRQoL, 15 for physical functioning, 5 for mental health, and 4 for social functioning. A 
total of 50 psychometric instruments were encountered.  
Conclusions: Considerable heterogeneity exists in methodology, operational concepts and 
applied outcome measures in the existing literature on HRQoL and psychological outcomes 
after LTx. Nevertheless, those studies generally point to significant improvements in both 
mental health and HRQoL post transplant. Further research clearly is warranted utilizing 
consistent outcome measures, including LTx-specific measures, and longitudinal study 
designs.  
Study registration: PROSPERO CRD42013006204. 
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4.2 Introduction 
Among the multiple aims of lung transplantation (LTx), the most important are to reduce 
disability, extend survival, and improve health-related quality of life (HRQoL) (Kugler et al., 
2007; Munro, Holland, Bailey, Button, & Snell, 2009; Rodrigue, Baz, Kanasky, & 
MacNaughton, 2005). Traditionally, patient survival has been the primary LTx outcome 
measured. With improved survival rates, however, post-transplant HRQoL has become an 
important component of any evaluation of benefits. Furthermore, lung transplant patients 
within different diagnostic groups do not necessarily experience the same survival benefits or 
exhibit the same post-transplant trajectories (Yusen et al., 2014). Therefore, it is clinically 
important to assess postoperative HRQoL and mental health, as well as to identify those 
patients at risk for poor post-transplant outcomes.  
In transplant medicine, a variety of assessment instruments have been suggested, 
though there is no standard inventory to formally evaluate health-related quality of life 
(HRQoL) or psychological outcomes after lung transplants. An overview of existing self-
report diagnostic instruments would assist researchers and clinicians in choosing the most 
appropriate psychometric instruments for assessing post-transplant outcomes in lung 
transplant populations. However, as yet, only a small number of authors have evaluated the 
relative merits of specific outcome screening instruments after organ transplantation of any 
kind (Cleemput & Dobbels, 2007; Goetzmann, Klaghofer, Spindler, et al., 2006; Klaghofer et 
al., 2008; Singer et al., 2013; Yusen, 2011). A comprehensive systematic review was 
presented by Singer et al., (2013) which thematically assessed published studies of HRQoL in 
lung transplant patients. However, scientific articles on mental and psychosocial health of 
LTx-recipients were not considered in this report. To address this knowledge gap, this paper 
systematically focuses on published empirical studies of HRQoL and psychological outcomes 
among adult lung transplant recipients. According to the definition of health, which was 
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mandated by the World Health Organization as “a state of complete physical, mental, and 
social well-being and not merely the absence of disease or infirmity” (WHO, 1948), we 
directed our analyses towards the three HRQoL-domains physical functioning, mental health, 
and social functioning. We considered this multidimensional approach essential to adequately 
evaluating the postoperative clinical management of adult lung transplant recipients. 
Moreover, these three HRQoL-domains have generally been considered when investigating 
postoperative outcomes after solid organ transplants (Cleemput & Dobbels, 2007; De Geest 
et al., 2013; Dew et al., 2000).  
The overall purposes of this systematic review were 1) to determine which validated 
self-report instruments are being used to assess HRQoL and psychological outcomes after 
lung transplantation; 2) to explore the study designs adopted for the eligible studies; 3) to 
review outcomes among those instruments that have been utilized most frequently; and 4) to 
provide recommendations for selecting appropriate outcome measures. 
 
4.3 Methods 
By systematic literature review, validated and standardized outcome measures with well-
known psychometric properties were identified that had been applied to evaluate HRQoL and 
psychological outcomes following lung transplants. Data extraction and the study review 
process were conducted following the guidelines of the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) (Moher, Liberati, Tetzlaff, & Altman, 
2010). In accordance with these guidelines, our systematic review protocol was registered 
with the International Prospective Register of Systematic Reviews (PROSPERO) 
(registration number: CRD42013006204).  
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4.3.1 Search strategy 
A comprehensive literature search was performed to identify scientific studies that included 
at least one measure of HRQoL and/or psychological outcome after lung transplantation. For 
the purposes of this review, physical functioning was defined in terms of the level of physical 
activity in daily life, symptom experiences (pain), and the physical side effects of 
immunosuppressant medication. Mental health was considered the patient’s levels of anxiety, 
depression and/or psychological distress; and social functioning was characterized in terms of 
the patient’s quality of relationships, social support, and level of life satisfaction. A 
systematic search of electronic databases, including Psychinfo and Medline/PubMed, was 
conducted from inception to March 2014. Keywords used for the search included lung 
transplantation, physical functioning, symptom experience, mental health, anxiety, 
depression, distress, social functioning, life satisfaction, and health-related quality of life. 
 
4.3.2 Eligibility criteria 
English- and German-language studies were eligible if they examined any form of HRQoL or 
psychological outcome of lung transplant recipients, in terms of physical functioning, 
psychological functioning, and/ or social functioning using standardized validated 
instruments. Considered for inclusion were also studies on pre- versus post-comparison of 
lung transplant patients. Only studies involving patients who were adults (≥ 18 years old) at 
the time of lung transplantation were included. Studies were excluded if they involved solely 
lung transplant candidates (i.e. patients referred for lung transplant), pediatric lung transplant 
recipients, or recipients of additional solid organ transplants, such as stem cells, bone 
marrow, liver, kidney, heart or heart-lung. Moreover, systematic reviews, meta-analyses, 
qualitative studies, and case-study investigations were excluded, as were unpublished 
manuscripts, Master’s or Doctoral theses, books and book chapters, studies for which only 
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abstracts were available, and studies for which data collection methods were not adequately 
reported.  
 
4.3.3 Data selection and extraction 
The first stage of paper selection was based upon titles and abstracts. Full-text articles were 
obtained for all abstracts meeting the inclusion criteria for further evaluation, and for articles 
that could not be rejected with certainty. The reference lists of papers meeting the eligibility 
criteria were screened for additional relevant papers that may have been missed by our 
electronic searches. Two researchers (A.S. and M.T.) independently evaluated the selection 
of eligible papers following the inclusion and exclusion criteria. In cases of disagreement, 
consensus was achieved by discussion. The process of study selection is outlined in Figure 4. 
The evaluation of data was processed by means of qualitative description. Results were 
summarized in tables and presented in a narrative form.  
 
4.4 Results 
The search strategy identified 371 titles and abstracts. Of these, 279 were retrieved for further 
assessment and 63 papers selected for inclusion in the final review. All eligible articles were 
published between 1994 and 2013.  
 
4.4.1 Study characteristics 
Study designs used in the 63 eligible studies were not always reported clearly. The majority 
of the papers (54%) used a cross-sectional study design that predominantly assessed lung 
transplant patients twelve months postoperative or later (68%). The duration of follow-up 
ranged from six months to 8.5 years post transplant. The average sample size across all 
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studies was 80.1 (range: 10 - 287) participants. Examination of the studies that described 
participants’ age ranges revealed an average participant age of 46.1 years (age range: 29 –
years). Fifty-two percent of the participants across the 63 studies were male. The most 
frequent underlying diagnosis for lung transplantation was chronic obstructive pulmonary 
disease (COPD) (37.8%), followed by cystic fibrosis (35.6%) and idiopathic pulmonary 
fibrosis (17.7%). Nine percent of the patients suffered from primary pulmonary hypertension 
and 19.9% suffered from some other disease. The studies included in the review are 
summarized in Table 2. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Figure 4. Search retrieval process  
Full text analyses (n = 279) 
Included studies from query: n = 63 
Exclusions (n = 216) 
 
1.  Methodological issues (case 
reports, qualitative studies, reviews, 
commentary (n=16) 
2.  Only abstract available (n= 15) 
3.  Patients referred for LTx (LTx-
candidates) (n = 53) 
4.  Paediatric LTx-candidates and 
recipients ( n= 28) 
5.  LTx-recipients of stem-cells, bone 
marrow, liver, kidney, and heart 
TPL (n= 16) 
6.  Caregiver of LTx-patients (n= 6) 
7.  Not concerning the study topic (n= 
82) 
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4.4.2 Outcome measures 
All studies included in our analysis used at least one psychometric instrument. A variety of 
outcome measures were administered: 50 different psychometric measures in total. Of 13 
different HRQoL outcome measures identified, the 36-Item Short Form Health Survey (SF-
36) (Ware & Sherbourne, 1992) was the most commonly used (19 studies). Standardized 
questionnaires were rarely used to evaluate physical functioning-related issues, like pain or 
symptom occurrence; only seven standardized questionnaires were encountered. Physical 
functioning was more commonly assessed by means of one or more exercise tolerance tests. 
The most frequent self-reported instrument applied to measure physical functioning was the 
Karnofsky Performance Status Scale (seven studies) (Karnofsky & Burchenal, 1949). 
Twenty-one different outcome measures were identified assessing mental health, the most 
frequently-used measure being the State-Trait Anxiety Inventory (STAI; 9 studies) (Spielberg 
& Vagg, 1980), followed by the Hospital Anxiety Depression Scale (HADS; 8 studies) 
(Zigmond & Snaith, 1983). Six different instruments rated social function, the most often 
used instrument being the Short-Form Social Support Questionnaire (F-SoZu) (Sommer & 
Fydrich, 1998); however, this was utilized in only three studies. The psychometric 
instruments used in the eligible studies to assess HRQoL and psychological outcomes of lung 
transplant recipients are summarized in Table 3.  
 
4.4.3 HRQoL and psychological outcomes after LTx 
Health-related quality of life after LTx 
The majority of the studies (n = 32) investigating HRQoL after lung transplantation 
demonstrated a significant improvement in almost all HRQoL domains, except pain, within 
the first three years post-transplant (Finlen Copeland et al., 2013; Gerbase et al., 2005; 
Kunsebeck et al., 2007; Vermeulen et al., 2004). Some authors even reported the HRQoL of 
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transplant recipients to become comparable to that of the general population (Stavem et al., 
2000; Vermeulen, van der Bij, Erasmus, & TenVergert, 2007). More specifically, 
improvements in SF-36 domains were primarily related to better overall general health, 
physical health, vitality, and social functioning, fewer role limitations due to physical health, 
and total HRQoL (Archonti et al., 2004; Cohen, Littlefield, Kelly, Maurer, & Abbey, 1998; 
Limbos, Chan, & Kesten, 1997; Limbos et al., 2000; Rodrigue, Baz, Kanasky, et al., 2005; 
Rutherford et al., 2005; Stavem et al., 2000). Improvements reported in the Nottingham 
Health Profile (NHP) domains within the first 12 months post transplant included gains in 
mobility, energy, sleep, and activities of daily life, as well as less dyspnea (TenVergert et al., 
1998; Vermeulen et al., 2003; Vermeulen et al., 2004). Gender differences in HRQoL 
improvements post transplant were revealed by three different studies (Limbos et al., 1997; 
Rodrigue, Baz, Kanasky, et al., 2005; Santana et al., 2012) in which women reported more 
frequent and problematic post-surgery symptoms and a lower percentage gain in HRQoL 
than men.  
 
Longitudinal studies of HRQoL  
Only a small number of studies was identified examining HRQoL in patients surviving more 
than three years post-transplant (Kugler et al., 2005; Rutherford et al., 2005; Stavem et al., 
2000; Vermeulen et al., 2003). As such, the trajectory beyond three years post-transplant 
appears to remain uncertain, mostly due to the lack of data. At 38 months post-surgery, 
Stavem et al. (2000) reported significantly better scores in all SF-36 domains. In contrast, 
Vermeulen et al. (2003), investigating recipients 55 months post-transplant, observed a 
decline in several dimensions of HRQoL due to an increase in co-morbid conditions and the 
incidence of bronchiolitis obliterans syndrome (BOS). Similarly, in patients living 5 to 6 
years with their allograft, Kugler et al. (2005) noted significantly reduced HRQoL across all 
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subscales, except social functioning; reduced HRQoL was associated with BOS. Finally, 
Rutherford et al. (2005) reported significantly lower scores for the SF-36 parameters physical 
functioning, role-emotional, and general health, as well as considerably lower energy and 
social functioning among lung transplant recipients surviving 10 years postoperatively, 
relative to the normative population.  
 
Predictors of HRQoL after LTx 
BOS was the strongest determinant of physical health status, its presence associated with 
reduced energy, mobility and well-being (Kugler et al., 2005; Santana et al., 2012; 
Vermeulen et al., 2003; Vermeulen et al., 2007). Additionally, the side effects of 
immunosuppressants significantly impaired HRQoL (Smeritschnig et al., 2005). In a similar 
vein, pain was found to significantly reduce HRQoL and to increase depressive symptoms 
(Girard et al., 2006). However, pain was more prevalent in older recipients with unilateral 
transplants and in those with emphysema (Girard et al., 2006; Vasiliadis, Collet, & Poirier, 
2006). Further predictors of poor HRQoL were cystic fibrosis, a single lung transplant, older 
age at the time of transplantation, and recurrent infections (Kugler et al., 2005). Only a single 
study failed to identify a negative influence of incidence BOS or poor FEV1 recovery (forced 
expiratory volume in 1 second) on subjective HRQoL after LTx (Gerbase et al., 2005). 
Perceived social support was positively associated with HRQoL and psychological well-
being (Archonti et al., 2004). Lastly, an older study by Cohen et al. (1998) revealed sleep 
disturbances as a mediator between pre-transplant anxiety and post-transplant adjustment and 
HRQoL. 
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4.4.4 Physical functioning after LTx 
Pain 
The prevalence of postsurgical pain in LTx-recipients was 49% three months after 
transplantation in a study investigating health-related outcomes (Girard et al., 2006). 
Characteristically, patients with pain were older, more likely to have undergone a unilateral 
transplant, and more likely to have emphysema. According to Girard et al. (2006), 28% never 
used analgesics to control pain, whereas 38% used analgesics irregularly and 34% used them 
on a daily basis. Thirty-nine months postoperatively, 18% of transplant recipients reported 
persistent pain and, of those, 71% admitted to using a mild analgesic (Wildgaard, Iversen, & 
Kehlet, 2010). Patients with postsurgical pain also experienced pain in some other part of 
their body. The majority experienced pain when carrying heavy bags, working, and 
performing other strenuous activities, but also while driving, cooking, doing office work, and 
sitting down for more than 30 minutes. Pain was perceived to interfere with life in roughly 
50% of the respondents with pain, while sleep and HRQoL were disturbed in 57% and 54%, 
respectively (Wildgaard et al., 2010). 
 
Physical symptoms experienced after LTx 
Post-transplant, patients reported improved shortness of breath with activity 3, 9 and 12 
months after LTx and at rest, and less fatigue three months post-transplant. Despite these 
significant improvements, new symptoms occurred post-operatively, including distressful 
nausea, changes in taste, tremors, vomiting, stomach pain, and burning or numbness in the 
hands and/or feet, three and six months after surgery (Lanuza et al., 2012). Similar 
observations were reported by Dobbels et al. (2008) and Kugler et al. (2007). Both authors 
reported tremors (70%), hirsutism (68%), a Cushingoid appearance (39%), and muscle 
weakness (32%) as the most frequently-reported symptoms three months after the transplant. 
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Furthermore, women and younger patients reported significantly more frequent bodily 
symptoms and greater levels of symptom-induced distress than men (Dobbels et al., 2008; 
Kugler et al., 2007). Patients, and especially men suffering from adverse drug effects, 
admitted often attempting to reduce medication-related sides effect by postponing their 
medication intake (30%), or by either dropping (8%) or reducing doses (9%) (Kugler et al., 
2007). Olfactory performance was significantly below average in randomly selected 
outpatient LTx-recipients (Irani et al., 2010).  
 
Impact of physical symptom experience on mental health and HRQoL 
The experience of physical symptoms negatively influenced HRQoL across all dimensions 
(Kugler et al., 2007). Immunosuppression-induced adverse effects negatively influenced 
patient perceptions of HRQoL. Patients with BOS mentioned significantly more restrictions 
in the NHP dimensions of physical mobility and energy; this effect was noted 7, 19, 25, and 
31 months after surgery. Moreover, physical symptoms negatively impacted mental health 
(Kugler et al., 2007). Correspondingly, the average BDI score was higher among patients 
with pain (Girard et al., 2006). Similarly, patients with BOS reported significantly more 
depressive symptoms and anxiety, both one and two years after the transplant (Van Den et 
al., 2000). Also, the new-onset of diabetes after LTx was associated with psychological strain 
(Kugler et al., 2007). However, state anxiety was not different in patients with versus without 
pain (Girard et al., 2006). Conversely, patients with depressive symptoms tended to 
experience greater symptom occurrence and higher levels of symptom-related distress 
(Dobbels et al., 2008). 
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4.4.5 Mental health of LTx-recipients 
The most common psychiatric disorders found in lung transplant recipients that occurred 
primarily within the first year post-transplant were major depression (26-30%), panic 
disorder, adjustment disorders, and generalized anxiety disorders (Dew et al., 2012). Two 
studies found that pre-transplant depressive disorders did not predict survival after 
transplantation (Evon, Burker, Galanko, Dedert, & Egan, 2010; Woodman et al., 1999).  
 
Longitudinal studies of mental health outcomes after LTx 
Only one long-term study was identified that investigated mental health as long as 55 months 
after lung transplantation. According to Vermeulen et al. (2003), improvements in most 
mental health dimensions, including lower anxiety and depression levels and improved well-
being, were apparent until approximately 43 months after the transplant. However, beyond 43 
months, patients again started to experience increased anxiety and depression levels and 
reported lower levels of well-being, mostly due to renal failure, diabetes, drug-treated 
hyperlipidemia, and the onset of BOS.  
 
Predictors of mental health  
Pre-transplant risk factors for the onset of anxiety and depression during the first two years 
after transplant included a combination of pre-transplant psychiatric history, female gender, a 
longer wait for transplantation, early post-transplant health problems, and psychosocial 
characteristics - like poorer caregiver support and avoidant coping (Dew et al., 2012). 
However, psychiatric diagnosis pre-transplant did not appear to worsen post-surgical survival 
(Evon et al., 2010; Woodman et al., 1999). 
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4.4.6 Social functioning after lung transplantation 
Only three eligible studies addressed the psychosocial health of lung transplant recipients 
(Archonti et al., 2004; De Vito Dabbs et al., 2013; Goetzmann et al., 2005). Social support 
was found to be positively associated with HRQoL and inversely associated with levels of 
depression; and, when social support was perceived as positive, the risk of psychopathology 
was reduced (Archonti et al., 2004). While patient self-esteem was significantly related to 
social support (Goetzmann et al., 2005), low self-care agency was associated with 
significantly poorer caregiver relationship quality and more psychological distress. 
Accordingly, the quality of caregiver relationships was a significant predictor of postsurgical 
anxiety and depression (De Vito Dabbs et al., 2013). 
 
4.4.7 Psychometric properties of articles included 
The quality of the reporting and extent of psychometric assessment of the outcome measures 
varied. Relatively few studies (n= 7) indicated the psychometric properties of the instruments 
used in the lung transplant population (see Table 3), with Cronbach’s alpha ranging between 
.65 and .96. In the eligible studies, no transparence was given regarding any a priori power 
calculation to estimate the required sample size to satisfy study objectives. 
 
4.4.8 Major limitations of eligible studies  
Severe methodological limitations were encountered in almost all eligible studies, including 
selection/survivor bias (90%), the use of cross-sectional versus longitudinal designs (56%), 
heterogeneous group/confounding variables (46%), missing data (22%), small sample sizes 
(19%) that limited both statistical power and generalizability, short follow-up time (16%), 
and the lack of control/comparison groups (12%) (see Table 2). 
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Table 2. Summary of studies included in the review  
 Author, date Title Study design Sample Size Outcome measures Outcome Methodological limitations 
HRQoL Anyanwu et al., 2001  Assessment of quality of life in 
lung transplantation using a 
simple generic tool. 
Cross-sectional study design 
(candidates vs. recipients 6M – 
3 yr after LTx) 
 
255 EQ-5D 61% of LTx-candidates reported extreme 
problems in at least one EQ-5D-
dimension compared with 20% of single 
und 4% of bilateral LTx-recipients ≥ 3yr 
post-transplant. EQ-5D was a simple 
method for deriving a single utility value 
for HRQoL and was responsive to 
changes after LTx. 
 
Confounding variables 
(heterogeneous population) 
Cross-sectional study design 
Survivor bias 
 Archonti et al., 2004  
 
Physical quality of life and social 
support in patients on the waiting 
list and after a lung 
transplantation.  
Cross-sectional study design 
(candidates vs. recipients 5 – 
47M after LTx) 
20 BDI 
F-SoZu  
SF-36  
 
Sign. improvements post LTx were 
observed in physical functioning, vitality, 
health perception and social functioning. 
The perceived support correlated 
negatively with the level of depression. 
 
Cross-sectional study design 
Small study cohort 
Survivor bias 
Confounding variables 
(heterogeneous population) 
 
 Buschbach et al., 1994  Measuring the quality of life 
before and after bilateral lung 
transplantation in patients with 
cystic fibrosis 
 
Retrospective study design 
(12,14, 16M after LTx) 
6 Karnofsky Performance 
Index 
NHP 
VAS 
The preliminary results suggested that the 
improvements of quality of life for 
patients with cystic fibrosis after bilateral 
lung transplantation was comparable to 
the improvement of quality of life after 
heart transplantation. 
 
Small study sample 
Retrospective study design 
Survivor bias 
 Cohen et al., 1998  
 
Predictors of quality of life and 
adjustment after lung 
transplantation.  
Cross-sectional study design 
(candidates vs. LTx-recipients 
> 6M) 
60 BDI 
BPI (Basic Personality 
Inventory) 
MHI 
SF-36 
STAI  
 
 
Anxiety and psychopathology were found 
to predict post-transplant adjustment; 
greater pre-transplant anxiety predicted 
worse post-transplant HRQoL. Subjective 
sleep disturbances were associated with 
poorer adjustment and HRQoL. 
 
Cross-sectional study design 
Confounding variables 
(heterogeneous population) 
Missing data 
Survivor bias 
 Eskander et al., 2011  BODE index and quality of life 
in advanced chronic obstructive 
pulmonary disease before and 
after lung transplantation 
 
Prospective longitudinal study 
design (before vs. ± 4M pLTx) 
112 SGRQ 
SF-36 
VAS 
BODE was directly associated with 
SGRQ and inversely related to all other 
HRQoL measures (p < 0.05). Early post-
transplant improvements in HRQoL were 
also seen across the spectrum of BODE 
scores from 5 to 10. 
 
Short follow-up time 
Selection bias 
 Finlen Copeland et al., 
2013  
Impact of Lung Transplantation 
on Recipient Quality of Life 
 
Multicenter, prospective 
randomized longitudinal study 
(3, 6, 9, 12M after LTx) 
131 SF-36 Over the first year after lung 
transplantation, the SF-36 Physical 
Component Score significantly increased 
whereas the Mental Component score did 
not change from baseline.  
  
Missing data 
Survivor bias 
Short follow-up time 
 
 
 
 
 
Gerbase et al., 2005  
 
Health-related quality of life 
following single or bilateral lung 
transplantation: a 7-year 
comparison to functional 
outcome. 
Longitudinal follow-up study 
for 2 years after LTx 
44 FEV1 
SGRQ 
VAS 
6MWD  
 
 
Sign. improvements on the FEV1, 
6MWD and SGRQ were observed after 
LTx. Increased risk for patients with 
single LTx for lower FEV1 and increased 
risk for BOS was observed. 
 
Selection bias 
Missing data 
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Gerbase et al., 2008  
 
Long-term Health-related Quality 
of Life and Walking Capacity of 
Lung Recipients With and 
Without Bronchiolitis Obliterans 
Syndrome. 
 
Prospective longitudinal study 
followed (3, 6, 9, 12, 18, 24M 
after LTx) 
58 Record of clinical 
complications 
SGRQ 
6MWD 
 
 
 
BOS was a sign. predictor of lower 
SGRQ and reduced time free of clinical 
complications, but not of 6MWT. 
Survivor bias,  
Missing data 
Confounding variables 
(heterogeneous group) 
 Girard et al., 2006  
 
Prevalence and Impact of Pain on 
the Quality of Life on Lung 
Transplant Recipients.  
Cross-sectional study design; > 
3M after LTx 
96 BDI 
BPI (Brief Pain Inventory) 
SF-36 
STAI 
 
The prevalence of pain in LTx-recipients 
was 49%. Patients with pain were older, 
more likely to have undergone unilateral 
LTx, and more likely to have 
emphysema. BDI was higher for patients 
with pain. No sign. difference was found 
regarding anxiety. Pain-free patient had 
sign. higher physical component score in 
the SF-36. 
 
Cross-sectional study design 
Confounding variables 
(heterogeneous group) 
Survival bias 
 
 Goetzmann et al., 2008  Psychological response and 
quality of life after 
transplantation: a comparison 
between heart, lung, liver and 
kidney recipients. 
 
Cross-sectional study design (≤ 
20 yr after LTx) 
76 SF-36 
TxEQ 
 
72% of patients developed a feeling of 
responsibility for the received organ. 
Conscious feelings of guilt and shame 
were harbored by only a minority of 
patients. Lung transplant patients showed 
significantly better adherence and worry 
less about their transplant. 
 
Cross-sectional study design 
Selection bias 
Missing data 
 Gross et al., 1995  
 
Long-term health status and 
quality of life outcomes of lung 
transplant recipients. 
Prospective follow up study 
(before and 6 and 12M after 
LTx) 
18 IWB 
Karnofsky Performance 
Index 
MOS 20 
 
 
While LTx-candidates reported poor day-
to-day functioning, LTx-recipients were 
able to carry on normal activities 
(although with symptoms) but required 
occasional assistance from others. Also, 
LTx-recipients reported better 
functioning on the Karnofsky index and 
in every MOS dimension (p<.001).  
 
Short follow-up time 
Confounding variables 
(variance in follow-up time 
and sample size pre vs. post-
transplant) 
Selection bias 
 Ihle et al., 2011  
 
Effect of inpatient rehabilitation 
on quality of life and exercise 
capacity in long-term lung 
transplant survivors: a 
prospective, randomized study. 
Cross-sectional study design: 
inpatient rehabilitation program 
vs. medical standard therapy 
(4.5 ± 3.5yr after LTx) 
60 Cardiopulmonary exercise 
testing 
SF-36 
SGRQ 
Quality of Life Profile for 
Chronic Diseases 
questionnaire 
6MWD 
 
 
Both group sing. improved their maximal 
exercise capacity. In both study groups, 
HRQoL tended to improve. Sign. 
correlations were found for exercise 
capacity and HRQoL scales. 
Cross-sectional study design 
Confounding variables 
(temporal variation in data 
collection) 
Selection bias 
Lack of control group 
 Irani et al., 2006  Lung transplant recipients 
holding companion animals: 
impact on physical health and 
quality of life. 
Cross-sectional study design 89 FLZM 
HADS 
LOT 
F-SoZu 
In lung transplant recipients keeping pets 
the frequency of somatic complications 
was not higher compared to lung 
transplant recipients without pets. After 
LTx, pets were associated with a better 
HRQoL.  
 
Cross-sectional study design 
Survival / selection bias 
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 Kugler et al., 2005  
 
Health-related quality of life in 
two hundred-eighty lung 
transplant recipients. 
Cross-sectional study design, 
including LTx-recipients from 
3 to 14yr after LTx. 
280 Quality of Life Profile for 
Chronic Diseases 
Sign. reduced HRQoL was reported by 
patients living 5 to 6 yr with the allograft 
for all subscales, except for social 
functioning and was associated with 
incidence of BOS. CF-patients, patients 
with single LTx and patients of older age 
showed sign. decreased physical ability 
ratings. 
 
Non-randomized retrospective 
study design 
Confounding variables 
(heterogeneous group) 
 Kugler et al., 2007  Symptom experience after lung 
transplantation: impact on quality 
of life and adherence 
 
Cross-sectional study design, 
including LTx-recipients ≥ 3M 
after LTx 
287 Quality of Life Profile for 
Chronic Diseases 
Self-developed questionnaire 
with 91 items regarding 
adherence and symptom 
experience  
 
Women and younger patients reported a 
significantly higher level of symptom 
experience compared with their 
counterparts respectively. Symptom 
experiences negatively influenced 
HRQoL in all dimensions. Those who 
described experiencing adverse effects 
reported significantly more ‘‘drug 
holidays’’. 
 
Cross-sectional study design 
Selection bias 
Confounding variables 
(heterogeneous study group:  
single vs. bilateral LTx) 
 Kunsebeck et al., 2007  
 
Quality of life and bronchiolitis 
obliterans syndrome in patients 
after lung transplantation. 
Cross-sectional study design 
post LTx (> 1yr post LTx) 
119 BAI 
Center for Epidemiologic  
Studies-Depression Scale 
SF-12 
Zerssen List of Complaints 
 
41% of LTx-recipients developed BOS at 
5.6 yr after LTx. Actuarial freedom from 
BOS was 90% at 1 yr, 80% at 3 yr, and 
60% at 5yr after LTx. Recipients with 
BOS reported sign. lower well-being and 
HRQoL than those without BOS. Body 
functioning was mostly affected by BOS. 
 
Cross-sectional study design 
Selection bias 
Confounding variables 
(heterogeneous group: single 
vs. bilateral LTx) 
 Lanuza et al., 2000  
 
Prospective study of functional 
status and quality of life before 
and after lung transplantation. 
Longitudinal, repeated measure 
design (before, 1M and 3M 
after LTP) 
10 BSI 
SIP-136  
The General Health/QOL 
Rating Scale 
 
Post-transplant, patients reported sign. 
improvement with physical strength, 
current health, and HRQoL. Dramatic 
improvements in pulmonary function 
(FVC, FEV1 at 25 to 75%) were 
observed. The total number of 
psychological problems did not decrease 
sign. over time.  
 
Short-follow up time 
Small sample size 
 Limbos et al., 1997  
 
Quality of life in female lung 
transplant candidates and 
recipients. 
 
 
 
 
 
 
Cross-sectional study design (> 
6M after LTx) 
34 BCSC  
DSFI  
HADS 
RSEC  
SF-36  
 
No differences were found for emotional-
well-being, role limitations due to 
emotional health and social functioning. 
Significant differences were found 
between pre and post body satisfaction 
scores. The Pre group reported higher sex 
drive. 52% of the LTx-recipients scored 
below the 10th percentile in overall sexual 
functioning. 
 
Cross-sectional study design 
Selection bias 
Small sample size 
Lack of comparison group 
 Limbos et al., 2000  
 
Psychological functioning and 
quality of life in lung transplant 
candidates and recipients. 
Cross-sectional study design (> 
6M post LTx; candidates vs. 
recipients) 
73 BSI 
BCSC  
DSFI 
HADS 
RSES 
SF-36  
VAS 
 
Post LTx-patients had sign. better score 
on the SF-36 subscales physical health, 
role limitations and social functioning, 
visual analog scale, BSI, HADS. Many 
patients continued to experience 
impairments in psychological 
functioning.  
 
Cross-sectional study design 
Confounding variables 
(variance in sample size: 36 
candidates vs 73 recipients) 
Selection/ survival bias 
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 Lobo et al., 2004  Estimation and comparison of 
derived preference scores from 
the SF-36 in lung transplant 
patients. Quality of life research: 
an international journal of quality 
of life aspects of treatment, care 
and rehabilitation. 
 
Cross-sectional study design (≥ 
6M post LTx) 
99 CES-D Scale 
DS  
IIRS 
PS (Pulmonary Scale) 
SDS  
SF-36 
VAS 
 
 
Three practical methods of deriving 
preference scores form existing SF-36 
data (1. Fryback et al., 2. Nichol et al., 3. 
Brazier et al.) were compared. Any of the 
3 methods would detect differences in 
health states between groups. All 3 
methods provide compatible findings and 
yield scores with good construct validity.  
 
Cross-sectional study design 
Selection bias 
 Matthees et al., 2001  Use of complementary therapies, 
adherence, and quality of life in 
lung transplant recipients 
 
Cross-sectional study design (≥ 
6M post LTx) 
99 Self-report measure of 
medication adherence 
SDS 
The majority used at least 1 form of 
complementary and alternative medicine 
(CAM). Prayer, support groups and 
relaxation techniques were the most 
common. CAM users were adherent to 
their transplant regimen. Education, high 
symptom burden, female sex, and 
depression symptoms were associated 
with various types of CAM use. 
 
Cross-sectional study design 
Survival/ selection bias 
Confounding variables 
(heterogeneous study groups: 
comparison group was small; 
n = 11) 
 
 Rodrigue et al., 2005  
 
Does lung transplantation 
improve health-related quality of 
life? The University of Florida 
experience. 
Repeated measure design 
(before and ≥ 6M after LTP) 
66 FEV1 
SF-36 
TSFQ  
6MWD 
 
Significant improvements of HRQoL, 
FEV1 and 6MWD after LTx. Patient with 
longer time since LTx reported more 
frequent and problematic symptoms 
commonly associated with 
immunosuppression. 
 
Selection bias 
Confounding variables  
(heterogeneous study group: 
comorbidities, medical 
condition) 
 Rodrigue et al., 2006  
 
Are there sex differences in 
health-related quality of life after 
lung transplantation for chronic 
obstructive pulmonary disease? 
Repeated measure design. 
HRQoL before and after LTx 
(≥ 6M after LTx) 
37 FEV1 
SF-36  
TSFQ 
6MWD 
 
Substantial improvements in HRQoL, 
lung function, physical endurance for 
most patients. Women reported more 
frequent and problematic symptoms and a 
lower percentage gain in HRQoL than 
men. 
 
Selection bias 
 Rutherford et al., 2005  
 
Functional status and quality of 
life in patients surviving 10 years 
after lung transplantation.  
Cross-sectional study design 
(10 yr post TPL.) 
28 SF-36 29% of patients survived > 10 yr post 
LTx. Long-term survival after LTx was 
characterized by an absence or delayed 
development of BOS, low iatrogenic 
morbidity and a preserved mental, but 
reduced physical health status. 
 
Survival/ selection bias 
Small sample size 
 
 Santana et al., 2009  
 
Improvement in health-related 
quality of life after lung 
transplantation.  
Prospective longitudinal study 
(before, 3 and 6M after LTx) 
36 HADS 
HUI3  
Morisky’s and Godin’s 
Questionnaire  
 
The mean overall HUI3 scores were 
lower for LTx-candidates than recipients 
at 6M post LTx. Sign. results were found 
for HADS post-transplant. After 6M, 
LTx-recipients were more adherent to 
medication. 
 
Small sample size 
Selection/ survival bias 
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 Santana et al., 2012  
 
Patient-reported outcome 2 years 
after lung transplantation: does 
the underlying diagnosis matter? 
Cross-sectional study at 2yr 
post LTx 
214 HUI3 COPD and CF-patients displayed 
moderate, while pulmonary fibrosis and 
pulmonary arterial hypertension patients 
displayed severe disability. COPD-
Patients had the worst pain level whereas 
patients with pulmonary fibrosis and the 
worst emotion and cognition levels. BOS 
was the most important determinant of 
physical health status (p = .003). 
 
Cross-sectional study design 
Selection/ Survival bias 
 
 Shih et al., 2002  The context framing the changes 
in health-related quality of life 
and working competence before 
and after lung transplantation: 
one-year follow-up in Taiwan 
 
Prospective longitudinal study 
design (pre and 1, 3, 6, 12M 
after LTx) 
8 VAS Significant improvements in HRQoL 
after transplantation. The most evident 
improvement in HRQoL of LTx 
recipients occurred between 1 and 3 
months post-transplant. 
Small sample size 
Survival /selection bias 
Short follow-up time 
 
 Smeritschnig et al., 2005  Quality of life after lung 
transplantation: a cross-sectional 
study.  
Cross-sectional study (> 3M 
post LTx) 
94 HADS-D 
SF-36  
SGRQ 
 
All LTx-recipients showed better scores 
in SGRQ and enhanced HRQoL. HADS 
and SF-36 did not differ sign. compared 
with published normative data. Side 
effects of immunosuppression were sign. 
influencing HRQoL.  
 
Cross-sectional study design 
Selection bias 
 Stavem et al., 2000  
 
Health-related quality of life in 
lung transplant candidates and 
recipients. 
Cross-sectional study design 
(candidates vs. recipients on 
average 38M post LTx. 
31 HADS 
SF-36  
SGRQ  
VAS 
6MWD 
 
SGRQ and SF-36 in all dimension except 
pain, showed sign. better scores post-
transplant. 
Cross-sectional study design 
Confounding variables 
(heterogeneous study groups: 
15 candidates vs. 31 
recipients) 
Selection bias 
 
 Tegtbur et al., 2004  
 
Quality of life and exercise 
capacity in lung transplant 
recipients. 
Cross-sectional study design (7 
± 2M after LTx) 
27 Cardiopulmonary exercise 
Standardized German 
Quality of life profile for 
chronic disease self-rating 
questionnaire 
 
Subjective HRQoL in physical, 
psychological and social domains did not 
differ from values of the general 
population. The HRQoL physical domain 
correlated sign. with exercise capacity. 
 
Cross-sectional study design 
Selection bias 
Small sample size 
 
 Ten Vergert et al., 1998  The effect of lung transplantation 
on health-related quality of life: 
A longitudinal study.  
Prospective longitudinal study 
(before and 1, 4, 7, 13 and 19M 
post LTx) 
24 ADL 
IWB  
Karnofsky Performance 
Index 
NHP  
STAI 
ZUNG  
 
Before LTx, patients reported major 
restrictions in mobility and energy, low 
level of well-being and depressive 
symptoms. Pre-tansplant patients reported 
difficulties in performing ADL and in 
taking care of themselves. 4M post-LTx, 
patients reported improvements in 
mobility, energy, sleep, ADL and 
dyspnea. Improvements were maintained 
in the following 15M. 
 
Small sample size 
Selection/ survival bias 
Missing data 
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 Ten Vergert et al., 2001  Quality of life before and after 
lung transplantation in patients 
with emphysema versus other 
indications. 
 
Prospective longitudinal design 
(before and 4, 7, 13, 25 M after 
LTx) 
42 IWB  
Karnofsky Performance 
Index 
NHP  
STAI  
ZUNG 
 
 
Before transplantation, both groups 
reported major restrictions on the 
dimensions energy and mobility of the 
NHP, low experienced well-being, 
depressive symptoms, and high dyspnea. 
4M after LTx, most HRQoL-domains 
improved sign. in both groups. 
Improvements were maintained in the 
following 21M. 
 
Selection/ survival bias 
Short follow-up time 
 Van den Berg et al., 2000  Bronchiolitis obliterans 
syndrome after lung 
transplantation and health-related 
quality of life. 
Cross-sectional comparison & 
longitudinal analysis (4M, 7M, 
and every 6M post-transplant 
until 49M) 
27 IWB 
NHP  
STAI 
ZUNG 
 
BOS reported sign. more restrictions on 
the dimension physical mobility and 
energy of the NHP at 7, 19, 25, 31M. 
Patient with BOS reported statistically 
sign. more depressive symptoms and 
anxiety 1 and 2 yr after LTx.  
 
Cross-sectional study design 
Small sample size 
Selection/ survival bias  
 Vasiliadis et al., 2006  
 
Health-related quality of life 
determinants in lung 
transplantation. 
Cross-sectional cohort study 
(LTx-candidates vs. recipients) 
34 vs 71 SF-36  
Determinants associated 
with LTx (age, type of LTx, 
lung disease, hospitalization, 
days in hospital (LOS), 
infections) 
 
LTx was positively associated with all 
HRQoL domains. Clinically meaningful 
effects on physical HRQoL domains were 
observed with disease, type of transplant 
received and hospital stay. Gender played 
a role in mental health. 
 
Cross-sectional study design 
Confounding variables 
(heterogeneous group: 34 
candidates vs. 71 recipients) 
Selection/ survival bias 
 Vermeulen et al., 2003  
 
Long-term quality of life in 
patients surviving at least 55 
months after lung transplantation. 
Cross-sectional & longitudinal 
design (55M after LTx) 
28 IWB 
Karnofsky Performance 
Index 
NHP 
STAI 
ZUNG  
Questionnaire concerning 
lung-specific problems 
Questions reg. activities of 
daily life 
 
Until app. 43M after LTx, sign. 
improvements on most dimension of 
NHP, Karnofsky-Index, anxiety and 
depression, well-being, walking without 
dyspnea, activities of daily life could be 
performed without help by most patients. 
After 43M patients experiences more 
dyspnea, anxiety, depression and lower 
level of well-being. 
Cross-sectional study design 
Selection/ survival bias 
Small sample size for 
longitudinal study design 
 Vermeulen et al., 2004  
 
Improved quality of life after 
lung transplantation in 
individuals with cystic fibrosis.  
Prospective longitudinal design 
(1, 4, 7, and then every 6 M 
after LTx until 31M after LTx) 
35 IWB 
Karnofsky Performance 
Index 
NHP  
STAI  
ZUNG 
 
Between 1-4M after LTx, NHP, ZUNG & 
Karnofsky Index improved, and STAI 
and IWB occurred even within the 
reference value in both groups. 
Significant better scores in NHP 
dimension mobility 4M and sleep 13M 
post-LTx for CF-patients in contrast to 
non-CF patients. 
 
Selection/ survival bias 
Small sample size 
 
 Vermeulen et al., 2004  
 
The effect of bronchiolitis 
obliterans syndrome on health 
related quality of life. 
 
Longitudinal follow-up study 
(pre vs. 1, 4, 7 and then every 
6M after LTx) 
29 IWB 
NHP  
STAI 
ZUNG  
 
 
HRQL was negatively affected by the 
onset of BOS. After the onset of BOS, 
STAI scores remained stable and close to 
the value of the general population. 
ZUNG scores were significantly higher 
after the onset of BOS, and patients 
experienced a lower level of well being 
than the general population. 
 
Selection/ survival bias 
Missing data 
Small sample size 
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 Vermeulen et al., 2007  
 
Long-term health-related quality 
of life after lung transplantation: 
different predictors for different 
dimensions.  
Longitudinal follow-up study 
(pre vs. 1, 4, 7 and then every 
6M after LTx) 
140 NHP 
STAI 
ZUNG 
 
The presence of BOS, age and pre-
transplant scores were sign. for energy 
and mobility post-transplant. Regarding 
mobility, gender seemed to be an 
additional predictor. BOS was a predictor 
for anxiety and depression, and age was a 
predictor for anxiety. 
 
Selection/ survival bias 
Missing data 
 
 Vermeulen et al., 2008  
 
Pre-transplant quality of life does 
not predict survival after lung 
transplantation.  
Prospective longitudinal study 
(pre vs. 1, 4, 7, and every 6M 
after LTx) 
200 IWB 
Karnofsky Performance 
Scale 
NHP 
SDS-Zung  
STAI 
Survival rates at 1, 3, 5 yr were 85%, 
73%, and 69%. Pre-transplant HRQoL 
measures were unfavorable compared 
with values for the general population. 
No sign. predictors for survival after LTx 
were found. 
Selection/ survival bias 
Missing data 
 
Physical 
functioning 
Dierich et al., 2013  
 
The influence of clinical course 
after lung transplantation on 
rehabilitation success.  
Prospective longitudinal study 
(group comparison: > vs. <42 
days LOS; follow-up 42 days 
later 
138 ADL 
FEV1 
PWR (peak work rate) 
SF-36 
VC (vital capacity) 
VO2max (maximum oxygen 
uptake) 
6MWD  
 
FVC, FEV1, 6MWD, ADL and HRQoL 
improved in each cohort. 
Non-controlled, non-
randomized study 
Selection bias 
Confounding variables 
(heterogeneous study groups) 
 Dobbels et al., 2008  
 
Measuring symptom experience 
of side-effects of 
immunosuppressive drugs: the 
Modified Transplant Symptom 
Occurrence and Distress Scale. 
Cross-sectional pilot study; > 
3M post LTx (validation study 
of the 45-item MTSOSD) 
84 MTSOSD-59R The clarity of instructions and items has 
significantly improved compared to the 
previous version. Female patients showed 
a tendency toward higher symptom 
occurrence and sign. higher symptom 
distress compared to men. Patients with 
depressive symptoms had sign. higher 
symptom occurrence and higher symptom 
distress compared with patients without 
depressive symptoms. 
 
Short follow-up time 
 Gerbase et al., 2008  
 
Long-term Health-related Quality 
of Life and Walking Capacity of 
Lung Recipients With and 
Without Bronchiolitis Obliterans 
Syndrome. 
Prospective longitudinal study 
followed for 5.6 ± 2.9 yr after 
LTx 
58 Record of clinical 
complications 
SGRQ 
6MWD 
 
 
 
BOS was a sign. predictor of lower 
SGRQ and reduced time free of clinical 
complications, but not of 6MWT. 
Survivor bias,  
Missing data 
Confounding variables 
(heterogeneous study group) 
 Girard et al., 2006  
 
Prevalence and Impact of Pain on 
the Quality of Life on Lung 
Transplant Recipients. 
Cross-sectional study; > 3M 
after LTx 
96 BDI  
BPI 
SF-36 ( 
STAI 
 
The prevalence of pain in LTx-recipients 
was 49%. Patients with pain were older, 
more likely to have undergone unilateral 
LTP, and more likely to have 
emphysema. BDI was higher for patients 
with pain. No sign. difference was found 
regarding anxiety. Pain-free patient had 
sign. higher physical component score in 
the SF-36. 
 
Cross-sectional study design 
Confounding variables 
(heterogeneous study group) 
Survival bias 
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 Goetzmann et al., 2005  
 
Psychosocial situation and 
physical health in 50 patients > 1 
year after lung transplantation. 
Cross-sectional study design 
(after ≥ 12M post LTx 
48 F-SoZu 
HADS  
RSES 
 
The overall degree of anxiety and 
depression of LTx-patients was 
comparable to standard sample of an 
average population. Male LTx-patients 
were sign. more depressed than female 
recipients. Self-esteem was higher than in 
clinical comparison sample. 
 
Cross-sectional study design 
Selection/ survival bias 
 
 
 Ihle et al., 2011  
 
 
Effect of inpatient rehabilitation 
on quality of life and exercise 
capacity in long-term lung 
transplant survivors: a 
prospective, randomized study. 
 
Cross-sectional study design: 
inpatient rehabilitation program 
vs. medical standard therapy 
(4.5 ± 3.5 yr after LTx). 
60 Cardiopulmonary exercise 
testing 
SF-36  
SGRQ 
Quality of Life Profile for 
Chronic Diseases 
questionnaire 
6MWD  
 
Both group sing. improved their maximal 
exercise capacity. In both study groups, 
HRQoL tended to improve. Sign. 
correlations were found for exercise 
capacity and HRQoL scales. 
Cross-sectional study design 
Confounding variables 
(temporal variation in data 
collection) 
Selection bias 
Lack of control group 
 Irani et al., 2010  
 
Olfactory performance before 
and after lung transplantation: 
quantitative assessment and 
impact on quality of life. 
Cross-sectional study design 70 FLZM 
HADS 
Sniffin’ Sticks for olfactory 
performance 
 
Patients <55 yr had a lower olfactory 
performance both before and after LTx. 
General life satisfaction, health life 
satisfaction, and depression were sign. 
better in LTx-recipients. Better olfactory 
performance was sign. associated with 
better HRQoL before and after LTx. 
 
Cross-sectional study design 
Selection bias 
Confounding variables 
(variance in sample size: 22 
candidates vs. 70 recipients) 
 
 Kugler et al., 2007  
 
Symptom experience after lung 
transplantation: impact on quality 
of life and adherence. 
Cross-sectional study design, ≥ 
3M after LTx 
287 Quality of life profile for 
Chronic Diseases 
 
Women and younger patients reported a 
significantly higher level of symptom 
experience compared with their 
counterparts respectively. Symptom 
experiences negatively influenced 
HRQoL in all dimensions. Those who 
described experiencing adverse effects 
reported significantly more ‘‘drug 
holidays’’. 
 
Cross-sectional study design 
Selection bias 
Confounding variables 
(heterogeneous study group: 
single vs. bilateral LTx) 
 Langer et al., 2009  
 
Physical Activity in Daily Life 1 
Year After Lung Transplantation. 
Cross-sectional study (> 12M 
post LTx) 
22 Activity monitors 
SF-36 
6MWD  
  
 
Steps, standing time and moderate-
intensity activity of LTx-recipients were 
reduced by 43%, 29% and 66% relative 
to controls. Daily sedentary time was 
increased by 30%. 
 
Cross-sectional study design 
Small sample size 
Selection bias 
Confounding variables 
(heterogeneous study group: 7 
single vs 15 bilateral LTx) 
 
 Langer et al., 2012  
 
Exercise training after lung 
transplantation improves 
participation in daily activity: a 
randomized controlled trial. 
Randomized control study. 3M 
of supervised exercise training 
vs. control group with no 
intervention. Follow-up 1yr 
after LTx. 
 
40 Exercise training 3 times 
weekly during 3 months 
(walking, stair climbing, 
cycling about 90’)  
6MWD  
 
Sign. improvements in quadriceps fore, 
6MWD and self-reported physical 
functioning in intervention group. 
Cross-sectional study design 
Selection bias 
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 Lanuza et al., 2012  
 
A longitudinal study of patients' 
symptoms before and during the 
first year after lung 
transplantation. 
Prospective, repeated measure 
design (pre vs. 1, 3, 6, 12M 
post LTx) 
78 TSI Post-transplant sign. improvements in 
most frequent occurring and most 
distressing pre-transplant symptoms (e.g. 
shortness of breath with activity). Marked 
increases in frequency and distress of 
new symptoms (e.g. tremor). 
 
Selection bias 
Missing data 
Short follow-up time 
 Maury et al., 2008  
 
Skeletal muscle force and 
functional exercise tolerance 
before and after lung 
transplantation: a cohort study. 
Prospective longitudinal study 
(2.8M before LTx and 1.8 M 
and 3 M after LTx) 
36 Lung function 
Skeletal muscle force 
(Quadriceps force) 
6MWD 
 
 
26 Patients showed skeletal muscle 
weakness before LTx. The number of 
days in intensive care unit was sign. 
related to the observed deterioration in 
muscle force after LTx. Rehabilitation 
improved 6MWD and muscle force 
significantly (<.05), even though the 
evolution was less in female compared to 
male subjects. 
 
Selection bias 
Missing data 
Short follow-up time 
 Munro et al., 2009  
 
Pulmonary Rehabilitation 
Following Lung Transplantation. 
Prospective, repeated measure 
design 1, 2 and 3M after LTx. 
36 FEV1 
SF-36  
6MWD 
Sign. improvements in 6MWD, FEV1, 
FVC and all SF-36 domains. 
 
Short follow-up time 
Small sample size 
Selection bias 
Lack of control group 
 
 Van den Berg et al., 2000  Bronchiolitis obliterans 
syndrome after lung 
transplantation and health-related 
quality of life. 
Cross-sectional comparison & 
longitudinal analysis; 4M, 7M, 
and then every 6M post-
transplant until 49M 
27 IWB 
NHP  
STAI  
ZUNG 
 
BOS reported sig more restrictions on the 
dimension physical mobility and energy 
of the NHP at 7, 19, 25, 31M. Patient 
with BOS reported statistically sign. more 
depressive symptoms and anxiety 1 and 2 
yr after LTx. The increase in reported 
restriction occurred simultaneously with 
the development of BOS. 
 
Cross-sectional design 
Confounding variables 
(heterogeneous study groups) 
Selection/ survival bias 
 Wildgaard et al., 2010 
 
 
Chronic Pain After Lung 
Transplantation. A Nationwide 
Study. 
Cross-sectional study design 
(mean 39M after LTx) 
79 McGill Pain Questionnaire 
 
18% reported persistent pain. 71% of 
LTx-patients with postsurgical pain also 
had pain from another part of the body. 
Postsurgical pain was associated with 
sign. impaired HRQoL. 73% of LTx-
patients experienced sensory 
disturbances. 
Cross-sectional study design 
Confounding variables 
(temporal variation in data 
collection) 
Mental health Dew et al., 2012  
 
Onset and risk factors for anxiety 
and depression during the first 2 
years after lung transplantation. 
Longitudinal study with 
assessments at 2, 7, 12, 18, 
24M 
178 SCID Pre-transplant risk factors for mental 
illness after LTx included pre-transplant 
psychiatric history, female gender, longer 
wait for transplant, early post-transplant 
health problems and psychosocial 
characteristics (poorer caregiver support, 
avoidant coping). 
 
Selection/ survival bias 
Missing data 
Small sample size 
 Evon et al., 2010 Depressive symptoms and 
mortality in lung transplant. 
Prospective, longitudinal design 124 BDI Depressive symptoms pre-transplant did 
not predict survival after transplantation. 
Depressive symptoms pre-transplant did 
not predict survival after LTx. 
 
Selection/ survival bias 
Missing data 
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 Goetzmann et al., 2010  
 
Lung function, sociodemographic 
characteristics, and psychological 
reaction to transplant associated 
with chronic stress among lung 
recipients. 
Cross-sectional study (≥ 3M 
post LTx) 
76 TICS 
TxEQ 
Physical and 
sociodemographic 
conditions (lung function, 
BOS, working status, 
parenting) 
 
Chronic stress after LTx was significant 
lower than that in a normal community 
sample. Stress levels were not related to 
the time since transplantation. Worries 
concerning transplant were sign. 
associated with the patient’s chronic 
stress. 
 
Cross-sectional study design 
Selection bias 
 Goetzmann 
 et al., 2010  
 
Distress and alexithymia in lung 
recipients – psychosocial strains 
and associations with chronic 
allograft dysfunction. 
Cross-sectional design (≥3M 
after LTx) 
76 SCL-K-9 
TAS-20 
Physical health (FEV1, 
exhaled nitric oxide, 
comorbidity) 
 
Levels of distress and alexithymia were 
sign. higher in LTP-recipient than in a 
normal community sample. A positive 
correlation between BOS and distress was 
found. Distress was a predictor for new-
onset BOS 1 yr after LTx. No sign. 
correlations were found between 
alexithymia and physical parameters. 
 
Cross-sectional study design 
Selection bias 
Confounding variables 
(temporal variation in data 
collection) 
 
 Woodman et al., 1999  
 
 
Psychiatric Disorders and 
Survival After Lung 
Transplantation. 
Longitudinal study (1yr after 
LTx) 
30 PACT 
SCID  
 
Recipients with a history of anxiety and 
depression were more likely to survive 1 
year (80%). No significant differences in 
recipients without a psychiatric history in 
term of rejection reaction, BOS or 
noncompliance with treatment. 
Short follow-up time 
Selection/ survival bias 
Confounding variables 
(heterogeneous study group) 
Social 
functioning  
Archonti et al., 2004  
 
Physical quality of life and social 
support in patients on the waiting 
list and after a lung 
transplantation.  
Cross-sectional study design 
(candidates vs. recipients 5 – 
47M after LTx) 
20 BDI  
F-SoZu 
SF-36  
 
Sign. improvements post LTx were 
observed in physical functioning, vitality, 
health perception and social functioning. 
The perceived support correlated 
negatively with the level of depression. 
 
Cross-sectional study design 
Small study cohort 
Survivor bias 
Confounding variables 
(heterogeneous population) 
 
 DeVito et al., 2003  Psychosocial vulnerability, 
physical symptoms and physical 
impairment after lung and heart-
lung transplantation. 
 
Cross-sectional study design (2 
- 17M post LTx) 
50 SCL-90-R  
SCID-DSM-III-R  
SIP  
The 7-item Sense of Mastery 
Scale 
WCCL  
 
Elevated depressive and anxiety 
symptoms, a low sense of mastery, and 
the presence of concurrent medical 
complications were each associated with 
increased number of physical symptoms 
and physical impairment level.  
 
Cross-sectional study design 
Selection bias 
Confounding variables 
(temporal variation in data 
collection) 
 
 DeVito et al., 2013  
 
Quality of recipient-caregiver 
relationship and psychological 
distress are correlates of self-care 
agency after lung transplantation.  
 
Cross-sectional study design 
(with LTx-recipients of max. 
1yr post LTx) 
111 DAS 
Health Locus of Control 
Scale. 
PSCA 
SCL-90-R 
Patients with low self-care agency 
reported significantly poorer quality of 
caregiver relationship. The recipient-
caregiver relationship was sign. 
associated with self-care agency. 
 
Cross-sectional study design 
Selection bias 
Confounding variables 
(temporal variation in data 
collection) 
 
 Goetzmann et al., 2005 
 
Psychosocial situation and 
physical health in 50 patients > 1 
year after lung transplantation. 
Cross-sectional study design 
(after ≥ 12M post LTx 
48 F-SoZu 
HADS 
RSES  
 
The overall degree of anxiety and 
depression of LTx-patients was 
comparable to standard sample of an 
average population. Male LTx-patient 
were sign. more depressed than female 
recipients. Self-esteem was higher than in 
clinical comparison sample. 
Cross-sectional study design 
Selection/ survival bias 
 
Note. BOS = bronchiolitis obliterans syndrome; CF = cystic fibrosis; BODE = Body mass index, Obstruction, Dyspnea, Exercise. The BODE-index predicts the risk of death 
in patients with chronic obstructive pulmonary disease (COPD), and is used to identify candidates for lung transplantation; FVC = forced vital capacity; FEV1 = Forced 
expiratory volume in 1 second; HRQoL = health related quality of life; LTx = lung transplantation; pLTx = post lung transplantation; 6MWD = 6-min walking distance test. 
Abbreviations for test instruments are given in Table 3.  
4 Empirical work 1  53 
 
 
Table 3. Instruments used in eligible studies for assessing HRQoL and psychological outcomes after LTx. 
 Instrument Acronym Author Instruments utilized by 
(ID reference) 
Cronbach’s α 
HRQoL Body Cathexis Scale BCSC Secord and 
Jourard, 1953 
Limbos et al., 1997  
Limbos et al 2000  
not reported 
not reported 
 
 EuroQuol Health Utility and 
Health-related Quality of Life 
questionnaire 
 
EQ-5D EuroQol Group, 
1990 
Anyanwu et al., 2001  not reported 
 
 Health Utilities Index Mark 3 HUI3 Feeny et al., 
2002 
Santana et al., 2009  
Santana et al., 2012  
 
not reported 
not reported 
 
 Index of Well-Being IWB Campbell, 1976 Gross et al., 1995  
Ten Vergert et al., 1998  
Ten Vergert et al., 2001  
Van den Berg et al., 2000  
Vermeulen et al., 2003  
Vermeulen et al., 2004  
Vermeulen et al., 2008  
 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
 
 Medical Outcome Study Health 
Survey 
 
MOS 20 Steward et al., 
1989 
Gross et al., 1995  .81 - .91 
 Nottingham Health Profile NHP Hunt et al, 1985 Buschbach et al., 1994  
Ten Vergert et al., 1998  
Ten Vergert et al., 2001  
Van den Berg et al., 2000  
Vermeulen et al., 2003  
Vermeulen et al., 2004  
Vermeulen et al., 2007  
Vermeulen et al., 2008 
 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
 
 Quality of life profile for Chronic 
Diseases 
PLC Siegrist et al, 
1996 
Ihle et al., 2011  
Kugler et al., 2005  
Kugler et al., 2007  
Tegtbur et al., 2004  
not reported 
not reported 
not reported 
not reported 
 
 Sickness Impact Profile 136 items SIP-136 Bergner et al., 
1981 
DeVito et al., 2003 
Lanuza et al., 2000  
 
.86 
.92 
 St George’s Respiratory 
Questionnaire 
SGRQ Jones et al., 1991 Eskander et al., 2011  
Gerbase et al., 2005  
Gerbase et al., 2008  
Ihle et al., 2011  
Smeritschnig et al., 2005  
Stavem et al., 2000  
 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
 
 The General Health Questionnaire  
 
GHQ Goldberg and 
Hillier, 1978 
Lanuza et al., 2000  
 
.82 
 The 12-Item Short Form Health 
Survey 
 
SF-12 Ware et al., 1996 Kunsebeck et al., 2007  
 
not reported 
 
 The 36-Item Short Form Health 
Survey 
SF-36 Ware and 
Sherbourne, 
1992 
Archonti et al., 2004  
Cohen et al 1998  
Eskander et al., 2011  
Finlen Copeland et al., 2013  
Girard et al 2006  
Goetzmann et al., 2008  
Ihle et al 2011  
Langer et al, 2009  
 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
 
    Limbos et al., 1997  
Limbos et al., 2000  
Lobo et al., 2004  
Munro et al 2009 
Rodrigue et al., 2005 
Rodrigue et al., 2006  
Rutherford et al., 2005  
Smeritschnig et al., 2005  
Stavem et al., 2000  
Vasiliadis et al., 2006  
 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
 
 Health Status Visual Analog Scale VAS The EuroQol 
Group, 1990 
Buschback et al., 1994  
Gerbase et al., 2005  
Eskander et al., 2011  
Limbos et al., 2000  
Lobo et al., 2004  
Shih et al., 2002  
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
Physical 
functioning 
Brief Pain Inventory BPI Cleeland, 1989 Girard et al., 2006  
 
not reported 
 
 Dyspnea Assessment with visual 
analogue scale 
 Noseda et al., 
1992 
Stavem et al., 2000  
 
NA 
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 Dyspnea Scale  DS Comstock et al., 
1979 
Lobo et al., 2005  NA 
 Karnofsky Performance Status 
Scale 
Karnofsky-Index Karnofsky and 
Burchenal, 1949 
Buschbach et al., 1994  
Gross et al., 1995  
Ten Vergert et al., 1998  
Ten Vergert et al., 2001  
Vermeulen et al., 2003  
Vermeulen et al., 2004  
Vermeulen et al., 2008  
 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
 
 McGill Pain questionnaire 
 
MPQ Melzack, 1975 Wildgaard et al., 2010  
 
not reported 
 
 Modified Transplant 
Symptom Occurrence and Distress 
Scale 59-Revised 
 
MTSOSD-59R Moons et al., 
2001 
Dobbels et al., 2008  
 
not reported 
 
 Sniffin’ Sticks Test for olfactory 
performance 
SST Hummel et al., 
1997 
 
Irani et al., 2010  NA 
 Transplant Symptom Frequency 
Questionnaire 
 
TSFQ McNaughton et 
al., 1998 
Rodrigue et al., 2006  
 
not reported 
 
 Transplant Symptom Inventory TSI Moons et al., 
2001 
 
Lanuza et al., 2012  
 
.91 - .96 
 Zerssen List of Complaints Zerssen Zerssen et al., 
1976 
Kunsebeck et al., 2007  not reported 
 
Mental health Basic Personality Inventory BPI Kroner et al., 
1991 
Cohen et al., 1998  
Girard et al., 2006  
 
not reported 
not reported 
 
 Beck Anxiety Inventory BAI Beck and Steer, 
1993 
 
Kunsebeck et al., 2007  
 
not reported 
 
 Beck Depression Inventory BDI Beck, 1972 Archonti et al., 2004  
Cohen et al., 1998  
Evon et al., 2010  
Girard et al., 2006  
 
not reported 
not reported 
not reported 
not reported 
 
 Brief Symptom Inventory BSI Derogatis and 
Spencer, 1982 
Lanuza et al., 2000  
Limbos et al., 2000  
 
.73 - .80 
not reported 
 
 Centre for Epidemiologic Studies-
Depression Scale 
CES-D Radloff, 1977 Kunsebeck et al., 2007  
Lobo et al., 2004  
not reported 
not reported 
 Derogatis Sexual Functioning 
Inventory 
DSFI Derogatis, 1975 Limbos et al., 1997  
Limbos et al., 2000  
not reported 
not reported 
 
 Hospital Anxiety Depression Scale HADS Zigmond and 
Snaith, 1983 
Goetzmann et al., 2005  
Irani et al., 2006  
Irani et al., 2010  
Limbos et al., 1997  
Limbos et al., 2000  
Santana et al., 2009  
Smeritschnig et al., 2005  
Stavem et al., 2000  
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
 
 Illness Intrusion Rating Scale IIRS Devins et al., 
1994 
 
Lobo et al., 2004  not reported 
 
 Mental Health Inventory MHI Ware et al., 1987 
 
Cohen et al., 1998  
 
not reported 
 
 Psychiatric Assessment of 
Candidates for Transplantation 
 
PACT Olbrisch and 
Levenson, 1989 
 
Woodmann et al., 1999  
 
not reported 
 
 Rosenberg Self-Esteem Scale RSES Rosenberg, 1965 Goetzmann et al., 2005  
Limbos et al., 1997  
Limbos et al., 2000  
 
not reported 
not reported 
not reported 
 
 Symptom Distress Scale  SDS McCorkle et al., 
1998 
 
Lobo et al., 2004  
Matthees et al., 2001  
not reported 
not reported 
 Screening Subscale of Chronic 
Stress of the Trier Inventory for 
the Assessment of Chronic Stress 
 
TICS Schultz et al, 
2004 
Goetzmann et al., 2010  .92 
 State-Trait Anxiety Inventory STAI Spielberg et al, 
1980 
Cohen et al 1998  
Girard et al 2006  
Ten Vergert et al., 1998  
Ten Vergert et al., 2001  
not reported 
not reported 
not reported 
not reported 
    Van den Berg et al., 2000  
Vermeulen et al., 2003   
Vermeulen et al., 2004  
Vermeulen et al., 2007  
Vermeulen et al., 2008  
not reported 
not reported 
not reported 
not reported 
not reported 
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 Symptom Checklist 90-Revised 
 
SCL-90-R Derogatis, 1997 DeVito et al., 2003  
DeVito et al., 2013  
Goetzmann et al., 2010 
not reported 
.83 - .92 
not reported 
 The Life Orientation Test LOT Scheier and 
Carver, 1985 
 
Irani et al., 2006  
 
not reported 
 
 The Structured Clinical Interview 
for DSM-III-R 
SCID (DSM-III-
R) 
 
Spitzer, 1992 DeVito et al., 2003  
Dew et al., 2012  
Woodmann et al., 1999  
 
not reported 
not reported 
not reported 
 
 Toronto Alexithymia Scale TAS-20 Bagby and 
Parker, 1994 
Goetzmann et al., 2010  
 
not reported 
 
 Transplant Effects Questionnaire 
 
TxEQ Ziegelmann et 
al., 2002 
Goetzmann et al., 2008  
 
.65 - .92 
 
 
    Goetzmann et al., 2010   
 
not reported 
 
 The Ways of Coping Checklist WCCL Neacsiu et al., 
2010 
 
DeVito et al., 2003  
 
not reported 
 
 ZUNG Self-Rating Depression 
Scale) 
ZUNG-SDS Zung, 1965 Ten Vergert et al., 1998  
Ten Vergert et al., 2001  
Van den Berg et al., 2000  
Vermeulen et al., 2003  
Vermeulen et al., 2004  
Vermeulen et al., 2007  
Vermeulen et al., 2008  
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
not reported 
Social 
functioning 
Activity of daily living ADL Katz et al., 1963 Dierich et al., 2013  
Ten Vergert et al., 1998  
 
not reported 
not reported 
 
 Dyadic Adjustment Scale 
 
DAS Spanier, 1976 DeVito et al., 2013  
 
.86 
 Evaluation of the short-form social 
support questionnaire) 
F- SoZu Sommer and 
Fydrich, 1998 
Archonti et al., 2004  
Goetzmann et al., 2005  
Irani et al., 2006  
 
not reported 
not reported 
not reported 
 
 Multidimensional Health Locus of 
Control Scale 
 
MHLC Scale Wallton et al., 
1978 
DeVito et al., 2013  .78 
 Perception of Self-Care Agency PSCA Hansen and 
Bickel et al, 
1985 
 
DeVito et al., 2013  .95 
 Questions on Life Satisfaction FLZM Henrich and 
Herschbach, 
2000 
Irani et al., 2006  
Irani et al., 2010  
not reported 
not reported 
 
Note. Cronbach’s alpha as a measure of reliabilty of the instruments in LTx-population. NA = not applicable. 
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4.5 Discussion 
4.5.1 Principal findings 
We identified 63 studies, amongst which there were 50 different instruments used to evaluate 
HRQoL and psychological outcomes after lung transplants. These tools covered four distinct 
dimensions: HRQoL, physical functioning, mental health, and social functioning. A 
heterogeneous assortment of test instruments was encountered; but rarely were transplant-
specific test instruments used, even though lung-specific questionnaires have been developed 
(Jones, Baveystock, & Littlejohns, 1989; Jones, Quirk, Baveystock, & Littlejohns, 1992). 
While generic instruments are designed to assess overall physical, psychological and social 
function, they fail to address the unique emotional and behavioral concerns of transplant 
recipients, and might not be sensitive enough to screen for transplant-specific issues 
(Cleemput & Dobbels, 2007). Furthermore, the heterogeneity of the applied test instruments 
rendered comparisons between studies difficult. In short, there are no guidelines to indicate 
which outcome measures are most appropriate for assessing HRQoL and psychological 
outcomes following lung transplantation. Moreover, severe methodological limitations of the 
studies included in this review significantly hampered the interpretation of HRQoL and 
psychological outcome data. Consistent with other literature findings, selection bias, survival 
bias due to high mortality rates, loss of subjects during data collection, and inability to 
control for confounding variables, such as heterogeneous groups, temporal variation in data 
collection, or underlying comorbidities, were the most frequent identified constraints. 
Additionally, small samples sizes, missing data or the lack of prospective longitudinal study 
designs limited the results of many of the studies (Yusen, 2009, 2011).  
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4.5.2 HRQoL 
Among the four investigated psychosocial domains, HRQoL was the most frequently 
addressed, being evaluated in 39 of the papers. In transplant medicine, HRQoL has been 
widely accepted as an important outcome measure (Stavem et al., 2000). Appraising the 
articles, assessing HRQoL collectively demonstrates considerable postoperative improvement 
in HRQoL among lung transplant recipients, relative to their pre-transplant baseline. This 
finding has been reported in other reviews that have focused on HRQoL after lung 
transplantation (Rosenberger, Dew, DiMartini, et al., 2012; Singer et al., 2013). Although 
transplant recipients’ HRQoL levels are typically lower than the general population’s 
(Santana et al., 2009; Smeritschnig et al., 2005), they generally still report better physical 
function, fewer restrictions in social and leisure activities, more energy, and less discomfort 
than pre-operatively (Limbos et al., 1997). Moreover, the benefits of improved physical and 
psychosocial HRQoL appear to remain stable for a period of three to five years after the 
transplant (2006; Kugler et al., 2010; Rodrigue, Baz, Kanasky, et al., 2005; Stavem et al., 
2000; TenVergert et al., 1998; Vermeulen et al., 2003). However, evidence of maintained 
benefits within the physical and psychosocial HRQoL domains beyond five years is generally 
lacking, so that the outcome trajectories of these patients five to ten years following their 
transplants remain ambiguous. Based upon the few long-term longitudinal studies that have 
been published, it appears that, over the long-term, lung transplant recipients ultimately start 
to experience a decline across several dimensions of HRQoL, largely due to an increase in 
co-morbid conditions and the onset of BOS (Kugler et al., 2005; Rutherford et al., 2005; 
Vermeulen et al., 2003). These findings are supported by one-, three-, and five-year survival 
rates of 79%, 64% and 53%, respectively (Christie et al., 2012).  
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Some investigators attempted to determine if gender differences exist in HRQoL outcomes in 
response to lung transplantation. Three studies suggest that, relative to men, women 
experience more frequent and severe symptoms and a lower percentage gain in HRQoL 
(Limbos et al., 1997; Rodrigue & Baz, 2006; Santana et al., 2012; Vermeulen et al., 2007).  
Alternative theories have been proposed to explain these gender differences. For instance, it 
has been hypothesized, that the higher levels of psychological distress observed in female 
lung transplant patients may not be due to gender-specific vulnerabilities, but rather due to 
culturally-driven gender biases in symptom reporting, with females generally more willing to 
report psychological distress and males tending towards the denial and rationalization of 
feelings (Rankin, 1990; Sokol, Folks, Herrick, & Freeman, 1987). However, the small 
number of studies reporting on gender differences in HRQoL makes the interpretation of 
these findings difficult. Focusing on predictors of HRQoL following transplantation, a 
number of studies have consistently shown that BOS, the adverse effects of 
immunosuppressant medications, and pain significantly reduce HRQoL and increase 
depressive symptoms (Kugler et al., 2005; Santana et al., 2012; Vermeulen et al., 2003). In 
contrast, results regarding FEV1, the underlying diagnosis, patient gender and age, and 
recurrent infections as predictors of HRQoL following lung transplantation have been 
contradictory, with each variable supported by only a single study. Further empirical research 
is clearly warranted to examine whether these factors do, in fact, play a determinative role in 
HRQoL outcomes, along with research to explore the various mechanisms affecting HRQoL 
following lung transplants.  
 
4.5.3 Physical functioning  
Significant improvements from pre-transplant symptoms were reported by several authors 
(Dierich et al., 2013; Langer et al., 2012; Lanuza et al., 2012). In particular, physical function 
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tended to improve over the first several months (Munro et al., 2009), and males tended to be 
more likely to report improvements than females (Maury et al., 2008). However, despite 
successful health gains, many lung transplant recipients suffered from new symptoms, like 
postsurgical pain, the adverse effects of immunosuppressants, and the onset of BOS that 
interfered with both HRQoL and mental health (Dobbels et al., 2008; Girard et al., 2006; Van 
Den et al., 2000). Hence, interventions designed to improve physical functioning are 
important in post-transplant rehabilitation. Considerable success has been achieved by both 
in- and out-patient rehabilitation programs, with physical improvements lasting as long as 
nine months (Langer et al., 2012). Moreover, inpatient rehabilitation improved physical 
function even more impressively in patients with an extended length of stay (Dierich et al., 
2013).  
 
4.5.4 Mental health 
Thus far, there is no conclusive evidence with respect to the degree that mental health is 
affected following lung transplantation. Overall, the studies included in this review indicate 
that a considerable number of lung transplant recipients suffer from psychological distress 
and mental health problems, including a variety of psychiatric diagnoses like depression, and 
both anxiety and adjustment disorders. Moreover, in the long-term, mental health appears to 
ultimately decline, even if gains are achieved in the short term. There are even fewer data on 
potential predictors of impaired mental health, with only one study addressing this issue 
(Dew et al., 2012). In this paper, several predictors were named, but evidence from other 
studies is lacking. As a result of the few articles identified in which mental health was an 
outcome of interest, no clear conclusions can be drawn with regard to mental health 
following lung transplantation. Accordingly, further studies that are consistent in their 
selection of psychometric instruments are required.  
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4.5.5 Psychosocial health 
Although the quality of relationships with one’s primary caregiver, spouse and family are 
assumed to exert an influential impact upon psychological well-being throughout the peri-
operative recovery period and one’s long-term adjustment to post-transplant life 
(Rosenberger, Dew, DiMartini, et al., 2012), only three studies on psychosocial health were 
identified in our review. The psychological well-being of lung transplant recipients was 
reported to be similar to that of the normal general population (Goetzmann et al., 2005). 
Additionally, lung transplant recipients were found to have high levels of self-care agency 
(De Vito Dabbs et al., 2013).  
The evaluation of psychosocial issues within the care and treatment of the chronically 
ill is of both clinical and social relevance. As a matter of course, hospitals are continuously 
seeking to decrease hospital stays as a cost-cutting measure, and family care-givers are 
simultaneously being handed more and more responsibility for providing daily care to the 
chronically ill, a responsibility that is increasingly expanding the caregivers’ burdens. Thus, 
interventions designed to reduce psychological distress and strengthen the quality of 
relationships in both transplant recipients and their caregivers are indispensable.  
 
4.5.6 Strengths and limitations of this review 
This review was conducted following Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines. Study selection followed clear inclusion and exclusion 
criteria. Furthermore, two independent reviewers carefully assessed the selection of eligible 
studies. A limitation of our study is the potential for selection bias when identifying and 
reviewing evidence for each article selected for this review. In this regard, we excluded all 
studies that evaluated HRQoL and psychological outcomes of lung transplant candidates (i.e. 
patients referred for lung transplant), pediatric transplant recipients, and patients who had 
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received additional solid organ transplants. This restricted selection of studies might have 
biased our results, and certainly limits their generalizability. Further limitations are the small 
number of studies for almost all subcategories of HRQoL and psychological outcomes 
following lung transplant, as well as the variability that was apparent in study outcomes, 
study design, and study populations, so that drawing conclusions was difficult. Finally, we 
also excluded articles not published in either English or German, and research studies that 
utilized a strictly qualitative approach.  
 
4.5.7 Implications for practice and future research 
Overall, increasing attention has been paid to assessing the HRQoL and psychological 
outcomes of lung transplant recipients. However, a great assortment of validated and non-
validated outcome measures, as well as many different study designs, has been used, all in 
the absence of any gold standards or consensus guidelines. Comparing research findings 
between different studies is rendered difficult because of the extreme variability that exists. 
Moreover, because of limited sample sizes and the extreme diversity of outcome measures 
between studies, insufficient data currently exist to justify any measures over others for use in 
future studies within transplant medicine.  
Based upon our review, we suggest that a huge opportunity for future research lies in 
the development of guidelines to aid in the selection of outcome measures to assess 
psychological outcomes of lung transplant patients. We also recommend the development of 
transplant specific HRQoL-measures that concisely target physical symptoms and functional 
well-being, including pain and any adverse effects of immunosuppressants, similar to what 
has been adopted for research on cancer patients (Webster, Cella, & Yost, 2003). Finally, we 
suggest that the emphasis of further research should be on prospective longitudinal studies 
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with large enough samples, accounting for survival bias and confounding variables to allow 
for the identification of predictors of both good and poor transplant outcomes. 
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5.1 Abstract 
Background: It is crucial to evaluate the psychosocial trajectories of lung transplant 
recipients to identify patients who experience no significant improvement in health-related 
quality of life (HRQoL) and, thus, require additional psychosocial care.  
Objectives: To (1) assess psychosocial outcome trajectories in lung transplant recipients 
related to psychological distress and HRQoL during the first six months post-transplant; (2) 
identify patients with poor psychosocial trajectories; and (3) determine potential outcome 
predictors regarding psychological distress and HRQoL at six months post-transplant.  
Methods: A total of 40 patients were examined for psychological distress (SCL-K-9) and 
HRQoL (EQ-5D) during their first six months post-transplant. Hierarchical cluster analyses 
were performed to identify distinct types of postoperative outcome trajectory. Correlational 
analyses examined medical and psychosocial predictors of the outcome at 6 months post-
transplant.  
Results: Three distinctive clusters were identified, summarizing either (1) patients with 
optimal postoperative trajectories (35%), (2) patients with good postoperative trajectories 
(42%), and (3) patients with poor postoperative trajectories (23%). The latter tended to be 
older, to suffer from more severe disease, to have more co-morbidities, and to have had a 
prolonged ICU and/or hospital stay. Disease severity, length of stay and EQ-5D two weeks 
post-transplant were strong predictors of psychological distress and impaired HRQoL at six 
months of follow-up.  
Conclusion: Results underscore the psychosocial needs of patients with poor post-transplant 
trajectories. Further longitudinal research with larger subject samples is needed to further 
investigate outcome profiles of these patients and identify additional outcome predictors.  
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5.2 Background 
Lung transplantation is an established therapeutic option for end-stage lung disease, yielding 
successful outcomes in carefully selected patients characterized by reduced disability, 
extended survival and improved health-related quality of life (HRQoL) (Kugler et al., 2007; 
Munro et al., 2009; Rodrigue, Baz, Kanasky, et al., 2005). To date, more than 47’000 adult 
lung transplants have been reported worldwide to the Registry of the International Society for 
Heart and Lung Transplantation (ISHLT) (Yusen et al., 2014), while in Switzerland since 
1992, more than 700 lung transplants have been performed (Swisstransplant, 2013). During 
the last years, overall patient survival has progressively improved, and today, one-, three-, 
and five-year survival rates of 84%, 71% and 66.5%, respectively have been achieved in 
Zurich, comparable to results of international high-volume programs (Inci et al., 2013).  
To date, studies on psychosocial outcomes following transplantation have primarily 
compared the postoperative HRQoL-trajectories of different types of solid organ 
transplantation (Goetzmann et al., 2008; Myaskovsky et al., 2006; Pinson et al., 2000). In 
these studies, recipients of different solid organ transplants did not share the same HRQoL-
trajectories. In particular, the HRQoL-outcomes of lung transplant recipients appeared to be 
inferior to those receiving other solid organs (Kugler et al., 2010; Pinson et al., 2000). 
Interestingly, most studies look at the entire group, and do not distinguish between patients 
with improved postoperative HRQoL and patients with similar or worse quality of life 
compared to their pre-transplant scores.  
Understanding the predictive impact of psychosocial and medical variables on 
postoperative HRQoL could be useful when making choices regarding therapy. Although 
previous research has identified associations between psychosocial and medical 
characteristics and post-transplant HRQoL, the predictors of post-transplant HRQoL are still 
not well described for lung transplant patients. Only very few consistent data regarding 
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predictive factors for post-transplant HRQoL exists (Butler et al., 2003). In general, studies 
on predictors of post-transplant HRQoL in lung recipients demonstrate that bronchiolitis 
obliterans syndrome (BOS), the most common form of chronic lung allograft dysfunction 
(CLAD), the adverse effects of immunosuppressant medications, and pain significantly 
reduce HRQoL and increase depressive symptoms (Santana et al., 2012; Vermeulen et al., 
2003; Vermuelen, van der Bij, Erasmus, & TenVergert, 2007). In contrast, results on other 
potential outcome predictors - including age, gender, psychiatric history, longer waiting times 
for transplantation, and forced expiratory volume in one second (FEV1) – have been 
contradictory and supported only by single studies (Dew et al., 2012; Gerbase et al., 2005; 
Kugler et al., 2005; Rodrigue, Baz, Kanasky, et al., 2005).  
In light of the above, it is of clinical relevance to assess the psychosocial health of 
lung transplant patients to identify those at risk for unfavorable postoperative outcomes and 
make more informed therapeutic choices to enhance patients’ symptom experience. The main 
objectives of the current study were therefore: (1) to determine the post-transplant trajectories 
of lung transplant recipients over the first six months post transplant in terms of 
psychological distress and HRQoL; (2) to identify those lung recipients with poor 
postoperative trajectories; and (3) to assess potential short-term predictors and their impact 
upon psychological distress and HRQoL. This subject has clinical relevance with respect to 
the treatment of patients who undergo lung transplantation but fail to experience any 
improved quality of life.  
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5.3 Methods 
5.3.1 Participants 
Between January 2012 and April 2014, 72 lung transplants were performed at the Transplant 
Center at the University Hospital of Zurich, Switzerland. All patients who received 
transplants over this time period were considered to be eligible for inclusion, unless they 
were: (i) younger than 18 years of age, (ii) unable or unwilling to provide informed consent, 
or (iii) unable or unwilling to complete questionnaires in German. Forty-four consecutive 
adult lung transplant recipients qualified for the study. During data collection, four subjects 
unexpectedly withdrew from participations for medical or personal reasons (e.g., feeling 
overwhelmed by hospital routines and preparations for discharge, distressed, overly-tired, 
and/or short of time). One patient had to be excluded due to critical health conditions and 
repeated hospitalizations to the intensive care unit (ICU). The final sample included 40 
patients (Figure 5). 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Flowchart showing patient recruitment 
T1 (2W pLTx) 
(n= 44) 
T2 (3M pLTx) 
(n=42) 
T3 (6M pLTx) 
(n= 40) 
drop outs n = 2  
drop outs n = 2 
Final sample included: T1: 40; T2: 40; T3: 40 
re
cr
ui
tin
g 
ph
as
e 
44/72 LTx recipients eligible for study 
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5.3.2 Design and Procedures 
In this prospective, longitudinal study, 40 lung transplant recipients were examined at three 
different measurement time points (T1: two weeks; T2: three months; T3: six months after 
transplantation) to capture HRQoL changes over the first six postoperative months. 
Following approval by the Ethics Committee of the Canton of Zurich, Switzerland, all 
patients provided written informed consent prior to their participation. Eligible patients were 
asked to complete the same battery of questionnaires at every data collection point. While the 
initial assessment at T1 was performed during hospitalization, the follow-up assessments at 
T2 and T3 typically were conducted during regular transplant clinic out-patient visits at the 
University Hospital Zurich. Few patients were still hospitalized or admitted to hospital due to 
complications at T2 or T3. Demographic and medical data were retrieved from patient 
medical records. Medical data included the underlying diagnosis/indication for 
transplantation, the presence of co-morbid conditions, the time on the waiting list, the number 
of days spent in the ICU after transplantation, the length of hospital stay (LOS), and the 
mortality rate over the course of the data collection phase. 
 
5.3.3 Measures 
The Symptom Checklist (SCL-K-9)  
The German version of the Symptom Checklist-Short form (SCL-K-9) was used to assess 
overall psychological distress (Klaghofer & Braehler, 2001). The SCL-K-9 (Rosen et al., 
2000) is comprised of nine items, each rated on a five-point Likert scale ranging from 0 (not 
at all) to 4 (very strong). According to the original global severity index (GSI), a mean score 
(0- 4) for the nine items was computed, with higher values indicating greater distress (the 
community-based standard value = .41). The SCL-K-9 is highly correlated with the original 
SCL-90-R (Franke, 1995) and offers similarly good psychometric properties and sensitivity 
5 Empirical work 2 69 
 
 
to change, with a Cronbach’s alpha of .87. In our clinical sample, internal consistency of the 
SCL-K-9 over the three measurement points was good, with Cronbach’s alpha ranging from 
.75 to .84.  
 
EuroQuol (EQ-5D)  
All study subjects completed the EQ-5D, a 5-item self-administered survey instrument that 
measures HRQoL (EuroQol Group, 1990; Hinz, Klaiberg, Brahler, & Konig, 2006). The 
questionnaire covers five dimensions of health: 1) mobility, 2) self-care, 3) usual activities, 4) 
pain/discomfort, and 5) anxiety/depression. For each dimension, patients selected one of 
three graded responses, indicating no problems, some problems, or severe problems with the 
activity. A single global EQ-5D score (range 0 - 100) was generated by use of the sum model 
as describe by Hinz et al. (Hinz et al., 2006) (community-based standard value = 91.7). The 
EQ-5D is used in studies to assess psychotherapeutic treatment, where it has been shown to 
be valid, sensitive to change, and responsive in improvements in mental health. In the current 
study, the EQ-5D demonstrated acceptable to good internal consistency over the three data 
collection points, with Cronbach’s alpha ranging between .60 and .76. The lower level of 
internal consistency observed across the different outcome measures might be explained by 
the high level of homogeneity in our clinical sample.  
Additionally, we used a pre-transplant co-morbidity index developed by Barrios et al. 
(2014), consisting of ten extra-pulmonary co-morbidities that may have negatively impacted 
short- and long-term postoperative trajectories. This comorbidity index included the 
following factors: 1) BMI >30 kg/m2, 2) osteoporosis, 3) insulin-dependent diabetes, 4) 
arterial hypertension, 5) cardiac disease, 6) chronic liver disease, 7) diverticulosis, 8) 
gastroesophageal reflux, 9) history of malignancy, and 10) psychiatric disorders. The 
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comorbidity index was computed by summing up the number of comorbidities for each 
patient. Values between 0 and 10 were possible. 
 
5.3.4 Statistical analysis 
The Statistical Package for the Social Sciences (SPSS, version 22.0) was used to perform all 
statistical analyses, with a two-tailed probability value of .05 considered statistically 
significant (Corp, 2013). Descriptive statistics were reported as means and standard 
deviations, or as counts and percentages. Hierarchical cluster analysis was performed to 
generate homogeneous groups within complex data sets. We used squared Euclidean distance 
as a proximity measure and Ward’s minimum variance agglomerative method to determine 
different post-transplant trajectories (Ward, 1963) based on six variables (SCL-K-9 global 
severity index and EQ-5D score measured at T1, T2 and T3). All these variables were 
standardized prior to clustering. The clustering process starts with the same number of 
clusters as cases, and reduces the number of clusters step-wise using dissimilarities or 
distances between objects; that is, combining those clusters whose combination results in a 
minimum increase in the total within-group sum of squares. If a point is reached whereby 
clusters are combined that are dissimilar, the within-group sum of squares noticeably 
increases (as can be seen in the agglomeration schedule). The number of clusters prior to this 
rapid increase in the agglomeration coefficient is considered the natural grouping scheme 
(Hair & Black, 2000). However, it must be taken into account that this analysis was 
exploratory in nature, and that the choice of the number of cluster to extract is somewhat 
arbitrary. Patients’ characteristics were compared between the cluster groups using one-way 
ANOVA, with Bonferroni post hoc test to identify statistically-significant differences 
between specific cluster groups. Moreover, to generate some appreciation regarding the 
clinical significance of our results, effect sizes (Eta2 for interval scalded variables and 
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Cramer’s V for categorical variables) were computed according to Cohen (Cohen et al., 
1998). Values for Eta2 are categorized as small (0.01), intermediate (0.06), or large (.14) 
while for Cramer’s V, a value!of .1 is considered a small effect, .3 a medium effect and .5 a 
large effect. Pearson correlation coefficients were calculated to identify relevant predictor 
variables of psychological distress (SCL-K-9) and HRQoL (EQ5D) six months post-
transplant.  
 
Table 4. Demographic and medical data of LTx-recipients 
Variables 40 LTx-Recipients n (%) 
Male gender 22 (55) 
Median age (range) 50 (20 - 68) 
Education level  
Elementary 
Secondary 
Tertiary 
 
7 (17) 
21 (53) 
12 (30) 
Married 17 (43) 
Indication for LTx  
COPD 15 (38) 
Cystic Fibrosis 13 (33) 
Idiopathic Pulmonary Fibrosis 7 (17) 
Others 5 (12) 
ECMO-use 13 (33) 
Bilateral LTx 40 (100) 
Retransplant 2 (5) 
Average time on wait list (d) 270.5 (10 - 992) 
Days in ICU (mean; range) 4 (2 – 29) 
Weeks in hospital pLTx (mean; range)  4.5 (3 – 14) 
Note. LTx = lung transplantation; pLTx = post-transplant; COPD = chronic 
obstructive pulmonary disease; ECMO = extracorporeal membrane 
oxygenation; ICU = intensive care unit. 
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5.4 Results 
5.4.1 Demographic characteristics 
Detailed patient demographics and clinical characteristics are summarized in Table 4. The 
median age at the time of transplantation was 50 years (range 20 to 68). Of the 40 patients, 
55% were men and 43% were married. With respect to employment status, 45% were not 
working prior to transplant for health reasons, while 20% were already retired. Thirty-eight 
percent of the patients had been diagnosed with chronic obstructive pulmonary disease 
(COPD), which was the main indication for transplantation in our clinical sample, followed 
by cystic fibrosis in 33%. Six months after transplantation, all 40 patients were still alive.  
 
5.4.2 Cluster analysis 
The agglomeration coefficients generated by cluster analysis revealed a demarcation point 
between three- and four-cluster solutions, suggesting that a four-cluster solution best 
distinguished the post-transplant trajectories (Table 5). However, a four-cluster solution 
produced one cluster with only two patients. For statistical reasons, we therefore decided for 
a three-cluster solution. An inspection of the clustering tree (dendrogram) in Figure 6 
indicates a three-cluster solution as appropriate. The resultant three-cluster solution generated 
relatively well-sized postoperative psychosocial trajectories, labeled according to their most 
distinguishing characteristics (Figure 7). Cluster characteristics are displayed in Table 6. In 
this study, the terms ‘trajectories’ and ‘clusters’ are used as synonyms.  
Cluster A synthesizes those patients with optimal postoperative trajectories (n = 17; 
42%) in terms of a high EQ-5D and low SCL-K-9 score within two weeks of surgery. While 
EQ-5D further improved over the three data collection points, SCL-K-9 decreased 
progressively. At six months post-transplant, these patients reported HRQoL levels 
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comparable to those of a community-based sample (EQ-5D value of 91.7) (Hinz et al., 2006) 
and small but not significantly elevated SCL-K-9-values. Cluster B includes transplant 
recipients with good postoperative trajectories (n= 14; 35%), characterized by considerable 
reduced EQ-5D and high SCL-K-9 scores two weeks after surgery, but significant 
improvements in EQ-5D and SCL-K-9 at 6 months. EQ-5D-values at six months of follow-
up were slightly lower than those of the healthy norm population. Cluster C incorporates 
transplant recipients with poor postoperative trajectories (n= 9; 23%), with both a low EQ-5D 
and high SCL-K-9 score two weeks after transplantation, and only a small gain in EQ-5D 
while SCL-K-9 scores remained steadily elevated over the remainder of the first six months 
of follow-up. 
 
Table 5. Re-formed agglomeration table 
No of clusters Agglomeration last step Coefficients this step Change 
2 234.100 151.886 82.214 
3 151.886 111.244 40.642 
4 111.244 97.966 13.278 
5 97.966 85.793 12.173 
6 85.793 75.342 10.451 
Note. A clear demarcation point seems to be between three and four cluster solutions, suggesting that a four-
clusters solution best distinguished the cases. 
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Figure 6. The dendrogram generated by the cluster analysis. Each patient (n = 40) begins as single clusters and 
step-by-step the most similar clusters are progressively joined together resulting at the end of the process in a 
single cluster grouping all the patients. The distance along the x-axis represents a measure of similarity between 
the patients. A low value here indicates a low heterogeneity within the groups. 
   
Figure 2. Dendrogram using Ward Linkage. Rescaled distance cluster combine 
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5.4.3 Predictor analyses of post-transplant trajectory  
For predictor analyses to distinguish the three postoperative trajectories, the following 
demographic, clinical and psychosocial characteristics were included: sex, age, underlying 
diagnosis, disease severity, time on the waiting list, extracorporeal membrane oxygenation 
(ECMO) use, comorbidities number of days in the ICU and LOS following transplantation 
(Table 7). The median comorbidity index value across the 40 patients was 2 and ranged 
between 0 and 4 comorbidities. Thirty-five percent of the transplant recipients suffered from 
three or more comorbidities. Significant inter-group differences were identified only for LOS 
with a large effect size (eta2 = .53). No significant cluster differences were evident for all 
other investigated variables. However, medium to large effect sizes were found for age (eta2 = 
.07), disease severity (eta2 =.13), comorbidities (eta2 =.06), and number of days in ICU (eta2 = 
.08), indicating that relative to patients with either optimal or good postoperative trajectories, 
those with poor postoperative trajectories tended to be older, to suffer from considerably 
more severe disease, to have more co-morbid conditions, and to have spent longer periods of 
time in the ICU and hospital. No meaningful inter-cluster differences were identified for 
patient gender, underlying diagnosis, time on waiting list or ECMO-use prior to 
transplantation.  
 
5.4.4 Predictor analyses for psychological distress and HRQoL six months post-transplant  
Table 8 presents the results of correlation analyses used to identify associations between each 
potential outcome predictor and both the level of psychological distress (SCL-K-9) and 
HRQoL score (EQ-5D) six months post-transplant. Significant associations with the SCL-K-
9 score at T3 were evident for disease severity (r= .39; p= .001); length of hospital stay (r= 
.44; p= .005) and the EQ-5D score at T1 (r= -.37; p= .02).  
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Figure 7. Post-transplant trajectories in lung transplant recipients 
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Table 6. Clusters’ characteristics 
 Optimal trajectories 
(A) 
n = 17 (42%) 
 Good trajectories 
(B) 
n = 14 (35%) 
 Poor trajectories 
(C) 
n = 9 (23%) 
  
Between groups 
 
 M SD  M SD  M SD  df F p Bonferroni  post hoc test p 
 
T1 SCL-K-9 .5 .2  1.7 .6  .8 .3  2 37.2 <.001 
A vs. B  
A vs. C 
B vs. C  
<.001 
.105 
<.001 
 
T1 EQ-5D 80.6 14.3  53.6 13.4  46.7 21.1  2 17.9 <.001 
A vs. B  
A vs. C 
B vs. C  
<.001 
<.001 
.937 
 
T2 SCL-K-9 .2 .2  .6 .3  1.0 .4  2 21.2 <.001 
A vs. B  
A vs. C  
B vs. C  
.008 
<.001 
.004 
 
T2 EQ-5D 93.5 4.9  83.6 12.2  66.7 17.3  2 16.7 <.001 
A vs. B  
A vs. C  
B vs. C  
.058 
<.001 
.004 
 
T3 SCL-K-9 .2 .2  .5 .4  .9 .4  2 13.3 <.001 
A vs. B  
A vs. C  
B vs. C  
.027 
<.001 
.042 
 
T3 EQ-5D 93.5 7.0  89.3 8.3  64.4 17.4  2 23.8 <.001 
A vs. B  
A vs. C  
B vs. C 
.814 
<.001 
<.001 
 
Note. M = mean; SD = standard deviation; df = degrees of freedom; F = ANOVA F-test statistic; p = level of significance. 
 
 
  
78  Psychological Adjustment to Lung Transplantation  
 
 
 
Table 7. Sociodemographic and medical characteristics of the 3 clusters in 40 lung transplant recipients 
 Optimal trajectories (A) 
n = 17 (42%) 
 
Good trajectories (B) 
n = 14 (35%) 
 
Poor trajectories (C) 
n = 9 (23%) 
   
 M SD  M SD  M SD  effect sizes p-values 
Sex          .17 a .551a 
*male 11 27.5%  7 17.5%  4 10 %    
*female 6 15%%  7 17.5%  5 12.5%    
Age 46.5 16.6  44.2 13.9  54.6 15.4  .07 b .286b 
*Underlying Diagnosis*            .34 a .160a 
COPD 9 22.5%  3 7.5%  3 7.5%    
CF 6 15%  6 15%  1 2.5%    
IPF 2 5%  2 5%  3 7.5%    
Other 0 0  3 7.5%  2 5%    
Disease severity 1.8 .6  1.9 .3  2.3 .5  .13 b .075 b 
Time on waiting list 258.3 288.5  313.4 210.4  226.7 77.9  .02 b .700 b 
*ECMO-use 6 15%  4 10%  3 7.5%  .08 a .883 a 
Comorbidities 1.7 1.2  1.8 1.3  2.3 1.1  .06b .386 b 
Nr. of days in ICU pLTx 5.8 5.5  5.9 4.6  10.4 11.0  .08 b .210 b 
LOS 4.4 1.4  4.6 1.4  9.6 3.6  .53 b <.000 b 
Note. *values stated with n(%).  
a Chi-square test for comparison of nominal or dichotomized variables and Cramer’s V for computing effect sizes.  
bF-test for multiple comparison ANOVA with continuous variables and Eta2 for computing effect sizes.  
Statistical Significance: p < 0.05.  
Disease severity, scaled 1 – 3. Higher value indicates higher disease severity.  
Abbreviations: COPD = chronic obstructive pulmonary disease; CF = cystic fibrosis; IPF = interstitial pulmonary fibrosis; LOS = length of stay in weeks.
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Table 8. Predictor analyses for psychological distress and HRQoL six months post-transplant  
Medical factors 
T3 SCL-K-9 
(n = 40) 
T3 EQ-5D 
(n = 40) 
Age .25 -.20 
*Sex -.13 -.12 
Disease severity .39* -.42** 
Time on waiting 
list -.02 .24 
ECMO-use -.02 .29 
Comorbidities .16 -.05 
Nr. of days in 
ICU .11 -.36* 
LOS .44* -.72** 
T1 EQ-5D -.37* .39* 
*p ≤ .05; **p ≤ .01; ***p ≤ .001. 
*Statistical relationship computed by Spearman Correlation. 
Sex: 1 = male; 2 = female. 
 
 
The following variables were significantly correlated with T3 EQ-5D: disease severity (r= -
.42; p= .006); number of days in the ICU (r= -.36; p=.02); length of hospital stay (r= -.72; p= 
.001) and T1 EQ-5D (r= .39; p= .01). 
 
5.5 Discussion 
The aim of this prospective longitudinal study was to assess psychological distress and 
HRQoL trajectories in lung transplant recipients over the first six months following their 
transplantation, to identify those with poor postoperative trajectories and to explore potential 
outcome-related predictors and their impact upon psychological distress and HRQoL during 
the study period.  
80  Psychological Adjustment to Lung Transplantation  
 
 
We performed hierarchical cluster analysis – a useful statistical tool to classify subjects into 
homogeneous subgroups based upon similar characteristics – so as to identify distinctive 
post-transplant trajectories for psychological distress and HRQoL over those first six 
postoperative months. Our data revealed a three-cluster solution, distinguishing transplant 
recipients manifesting optimal, good and poor postoperative trajectories. Transplant 
recipients with optimal postoperative trajectories (42%) reported surprisingly high HRQoL 
levels and notably low levels of psychological distress shortly after transplantation, and by 
six months post-transplant, their reported HRQoL and stress levels were similar to healthy 
population values. Those patients with good trajectories (35%) experienced impaired HRQoL 
and elevated stress levels two weeks after transplantation, but by three months follow-up 
reported significantly increased HRQoL and significantly reduced psychological distress. 
This group of patients benefitted most from lung transplant surgery by demonstrating 
substantial improvements in HRQoL dimensions and levels of psychological distress over the 
first six months following transplantation relative to the other two cluster groups. Finally, 
almost a quarter of our clinical sample (23%) showed poor postoperative trajectories, 
suffering from elevated stress levels that continued to remain high over the first six months 
post-transplant, and experiencing only slightly increased HRQoL that remained low 
throughout the six-month observation period. These results indicate that lung transplant 
recipients respond in different ways to their surgery and that quality of life gain after 
transplantation varies greatly from patient to patient. The majority of patients appear to cope 
very well, while others seem to struggle postoperatively. For many patients, the 
transplantation itself, as well as the ICU stay, might be perceived as a traumatic stressor that 
can decrease HRQoL and trigger mental distress (Baranyi, Krauseneck, & Rothenhausler, 
2013). Additionally, the rehabilitation period can vary greatly from patient to patient. Given 
lung recipient’s own history of lung disease plus enduring functional impairments and 
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symptom distress post-transplant, may negatively affect the patient’s HRQoL perception 
(Dew et al., 2012). Furthermore, the concept of resilience might explain at least some of the 
different responses to transplantation. For instance, previous studies in transplant medicine 
illustrated that a high degree of resilience and self-efficacy (Schumacher, Sauerland, Silling, 
Berdel, & Stelljes, 2014) as well as social support (Archonti et al., 2004; De Vito Dabbs et 
al., 2013), are essential to successful coping with the transplant experience. The early 
identification of lung transplant patients with poor postoperative trajectories is therefore 
critical to initializing adequate outpatient psychiatric therapy or psychosocial support to 
thereby reduce psychological distress and enhance quality of life. 
As a second analytical step, we sought to identify differences between the cluster 
groups and thereby detect those with poor post-transplant trajectories. Our patients with poor 
postoperative HRQoL generally were older, more likely to suffer from more severe disease 
and more co-morbid conditions, and more likely to have had prolonged ICU and hospital 
stays. Previous studies have suggested a negative impact of co-morbidities on HRQoL after 
lung transplants (Kugler et al., 2005; Vermeulen et al., 2003). Our results are consistent with 
these findings, indicating that clinical complications (e.g., greater disease severity, a higher 
number of co-morbidities, and longer hospital stays) are associated with progressive quality 
of life deterioration over the early post-transplant period. With regards to demographic 
variables, in the psychosocial transplant literature, reduced HRQoL-gains have been 
commonly described in older lung transplant recipients, presumably because older patients 
have less energy and reserves to cope with the taxing postoperative period than those who are 
younger (Vasiliadis et al., 2006; Vermuelen et al., 2007). On the other hand, researchers have 
reported significant gender differences in overall HRQoL, reflecting better outcomes in men 
(Rodrigue & Baz, 2006; Santana et al., 2012), notwithstanding, we did not observe this.  
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Lastly, we explored potential predictors of psychological distress and poor HRQoL six 
months after transplantation. In particular, disease severity, the number of days spent in the 
ICU and hospital as well as self-reported HRQoL two weeks post-transplant predicted 
impaired HRQoL at six months of follow-up. Meanwhile, disease severity, length of hospital 
stay and self-reported HRQoL two weeks post-transplant significantly predicted level of 
psychological distress at six months. Age, gender, time on the waiting list, pre-operative 
ECMO-use, and the number of co-morbid conditions failed to predict six-month levels of 
psychological distress or HRQoL. Prospective studies on potential short-term outcome 
predictors and their impact upon psychological distress and HRQoL are lacking; therefore, 
direct comparisons with our data are impossible. However, our findings are similar to those 
of an earlier cross-sectional cohort study investigating HRQoL determinants among patients 
between one and five years since their lung transplant, suggesting that lung disease and 
events leading to hospitalization negatively affect most of the SF-36 (Short Form Health 
Survey) domains, while other variables like age, gender and FEV1 exert little to no influence 
on HRQoL (Vasiliadis et al., 2006).  
Taken together, among the investigated predictor variables, disease severity, the 
length of hospital stay and self-reported HRQoL two weeks post-transplant were the 
strongest predictors of both impaired HRQoL and elevated psychological distress six months 
after transplantation. Our results indicated that the post-transplant psychological distress and 
HRQoL appear to be influenced in the early postoperative phase predominantly from medical 
rather than psychosocial factors. Elevated psychological distress and impaired HRQoL in the 
early postoperative phase can have a persistent negative impact upon long-term mental health 
and HRQoL (Goetzmann et al., 2010). Thus, psychosocial care for those transplant recipients 
suffering from elevated stress levels and impaired HRQoL is of great importance. 
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5.5.1 Study strengths and limitations  
Strengths of the current study include our investigation of a lung transplant population treated 
exclusively by the transplant centre using a prospective, longitudinal study design, as well the 
use of a rigorous statistical methodology to identify distinct cluster groups, and the utilization 
of validated outcome measures with well-known psychometric properties. Potential 
limitations include the relatively small study sample. Due to the small sample, our results 
lack statistical power, meaning that the results of our cluster analyses were presented only 
descriptively. Moreover, we surveyed lung transplant recipients over a relatively short period 
of time (only six months). The follow-up of lung transplant recipients over several years 
would add further insights into the development of post-transplant psychosocial trajectories 
and outcome predictors. Although our findings should be interpreted with caution due to 
these limitations, we believe that our study provides realistic and valid predictors for early 
postoperative psychosocial trajectories and outcomes. 
 
5.5.2 Conclusions 
The psychosocial care of transplant recipients who suffer from emotional distress is critical to 
maximizing recovery and outcomes. The assessment of post-transplant psychological distress 
and HRQoL in terms of trajectories instead of considering only outcomes at discrete time 
points is beneficial in identifying patients who experience no significant postoperative 
improvement in HRQoL. However, since we only studied patients for six months, additional 
longitudinal research with larger samples remains necessary to clarify the long-term post-
transplant trajectories of these patients and to identify other potentially important outcome 
predictors.  
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6.1 Abstract 
Background: Understanding the impact of transplantation on patients’ perceived well-being 
is crucial to guide supportive psychosocial interventions. However, little attention has been 
paid to the individual patients’ experiences with lung transplantation. 
Aim: To gain a more comprehensive view of patients’ experiences with transplantation and 
their adjustment to normal life within the first six months post-transplant. 
Methods: Forty lung transplant patients were interrogated at three different measurement 
time points (T1: two weeks; T2: three months; and T3: six months post-transplant) using 
semi-structured interviews to address their thoughts, feelings and attitudes with respect to 
the transplantation process, their new lungs, the organ donor, and their medication. 
Interviews were analyzed by means of qualitative content analysis as per Mayring.  
Results: ‘Physical benefits’, ‘fear of rejection’, ‘gratitude towards the donor’ and ‘side 
effects’ were the most frequently named themes with respect to the transplantation process, 
new lungs, donor and medication regimen. Most themes remained unchanged over time. 
While the frequency of comments about intensive care unit delirium and worries regarding 
donated organ quality decreased significantly over time, mentions of restrictions in everyday 
life increased significantly. Gender comparisons revealed only marginal differences in the 
response categories. 
Conclusions: Improvements in physical function during the early postoperative phase may 
be limited by the onset of clinical complications, fear of rejection and infections, medication 
side effects, and restrictions in everyday life. Listening attentively to patients, addressing 
their concerns in a timely fashion, and actively psychological intervening when mental 
health problems arise are crucial for the effective management of lung transplant patients. 
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6.2 Introduction 
Lung transplantation (LTx) is an established therapeutic option that extends survival and 
improves health-related quality of life (HRQoL) in selected patients with end-stage lung 
disease (Dierich et al., 2013; Kugler et al., 2005). The majority of lung transplant recipients 
experience a dramatic improvement in their underlying health condition, particularly over the 
first few months after transplantation (Lanuza, Lefaiver, Mc Cabe, Farcas, & Garrity, 2000). 
Improvements primarily include overall general health, physical health, vitality, and social 
functioning, with patients experiencing fewer role limitations due to physical health relative 
to their pre-transplant level of function (Archonti et al., 2004; Cohen et al., 1998; Limbos et 
al., 1997; Limbos et al., 2000; Rodrigue, Baz, Kanasky, et al., 2005; Rutherford et al., 2005; 
Stavem et al., 2000). However, even in patients with successful clinical outcome, lung 
transplantation does not lead to the complete recovery of health and is frequently associated 
with long-term medical complications, including graft dysfunction, recurrent infections, and 
the side effects of immunosuppressive drugs that affect approximately 40% of LTx patients 
(Inci et al., 2013). In addition, mental health problems commonly occur, including depressive 
disorders, adjustment disorders, and generalized anxiety disorders with prevalence rates up to 
30% (Dew et al., 2012; Goetzmann, Irani, Schwegler, Stamm, Bricman, et al., 2010). These 
medical and psychological complications contribute to limitations in physical fitness, and can 
negatively influence a patient’s ability to cope with their new graft, their adherence to 
pharmacologic therapy, and their postoperative HRQoL (De Perrot et al., 2004; Xu et al., 
2012).  
The lung transplant procedure creates complex ongoing medical and psychological 
challenges for patients, starting prior to surgery and extending far beyond the first year of 
survival. After transplantation, patients must follow a strict medical regimen and are expected 
to perform a variety of health-promoting behaviors. These medical routines are often 
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perceived as stressful and disruptive, because they interfere with daily activities and patients’ 
interests (Xu et al., 2012).  
Qualitative data analyses based on patient narratives could provide valuable insights 
into post-transplant adjustments following lung transplantation. Presently, few studies have 
been published that qualitatively examined the subjective experience of lung transplantation. 
Accessible qualitative studies addressing patients’ transplant experiences have investigated 
the psychological processing of transplantation (Goetzmann et al., 2009), feelings of guilt and 
relationships with the donor (Neukom et al., 2012), symptom experiences and reactions to the 
threat of rejection (De Vito Dabbs et al., 2004), post-transplant compliance behaviors 
(Goetzmann, Moser, et al., 2006), and patient experiences with education and support after 
transplantation (Ivarsson, Ekmehag, & Sjoberg, 2013). However, these studies were 
preliminary and hampered by methodological limitations, including the use of small study 
samples and restrictions in data collection (e.g. no tape recording, temporal distortion in data 
collection).  
The underlying aim of this prospective qualitative study was to provide a 
comprehensive view of patients’ postoperative experiences with their transplant and 
adjustments to normal life during the first six months following transplantation. We 
hypothesized that a deeper understanding of the themes that emerge within the early 
postoperative phase and how lung transplant patients cope with their post-transplant situation 
may help professionals to respond more competently to patients’ needs, especially to those 
who suffer from increased emotional distress post-operatively. 
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6.3 Methods 
6.3.1 Patients 
Between January 2012 and April 2014, 72 lung transplants were performed at the Transplant 
Center at the University Hospital of Zurich, Switzerland. All patients who received lung 
transplants over this time period were considered eligible for inclusion, unless they were: (i) 
younger than 18 years of age, (ii) unable or unwilling to provide informed consent, or (iii) 
unable or unwilling to complete questionnaires in German. Forty-four consecutive adult LTx 
recipients qualified for the study. During data collection, 3 subjects unexpectedly withdrew 
from participation for medical or personal reasons (e.g., feeling overwhelmed by hospital 
routines and preparations for discharge, distressed, overly-tired, and/or short of time). One 
patient had to be excluded due to critical health conditions and repeated admissions to the 
intensive care unit (ICU). The final sample included 40 patients. Interview data were 
supplemented with demographic and clinical information obtained from medical records.  
 
6.3.2 Procedures 
The patients were interviewed at three different time points (T1: two weeks; T2: three 
months; and T3: six months post-transplant) regarding their thoughts, feelings and attitudes 
with respect to the transplantation process itself, the new lungs they had received, the organ 
donor, and the medication they had been prescribed post-transplantation. While the first 
interview at T1 was performed during the initial hospitalization, the follow-up interviews at 
T2 and T3 typically were conducted during regular transplant clinic out-patient visits at the 
University Hospital Zurich. A few patients either still were hospitalized or had been 
readmitted to hospital due to complications at T2 or T3. All patients provided written 
informed consent prior to their participation. The patients were informed about their right to 
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withdraw from the survey at any time. The study was approved by the Ethics Committee of 
the Canton of Zurich, Switzerland.  
 
6.3.3 Data collection 
Eligible patients were invited to participate in a semi-structured interview. The interviews 
were conducted by three different investigators (A.B., V.H., A.S.) who worked either as a 
psychiatrist or clinical psychologist in the Department of Consultation-Liaison Psychiatry at 
the University Hospital of Zurich. All interviews were tape-recorded and then transcribed 
verbatim (A.S.). The interviews lasted, on average, 20 minutes (range 10 to 30 minutes). The 
core questions asked in the semi-structured interview are listed in Table 9. 
 
Table 9: Questions in the semi-structured interview 
Interview questions 
1 What thoughts, feelings and attitudes do you have with respect to the transplantation process itself? 
2 What thoughts, feelings and attitudes do you have with respect to the new lung(s)? 
3 What thoughts, feelings and attitudes do you have with respect to the organ donor? 
4 What thoughts, feelings and attitudes do you have with respect to your current medication regimen? 
Note. These broad interview questions were supplemented by appropriate open-ended questions.  
 
6.3.4 Data analysis 
Qualitative analysis 
The 120 interviews (40 patients; 3 data collection points) were analyzed by qualitative 
content analysis as per Mayring (2008), using the qualitative data analysis software 
ATLAS.ti, version 5.2 (atlas.ti, 2015). Mayring’s (2008) qualitative content analysis is one of 
the most frequently used qualitative methodological approaches in social research in German-
speaking countries. 
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In the present study, four main categories were defined deductively from the semi-structured 
interviews. They were: ‘the lung transplantation procedure itself’, ‘the new lungs’, ‘the 
donor’, and ‘the medication regimen’. One author rated the interviews (A.S.). Using the 
research questions, text material was analyzed by stepwise inductive construction of coding 
categories (codes), which were then assigned to the main categories. After 10% of the text 
material was analyzed, the codes were re-evaluated and revised (N.D.; L.G.). The number of 
responses determined the relevance of each code. Inter-rater reliability of the defined codes 
was evaluated (N.D.), by rating a random sample of 20% of the quotations that had 
previously been coded by the first author. In cases of disagreement, consensus was achieved 
by discussion and adjustment of the codes. Inter-rater reliability was calculated as Cohen’s 
kappa across all main categories. The two code assignment ratings achieved excellent inter-
rater reliability, as indicated by Cohen’s kappa values ranging between .89 and .97 (category 
LTx: .97; category new lungs: .92; category donor: .95; category medication regimen: .89). 
 
Quantitative analysis 
Qualitative analysis was followed by quantitative analysis to examine the frequency of 
mentioned codes and changes in the response categories over time. The data consisted of 
binary variables (mentioned: 1; not mentioned: 0) for each unique code identified during 
qualitative analysis. The Statistical Package for the Social Sciences (SPSS, version 22.0) was 
used to perform all statistical analyses, with any two-tailed probability value less than .05 
considered statistically significant (IBM Corp, 2013). Descriptive statistics were reported as 
median and range, or as counts and percentages, as appropriate. To test for changes between 
the three data collection points (T1-T3), Cochran’s Q test and McNemar’s test were used to 
identify statistically-significant differences between the time points. Gender comparisons 
were conducted via Fisher’s exact test. 
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6.4 Results 
6.4.1 Sample characteristics 
Participants included 21 male and 19 female lung transplant recipients with a median age at 
the time of transplantation of 52 years (range 20 to 68). Of the 40 patients, 43% were 
married. With respect to employment status, 45% were not working prior to their transplant 
for health reasons, while 20% were already retired. The main indication for transplantation in 
our clinical sample was chronic obstructive pulmonary disease (COPD; 38%), which was 
followed by cystic fibrosis in 30%. Six months after transplantation, all 40 patients were still 
alive. Demographic and clinical characteristics are summarized in Table 10. 
 
 
Table 10: Demographic and clinical characteristics of lung transplant (LTx) recipients 
Variables 40 LTx recipients n (%) 
Male gender 21 (53) 
Median age (range)  52 (20 - 68) 
Education level  
Elementary 
Secondary 
Tertiary 
 
6 (15) 
25 (63) 
9 (22) 
Married/ in partnership 29 (73) 
Primary indication for LTx  
COPD 15 (38) 
Cystic Fibrosis 12 (30.0) 
Idiopathic Pulmonary Fibrosis 8 (20.0) 
Others 5 (12) 
Bilateral LTx 40 (100) 
Time on waiting list (d) (median; range) 224 (10 - 992) 
Days in the ICU (median; range) 4 (2 – 29) 
Weeks in hospital pLTx (median; range)  4 (3 – 14) 
Note. LTx = lung transplantation; pLTx = post-transplant; COPD = chronic 
obstructive pulmonary disease; ICU = intensive care unit. 
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6.4.2 Qualitative data 
Text analysis revealed six codes for the theme ‘transplantation’, four codes for the theme 
‘new lungs’, five codes for the theme ‘donor’, and seven codes for the theme ‘medication 
regimen’. The identified codes and categories are described and exemplified with patient 
quotations below. 
 
Thoughts, feelings and attitudes about the transplantation process itself 
Thoughts, feelings and attitudes about transplantation can be encompassed by the themes 
‘physical benefits’, ‘physical complaints’, ‘psychological distress’, ‘psychological benefits’, 
‘coping strategies that could positively affect recovery’, and ‘ICU delirium’.   
 
I. Physical benefits 
With respect to the transplantation procedure, ‘physical benefits’ was the category most often 
mentioned by patients (T1: 75%; T2: 83%; T3: 73%). Patients spoke about how the 
transplantation had saved their life and frequently associated the lung transplantation event 
with prolonged survival, a second chance at living, or a gift of life. Furthermore, physical 
benefits encompassed significant improvements in physical function, vitality and health 
perceptions, such as being able to breathe again, being able to walk without supplementary 
oxygen, generally having more energy for conducting day-to-day activities, and being able to 
participate in sporting activities like hiking, riding a bicycle and playing tennis, or to play 
music. Many patients expressed relief about no longer suffering from respiratory distress, 
coughing or always having mucus in their lungs.  
‘It is crazy how quickly one forgets how bad it was before transplantation… I was no longer 
mobile; I could not feed myself; drinking was difficult; and going to the toilet required an 
enormous effort… I had to refuse to do many enjoyable things. My life was restricted by my 
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poor physical condition, which included shortness of breath, fatigue and difficulty exercising. 
Now I can breathe without being exhausted, I can walk without getting short of breath, and 
can speak or laugh simultaneous with walking. It is simply marvelous that today I can pursue 
hobbies, walking outside in nature, riding a bike...’ 
 
II. Physical complaints 
Despite significant physical benefits, patients also reported numerous physical complaints 
(T1: 58%; T2: 60%; T3: 48%). The most frequent were pain and discomfort, feeling pressure 
at the incision site, nausea, fatigue, feebleness, muscle weakness, poor digestion, diarrhea, 
and recurrent infections. A few patients disclosed having subsequently been diagnosed with 
cancer, diabetes or hypertension.  
‘It bothers me that I am still not physically fit. Even though I train regularly, I lack muscle 
strength and quickly get exhausted. I am very tired and need a lot of rest. After a busy day, I 
am so tired that I can hardly do anything.’  
 
III. Psychological distress 
Records indicated that psychological adjustment to transplantation was associated with 
considerable psychological distress (T1: 48%; T2: 30%; T3: 38%), including feelings of 
being overwhelmed, helplessness, lack of control, nervousness, and being worried about 
complications or organ failure. Common characteristics of the difficulty to adjust to the 
postoperative situation were depressed mood, anxiety, emotional disturbances, and sleep 
difficulties. Psychological distress also occurred because of the prolonged rehabilitation 
process, major side effects of medication, social isolation for fear of infections, insecurity in 
physical symptom recognition and in dealing with medication, and repeated hospital 
admissions.  
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‘Physically, I am in good condition. However, when I became able to leave the hospital and 
go home, suddenly I found myself suffering from a number of fears. I had great difficulties 
structuring and organizing my daily life. I quickly felt distressed and overwhelmed doing 
things that used to be easy for me. My wife worked full-time and could not be with me all day. 
I was not able to cope with the situation at home and felt like I was going crazy. So I let 
myself be hospitalized again.’  
 
A few patients expressed distress due to still being on sick leave while in good physical 
condition. Those patients felt bored staying at home all day and not having meaningful 
activities to engage in.  
 
IV. Psychological benefits 
In addition to physical improvements, psychological benefits were observed following lung 
transplantation (T1: 33%; T2: 38%; T3: 28%). Typically, after surgery, patients felt elated 
and experienced a sense of relief and satisfaction with their steadily-improving lung function. 
In particular, psychological benefits were related to gains in mobility, autonomy, self-care 
and usual activities, as well as in reduced psychological distress and anxiety. Likewise, 
patients were happy to again be able to take care of their family and to engage in social and 
cultural activities and pursue hobbies.  
‘Thanks to the transplant, I can again provide care for my family. At the time I was sick, I 
always felt I was a bad mother. This feeling bothered me deeply … Before transplantation, I 
had no energy at all and had to tell my children that they had to look after themselves or that 
they had to go somewhere alone. Today, I thoroughly enjoy that I can be there for my family. 
But I also enjoy that I can be independent again; that I can meet friends and go to parties.’  
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Prior to transplant, physical impairments resulted frequently in feelings of low self-
confidence and withdrawal from social life. After lung transplantation, some patients reported 
to have experienced a boost in self-confidence: ‘Because I can speak without getting out of 
breath and generally have more energy, it is much easier for me to approach to people and I 
feel more like going out’.  
 
V. Coping strategies promoting recovery   
A small proportion of patients mentioned various coping strategies that might have positively 
affected their recovery and adjustment to post-transplant life (T1: 28%; T2: 18%; T3: 28%). 
Among adaptive cognitive coping styles, adopting a positive life orientation, focusing on the 
future and not thinking too much about possible complications were highlighted.  
‘From the very first, I decided not to think too much about the transplant and possible 
complications. I simply take each day as a gift. There are few people who wonder what I will 
do when my new lungs stop working. I tell them that I don’t want to discuss such an 
eventuality. I will not allow myself to harbor such negative thoughts. I live with the transplant 
from day to day, being thankful for every good moment I can have with my new lungs.’  
 
Other coping strategies were based on problem-focused, information-seeking or social 
support-seeking behaviors, like promoting information about organ donation and providing 
donor cards to friends and working colleagues, and talking about their experiences with other 
transplant patients and thus supporting each other. Only a few patients mentioned a change in 
their emotional reactions, like being much calmer in stressful situations. In general, any 
meaningful activity – like attending a course, returning to work, enjoying one’s family and 
garden, going on holidays, and holding one’s pet, facilitated the recovery and resumption of 
normal life.  
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VI. ICU delirium 
Memories of intensive care unit (ICU) delirium were reported by only a minority of patients 
(T1: 23%; T2: 5%; T3: 10%). Patients described their delirium states as ‘dreamlike 
experience’, ‘a delirious condition between half-asleep and half-awake’, ‘crazy dreams’, 
‘nightmares’, ‘fantasies, and ‘illusions’. The contents of hallucinations were primarily lost 
orientation, distorted feelings, chaotic thoughts, diffuse fears, and feeling threatened. Subjects 
described their delusions as ‘perfectly real’. Some believed that their hallucination happened 
at the exact moment of transplantation.  
 ‘The hallucination started with a beautiful dream; there was wonderful music and everyone 
was happy. But then, an evil woman came to kill me. I was fastened to the bed. I couldn’t 
move or defend myself. I was terribly afraid; it was an awful feeling to be so helpless…’ 
 
Thoughts, feelings and attitudes about the new lungs 
The category ‘new lungs’ contained four subcategories: ‘fear of transplant rejection’, 
‘fantasies regarding new lungs’, ‘satisfaction with new lungs’, and responsibilities for the 
new lungs’.  
 
I. Fear of transplant rejection 
The most frequently mentioned theme with respect to the category ‘new lungs’ was ‘fear of 
transplant rejection’ (T1: 53%; T2: 45%; T3: 55%), which also included the fear of 
infections, fear of losing the graft, and fear of requiring a second transplant. The majority of 
patients anticipated that, sooner or later, their transplant would be rejected.   
‘I do not know how the future looks like. I do not know if my body will reject the transplant or 
when. I only hope that good lung function can be maintained for a long time and that I have 
few medication side effects and little to no evidence of rejection. However, the latent fear of 
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rejection is always present. Every time I need to go to the clinic to check my numbers (e.g., 
oxygen levels, spirometry testing, pulmonary function tests, and blood tests), I worry about 
my health, even though I am feeling well.  It is confusing, because you cannot rely on how 
your body feels; you can never be certain…’ 
 
The threat of organ rejection was associated with better symptom recognition and reporting. 
Most patients reported paying great attention to symptoms. However, many patients 
described insecurity in how to interpret their symptoms, because the symptoms associated 
with rejection often were identical to those related to everyday illnesses (cold, the flu, etc.). 
This ambiguity with symptom recognition resulted in health-concerns, careful illness 
behavior, and the fear of making mistakes.  
 
II. Fantasies regarding the new lungs 
About one third of the patients mentioned fantasies regarding the new lungs (T1: 40%; T2: 
38%; T3: 35%) with respect to their body image and identity. Approximately one third of the 
patients reported that they perceived the new lungs to be part of themselves (T1: 28%; T2: 
35%; T3: 28%) and used statements like ‘the lungs belong to me’, ‘the lungs became part of 
me’, or ‘I have fully adopted the lungs’. While one patient gave the new lungs a name (‘the 
new lungs are my Empress, so I call them Sissi’), another patient said that she had accepted 
the new lungs as part of herself and that she therefore did not need to give them a name. She 
added that she did not give too much thought to her new lungs. She just lived with them. Two 
patients had the feeling that their lungs had been repaired instead of replaced (T1: 5%; T2: 
3%; T3: 3%).  
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‘The advantage is that you cannot see the transplant. If I had the hand of a Chinese woman, I 
would be constantly reminded that I carry something foreign. But I cannot see the lungs, so I 
can live with the idea that my old lungs simply got cleaned.’ 
 
A minority of patients mentioned perceiving their new lung(s) as a foreign object (T1: 8%; 
T2: 5%; T3: 3%), though this feeling tended to decrease over time. They made statements 
like: ‘the lungs are something new’, ‘as of yet, the lungs have not arrived’, ‘the lungs need to 
get used to my body’, and ‘this represents a dynamic process that takes awhile’. Thoughts 
regarding the new organ spontaneously transferred to the donor and to the fact that they were 
alive because someone else had died.  
 
III. Satisfaction with the new lungs   
The patients who reported ‘satisfaction with the new lungs’ were mostly patients who had 
experienced optimal postoperative trajectories without complications or recurrent infections. 
This might also explain why this code was named by only a small proportion of patients (T1: 
18%; T2: 35%; T3: 20%).  
 
IV. Responsibility for the new lungs 
A few patients expressed feelings of responsibility for their new lungs (T1: 13%; T2: 8%; T3: 
10%) and reported perceiving the new lungs as ‘a gift’, as ‘something of particular value’ that 
they have to take care of and look after.  
‘My thoughts mainly revolve around my new lungs. Everything I do, I do out of respect for 
my new lungs. I do hope that everything goes well and that the lungs remain working for a 
long time. I am therefore very committed to taking the best care of myself and paying 
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attention to any abnormal changes I feel. It is equally important to me that I work closely 
with the transplant team to monitor my condition.’ 
 
Thoughts, feelings and attitudes about the donor  
Analysis of the ‘thoughts, feelings and attitudes about the donor’ category resulted in five 
codes, which included ‘gratitude’, ‘thoughts regarding the bereaved’, ‘fantasies regarding the 
donor’, ‘dealing with the donor’s death’, and ‘worries regarding the donated organ’s quality’.  
 
I. Gratitude 
Of all the codes‚ ‘gratitude’ was the most frequently mentioned (T1: 83%; T2: 88%; T3: 
80%). The vast majority of patients expressed deep feelings of gratitude for the donor’s 
generosity and for the opportunities the new organ(s) had given them. Patients spoke about 
the donor as ‘an angel who saved my life’, or ‘someone who gave me my life back, the most 
precious gift anyone can give…’. Patients frequently expressed their gratefulness to the 
donors by taking good care of the organ or by thinking of the donor when celebrating the 
anniversary of their transplantation.   
‘Especially on my birthday, but also on the anniversary of my transplant, I think of the donor 
and I realize that I would not have become this old without the donor’s lungs. I am grateful to 
the donor that he donated his organs so I feel obligated to take care of my new organ and do 
everything I can to keep the lungs going’. 
 
Despite feelings of gratitude, many patients felt that there was no purpose to them having 
further thoughts about the donor: ‘I am thankful to the donor, but otherwise do not concern 
myself with thoughts about them’. 
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II. Thoughts regarding the bereaved 
The most frequently mentioned code in this category was ‘thoughts regarding the bereaved’ 
(T1: 25%; T2: 35%; T3: 33%) who were undoubtedly in mourning. Similar to their thoughts 
about the donor, the patients expressed feelings of gratefulness towards the relatives for 
having agreed to the removal of their loved one’s organs, while simultaneously 
acknowledging the difficulties inherent in making this decision (‘I think the bereaved family 
needs a lot of strength to decide, at the last moment, whether an organ should be donated’). 
Many patients would like to return the favor by writing an anonymous thank-you letter to the 
bereaved family: ‘Maybe it would be nice for the bereaved family to hear that someone is 
grateful for the donated lungs. I have three children who fully need me’.  Simultaneously, 
patients felt sympathy for the bereaved: ‘I often think of the bereaved family. While I have 
had this transplant for six months, it is only six months ago that the donors’ relatives suffered 
a significant loss. This is definitely not easy’.  
 
III. Fantasies regarding the donor 
A small percentage of patients (T1: 30%; T2: 30%; T3: 23%) spoke about their speculations 
with respect to the donor. They wondered about the donors’ gender, age and personality, as 
well as the circumstances surrounding the donor’s death. Driven by curiosity, a few patients 
researched the newspaper to identify fatal accidents and thereby discover more about the 
donor’s death.  
Only a few patients felt somehow connected to the donor (T1: 13%; T2: 8%; T3: 10%) and 
described their relationship as ‘a sensation of relatedness’, ‘congeniality of souls’, ‘having 
something in common’ or ‘he continues to live through me and I continue to live through 
him’.  
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Only two patients thought about having adopted the donor’s characteristics (T1: 0; T2: 5%; 
T3: 3%): ‘Since I have had the new lungs, I am simply thrilled to go shopping. My friends tell 
me jokingly that I received the lungs from a former shopping queen’, or ‘Since I have had 
this transplant, I have had a craving for black coffee. I keep wondering if this has something 
to do with my new lungs’. 
 
IV. Dealing with the donor’s death 
There were two different types of response related to the donor’s death (T1: 25%; T2: 15%, 
T3: 18%). One group of patients (35%) was affected by feelings of sadness and latent 
feelings of guilt regarding the donor’s death, and expressed emotional difficulties accepting 
that the donor had to die so they could get the organ. ‘Shortly after transplantation, I 
reflected on this for a long time — that someone had to die so I could continue to live. Only 
after many discussions with my caregiver did I come to understand that the donor had to die 
anyway, regardless of whether I received the lungs or not’. The other group of patients (28%) 
presented themselves as detached from any emotional involvement with the donor’s death 
and reasoned that ‘the donor had to die anyway’; ‘it was not my fault that the donor had to 
die’; or ‘I assume that the donor consented to donating organs after his death’. 
 
V. Worries regarding donated organ quality  
While at T1, six patients talked about being worried regarding the quality of the donated 
organ, at T2 and T3 only one patient mentioned these fears (T1: 18%; T2: 3%, T3: 3%). The 
fears were related to thoughts like ‘I hope the donor lived a healthy life and I’ve received 
healthy lungs’, or ‘especially uncertainty about who the donor was, whether he had taken 
care of himself, whether he had led a healthy life or whether he has smoked, bother me. After 
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all, the new lungs are a foreign object inside my body; I do not know the lungs and I did not 
know the donor’.  
 
Thoughts, feelings and attitudes about the medication regimen 
I. Side effects 
The code ‘side effects’ had the highest rates of mention (T1: 78%; T2: 75%; T3: 78%) within 
the category ‘thoughts, feelings and attitudes about the medication regimen’. Numerous side 
effects were named, including nausea, vomiting, change in taste, stomach pain, 
gastrointestinal complaints, hirsutism, Cushingoid appearance, weight gain, and swelling. In 
addition, neurotoxic effects of immunosuppression were reported, like tremors, headaches, 
light sensitivity, restlessness, neuropathy (burning and numbness in hands/feet), insomnia, 
and mood swings.  
 
In the early postoperative phase, patients were most concerned about dealing with the nausea 
and vomiting caused by their new medication.  
‘In the beginning, I had to take the medications two or even three times because I vomited 
them all up. Even thinking about the medication, I had to throw up. I had troubles accepting 
that I have to take so many drugs’. 
Side effects that frequently were reported later in the postoperative period were tremors, 
swelling, and weight loss or weight gain. 
‘I suffer from severe tremors. I cannot pour a mug without spilling. The tremors sometime 
drive me crazy. I would like to take less cyclosporine, but that could be the final blow for my 
transplant.’  
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Concerns also related to long-term adverse effects and damage to other organs, as well as at 
the mercy of physicians. ‘The feeling of being at the mercy of the transplant team, without 
being involved in decisions, makes me feel helpless. Sometimes I feel like a passenger in a 
plane, but worse’. Metaphorical concepts of treatment included the idea that drugs attack and 
destroy one’s body. Patients referred to drugs as ‘little bombs’, ‘an enormous load of 
chemistry’, ‘a necessary evil’, and ‘an unresolved dilemma’. 
 
II. Benefits of medical treatment 
Despite the many complaints resulting from medical treatment, most patients were aware of 
the importance and necessity of their drugs (T1: 73%; T2: 60%; T3: 68%). Mentioned 
advantages of the medical treatment were: ‘the medical treatment ensures that the lung is not 
rejected’; ‘thanks to the medication, I am doing fine’; ‘the drugs give me a chance to survive, 
a chance to live’; ‘without the drugs, the transplant won’t work’; and ‘they are protection 
against infections and rejection’. 
 
III. Restrictions in everyday life 
Feeling restricted in everyday life as a consequence of the strict medical regimen and side 
effects increased significantly over time and was most pronounced at T2 and T3 (T1: 43%; 
T2: 70%, T3: 65%). On one hand, restrictions referred to the large number of medications 
required and the strict dosing schedule: ‘My everyday life must comply with that strict drug 
schedule. I don’t feel free anymore; my life is determined by my medication regimen’. On the 
other hand, for many patients, following the medication regimen implied not only an 
expenditure of time but also organizational responsibilities. Additionally, some felt that their 
required adherence to strict diets was somehow an invasion into their everyday life.  
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‘Sometimes it is very hard to follow the medication regimen, and taking the medication is 
very time-consuming. I get up at 8.00 a.m.; I measure my blood glucose and take my 
medication. Then I need a break to recover from nausea. I then continue with my inhalers. It 
isn’t until about 11 a.m. that I’m done with the whole program. Furthermore, I have to follow 
a strict diet: eating cheese, eggs or raw meat is prohibited. In addition to that, the many 
follow-up appointments restrict my everyday life. Sometimes I feel time pressured. I also feel 
restricted in my private life. For instance, I cannot spontaneously go out for dinner with my 
husband because I have to be home in time to take my medications; and, when I want to go 
on holiday, I have to plan carefully what I need to bring. I have to think not only of my pills, 
but also my inhalers, the blood pressure meter, the home spirometer, the cold box for the 
medication… this is just tedious.’ 
 
IV. Adherence to medication 
The code ‘adherence to the medication regimen’ included statements regarding attitudes and 
intentions, beliefs and satisfaction relating to the medication as well as perceived behavioral 
control of the prescribed intake of medication. Slightly more than one third of the patients 
rated their adherence to their medication regimen as good (T1: 38%; T2: 35%; T3:43%). 
Sustained motivation for regular medication intake stemmed from the belief that the 
medications were imperative for their survival (‘the medications are indispensible to life’), 
but also from a sense of commitment and responsibility towards the donor and the transplant 
team (‘I feel obliged to take care of the matter, mainly out of respect for the donor, but also 
for the transplant team’). Patients also admitted that they had ‘accepted the fact of taking 
medication all (their) life’, and that taking medication had become routine: ‘the medications 
are as much a part of my life as the daily brushing of teeth’; ‘the medication became part of 
my life’. 
106  Psychological Adjustment to Lung Transplantation  
 
 
Only a very small minority of patients admitted to having missed a dose of medication, taken 
drug holidays, postponed drug intake, or failed to follow a dietary program or health behavior 
(T1: 3%; T2: 3%, T3: 5%).  
‘The medications make me feel depressed, so I frequently postpone them… And the inhaler 
causes nausea and shortness of breath and scrapes my throat. Therefore, instead of daily, I 
inhale every five days.’  
 
V. Coping strategies to manage the medication regimen 
Coping strategies related to the management of medication were mentioned only by a 
minority of patients, but the reported use of such strategies increased over time (T1: 5%; T2: 
18%; T3: 20%). Principally, two different coping styles were observed: on one hand, 
adaptive cognitive coping styles were used, characterized by cognitive flexibility in terms of 
modifying one’s way of thinking and distancing oneself from the problem of medications (‘I 
don’t want the medication to determine my life, I’d rather focus on things I could not do 
anymore before the transplant’; and ‘the medications don’t cause any problems; I have 
accepted them as part of the game’). On the other hand, patients adopted problem-focused 
strategies or tricks to make the handling of medications easier and more pleasant (‘I take the 
medication together with a yoghurt’; ‘I have shifted the drugs so I only have to take them 
twice a day’; and ‘I always try to do something useful or something I like while I have to use 
the inhaler. Usually, I read the newspaper or watch the news’).  
 
VI. Insecurities dealing with medical treatment 
Insecurities dealing with medical treatment were largely restricted to T1 and only mentioned 
by a few patients (T1: 8%; T2: 0; T3: 3%).  
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‘When I have a migraine and throw up, I become worried because I don’t know whether or 
not my body has already absorbed the drugs. I always have doubts about whether I should 
take them once again. I worry and wonder: how bad is this now?’ 
 
6.4.3 Quantitative analysis 
The frequency of responses and changes over time are shown in Table 11, and the rank orders 
of response categories are depicted in Figure 8. The most frequently-mentioned codes with 
respect to the categories ‘lung transplant’, ‘new lungs’, ‘donor’ and ‘medication regime’ were 
‘physical benefits’ (T1: 75%; T2: 83%, T3: 73%), ‘fear of rejection’ (T1: 53%; T2: 45%; T3: 
55%), ‘gratitude’ (T1: 83%; T2: 88%; T3: 80%), and ‘side effects (T1: 78%, T2: 75%, T3: 
78%), respectively. Significant changes in response frequencies over the three data time 
points were identified only for ‘ICU delirium’ (Cochran’s Q = 6.000; p = .05), ‘worries 
regarding donated organ quality’ (Cochran’s Q = 8.000; p = .02), and ‘restrictions in 
everyday life’ (Cochran’s Q = 6.462; p = .04). While response rates for ‘ICU delirium’ (T1 
vs. T2: p = .04; T1 vs. T3: p = .23; T2 vs. T3: p = .69) and worries regarding donated organ 
quality’ (T1 vs. T2: p = .07; T1 vs. T3: p = .07; T2 vs. T3: p = 1.000) diminished over time, 
rates for ‘restrictions in everyday life’ increased (T1 vs. T2: p = .04; T1 vs. T3: p = .09; T2 
vs. T3: p = .81). Gender comparisons revealed only marginal differences in response rates, 
with women more frequently mentioning coping strategies with respect to recovery at T1 (p = 
.05) and more side effects at T2 (p = .04) than men.  
 
6.5 Discussion 
Using qualitative content analysis, we found ‘physical benefits’, ‘fear of organ rejection’, 
‘gratitude’, and ‘medication side effects’ to be mentioned most frequently within the 
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predefined categories ‘lung transplant’, ‘new lungs’, ‘donor’ and ‘medication regimen’, 
respectively. Interestingly, the response rates, by category, hardly changed over time, 
indicating that most themes that patients were concerned about initially remained unchanged 
over the first six postoperative months.  
 
Table 11: Changes in response categories over time 
 
T1 
n = 40 
 T2 
n = 40 
 T3 
n = 40 
 Test statistics 
Category LTx n %  n %  n %  Cochran’s Q p 
Physical benefits  30 75  33 83  29 73  2.000 .37 
Physical complaints  23 58  24 60  19 48  1.750 .42 
Psychological distress  19 48  12 30  15 38  3.083 .21 
Psychological benefits  13 33  15 38  11 28  1.412 .49 
Coping strategies promoting 
recovery 
11 28  7 18  11 28  1.600 .45 
*ICU delirium 9 23  2 5  4 10  6.000 .05 
Category new lungs            
Fear of transplant rejection  21 53  18 45  22 55  1.083 .58 
Fantasies regarding new lungs 16 40  15 38  14 35  .273 .87 
Satisfaction with new lungs  7 18  14 35  8 20  4.526 .10 
Responsibility for new lungs 5 13  3 8  4 10  .667 .72 
Category donor            
Gratitude 33 83  35 88  32 80  .933 .63 
Thoughts regarding the bereaved 10 25  14 35  13 33  1.625 .44 
Fantasies regarding donor 12 30  12 30  9 23  .900 .64 
Dealing with donors’ death 10 25  6 15  7 18  1.529 .47 
*Worries regarding donated 
organ quality 
7 18  1 3  1 3  8.000 .02 
Category medication regimen            
Side effects 31 78  30 75  31 78  .118 .94 
Benefits of medical treatment 29 73  24 60  27 68  1.407 .50 
*Restrictions in everyday life 17 43  28 70  26 65  6.462 .04 
Adherence to medication  15 38  14 35  17 43  .519 .77 
Coping strategies to manage 
medication regimen 
2 5  7 18  8 20  5.636 .06 
Non-adherence to medication 
regimen 
1 3  1 3  2 5  .667 .72 
Insecurities dealing with 
medication treatment 
3 8  0 0  1 3  3.500 .17 
Analyses over time conducted by means of Cochran’s Q test for categorical variables. 
*McNemar test was used to identify statistically-significant differences between the time points. 
ICU delirium: T1 vs. T2: p = .04; T1 vs. T3: p = .23; T2 vs. T3: p = .69 
Worries regarding quality of donated organ: T1 vs. T2: p = .07; T1 vs. T3: p = .07; T2 vs. T3: p = 1.000 
Restrictions in everyday life: T1vs T2: p = .04; T1 vs. T3: p = .09; T2 vs. T3: p = .81 
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Figure 8: Frequency and rank order of response categories. Note: * indicates statistically significant difference. 
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Only three response categories changed in the frequency of mention over those first six 
months. While thoughts about ICU delirium and worries regarding donated organ quality 
decreased significantly within the first three months, concerns about restrictions in everyday 
life increased over six months. The lengthy process required for recovery and adjustment to 
transplantation, which typically spans several years, might explain the relative absence of 
change over time. At six months post-transplant, patients are only starting to resume their 
normal daily routines (Rosenberger, Dew, DiMartini, et al., 2012). Also notable in our results 
is that, contrary to other investigations that found women to experience more frequent 
problematic symptoms and lower gains in HRQoL than men (Kugler et al., 2007; Rodrigue & 
Baz, 2006), we encountered only marginal gender differences with respect to psychological 
adjustments to transplantation. By reason of lack of statistical significance over time and 
between the genders, for this paper, it is more fruitful to consider the content of the respective 
response categories qualitatively. 
 
6.5.1 The transplantation process 
In line with a number of other, already-published outcome studies (Finlen Copeland et al., 
2013; Kunsebeck et al., 2007; Vermeulen et al., 2004), the majority of narrations indicated a 
positive impact of lung transplantation on health status and well-being. Patients 
acknowledged marked improvements in their physical function, vitality, mobility, level of 
autonomy, and self-care, and reduced psychological distress and anxiety. This being said, 
physical complaints were mentioned almost as often as physical benefits. The main physical 
issues were nausea, fatigue, feebleness, gastrointestinal disorders, and recurrent infections. 
Adjusting to new stresses associated with post-transplant life can trigger mental health 
problems (Rosenberger, Dew, DiMartini, et al., 2012). Consistent with other studies that 
identified elevated risks of mental health problems and psychological distress in lung 
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transplant recipients (Dew et al., 2012; Kugler et al., 2007; Limbos et al., 2000), 30% of the 
patients in our sample reported features of psychological distress. In our study cohort, 
psychological distress within the first six months post-transplant was primarily linked to 
feelings of being overwhelmed, sensing a loss of security, feeling anxious at the time of 
discharge, having latent feelings of guilt over knowing that some other person had to die for 
them to receive their organ, worries about the threat of infections and organ failure, severe 
medication side effects, and perceived significant restrictions in everyday life.   
Adopting active coping mechanisms can help one to deal with the stress-related 
experiences of transplantation, especially during the early postoperative phase (Nilsson, 
Forsberg, Lennerling, & Persson, 2013). In our study, the number of patients who mentioned 
coping strategies was surprisingly low. However, those respondents who used coping tended 
to use positive coping strategies (to promote positive well-being). In particular, these patients 
brought up problem-focused, information-seeking, and social-support seeking coping 
strategies. The training of pre- and post-transplant coping skills is important, as there is 
evidence that the use of problem-focused coping strategies positively influences post-
transplant outcomes (Golfieri et al., 2007).  
Even though ICU delirium following transplantation is commonly experienced in lung 
transplant recipients (Smith et al., 2015), in our study, only a small minority of patients 
(23%) reported the experience of delirium in their narrations, indicating that most patients 
seemed to remember little to none of their time in the ICU. Consistent with other findings on 
ICU delirium in transplant patients (DiMartini, Dew, Kormos, McCurry, & Fontes, 2007; 
Flynn et al., 2013), the main themes of ICU dreams were ‘feelings of threat’ and ‘fears about 
death’, both of which might reflect the patients’ uncertainty, lack of control, lack of trust, and 
presence of constant agony pre-transplant. Moreover, thoughts about ICU delirium 
diminished significantly over the first six months post-transplant. Although a few reports 
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have been published suggesting that individuals can be adversely affected by transplant and 
ICU experiences (DiMartini et al., 2007; Flynn et al., 2013), our accounts revealed no 
evidence of psychological difficulties following the ICU stay.  
 
6.5.2 New lungs 
In our patient sample, ‘fear of transplant rejection’ was one of the most prevalent concerns 
post-transplant (more than 50% of all patients), resulting in illness behavior, fear of making 
mistakes, and social isolation. During postoperative management, the transplant team plays a 
pivotal role by communicating confidence via the regular monitoring of each patient’s health 
condition. At the same time, being reliant on the transplant team interfered with many 
patients’ desires for independence and self-reliance. On the other hand, to prevent infections 
and rejection, patients must assume some level of responsibility for attentively watching for 
changes in their condition, precociously reporting symptoms, and recognizing their shared 
responsibility with the transplant team, so as to achieve an acceptable quality of life within 
the limits imposed by their illness (De Vito Dabbs et al., 2004).  
When asked about their thoughts and feelings towards their new lungs, many patients 
mentioned having ‘adopted’ the new organ. While most patients believed that the new organ 
had become a part of them and, thus, reasoned not needing to think further about the lungs, a 
minority of patients regarded their new lung as a ‘foreign object’ or as their ‘own lungs that 
were repaired’.  
 
6.5.3 Donor 
Our transplant recipients were characteristically deeply grateful to their donors. However, 
about half of the patients emphasized not having any further thoughts about the donor and 
viewed the transplantation as a mechanical and rational process. In contrast, however, a few 
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patients mentioning continuous speculations about the donor or the lung(s) (as mentioned 
above), like divining the donor’s personality or figuring out what relationship they might still 
have with the donor. Some patients felt connected to the donor; others wondered whether 
they had adopted some of the donor’s characteristics; and still others felt that their new organ 
was continuing to live within them. Likewise, a few patients had worries regarding the 
quality of their donated organ, perceiving the new lung(s) as something foreign, and being 
unable to comprehend their origin. According to Goetzmann et al. (2004), patients’ fantasies 
and speculations about their new lungs or the lung donor represent a coping mechanism, 
similar to dreams, that helps them to process their transplant experience and mentally 
integrate the graft into their own body image. A more philosophical explanation was given by 
Quintin (2013), who assumed that the act of thinking and having fantasies related to the 
experience of organ transplantation enables patients to gain a greater understanding of what is 
entailed and, thus, give it meaning. As such, speculating and fantasizing about the new lungs 
and donor, is a way for them to come to terms with the transplant experience. Our patient 
narratives underscored how undergoing lung transplantation is a complex physical and 
psychological challenge that can substantially affect both a patient’s self-identity and 
perceived meaning of life.  
 
6.5.4 Medication regimen 
Life-long maintenance of a complex medical regimen is crucial to preventing acute and 
chronic rejection and the loss of the lung allograft. Unfortunately, many of these medications 
have severe side effects and thus can induce considerable morbidity, thereby impacting the 
patient’s physical function (Finlen Copeland et al., 2013). Suffering from side effects was 
mentioned by the majority of our study sample. Consistent with the literature, our analysis 
revealed that side effects arising from the immunosuppressive treatment ranged from 
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transient to permanent and varied in the level of psychological distress they produced 
(Rosenberger, Dew, DiMartini, et al., 2012).  One positive finding is that, despite the 
frequency of side effects mentioned, most patients understood the importance of following 
the immunosuppressive regimen as prescribed, and that failure to take immunosuppressive 
medications could be life-threatening.  
Strict adherence to medications is particularly important for lung transplant patients, 
due to the high risk of infections and the potential for either acute or chronic rejection. With 
regular follow-up visits in the outpatient clinic, the majority of lung transplant patients 
exhibited good adherence over their first six months post-transplant (De Geest et al., 2014; 
Dew et al., 2007). Non-adherence to their medication regimen was admitted by just two 
patients. 
Similar to De Vito et al. (2004), our analysis revealed that early post-transplant 
adjustment was predominantly affected by severe side effects, fears of organ rejection, and 
restrictions in everyday life. At some point, patients typically come to the realization that 
they have replaced one disease for another. Despite the many restrictions arising from 
transplantation, it is crucial for them to identify ways to live as normal as possible. 
Developing coping strategies can be important in dealing with the challenges of their onerous 
medical regimen. Only 20% of our patients reported using coping strategies to facilitate their 
medical regimen. Our results underscore the importance of interventions to improve 
adherence to self-care and proper medication-taking behaviors post transplant (De Geest et 
al., 2005). 
 
6.5.5 Study limitations and strengths 
The findings reported here must be interpreted taking into consideration certain 
methodological limitations. First among these is the risk of subjectivity in the interpretation 
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of answers. Using an independent rater to assess the accuracy of the codes chosen minimized 
this risk of bias. A second limitation of our study was the potential for selection bias, as we 
only included patients who were physically and mentally fit enough to attend the interviews. 
Furthermore, some participants appeared to have difficulties articulating their experiences 
with transplantation or responding to the questions posed. Given the study’s qualitative 
design, however, our findings are not meant to ‘accurately’ represent the experience of all 
lung transplant patients. Notwithstanding, we assume that our findings will have relevance 
for other transplant centers. Study strengths were the use of a prospective, qualitative study 
design with a relatively large sample without any drop-outs.  
 
6.5.6 Conclusions and implications for clinical practice 
The themes identified here, related to the experience of lung transplantation and adjustment 
to life as a transplant recipient, should increase healthcare-giver awareness of the many 
physical, psychological, social and behavioral challenges transplant recipients are confronted 
with during the early postoperative period. Improvements in physical function during the 
early postoperative phase may be limited by the onset of clinical complications, fear of 
rejection and infections, medication side effects, and restrictions in everyday life. 
Understanding this may help healthcare providers to enhance their practice, via listening 
attentively to patient narratives, addressing patient concerns in a timely fashion, and initiating 
active and/or pro-active interventions when mental health problems arise and start to 
adversely impact their patients’ quality of life. Psychological support is of great importance 
to facilitate the early postoperative management.  
Further qualitative research is required, considering the first 2-3 years after LTx, to 
elucidate the impact of lung transplantation on patients’ wellbeing in the long-term. 
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7 General discussion 
The underlying purpose of this thesis was to evaluate health-related quality of life and 
psychological outcomes after lung transplantation and to investigate psychological 
adjustment to lung transplantation within the first six months post-transplant. Taken together, 
by employing three different research methodologies, the findings of the three empirical 
works contained herein contribute a more holistic understanding to the growing body of 
literature in transplant medicine. 
In this chapter, the main results of the studies are briefly summarized and a general 
discussion of the results is offered, including the strengths and limitations of this three-part 
research project as a whole, suggestions for future research, and conclusions drawn by 
synthesizing the combined results. 
 
7.1 Summary of the results 
Empirical work 1: A systematic review of health-related quality of life and psychological 
outcomes following lung transplantation 
The primary objectives of this systematic review were to assess the assortment of self-report 
instruments used to assess HRQoL and psychological outcomes following lung 
transplantation, to explore the study designs and methodology adopted for the eligible 
studies, to review the outcomes of instruments that have been applied most frequently, and to 
provide suggestions regarding which instruments to use. Our results revealed considerable 
heterogeneity in the approaches, methodologies and outcome measures utilized in published 
studies on HRQoL and psychological outcomes after lung transplantation. Methodological 
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limitations potentially biased conclusions regarding the effects of lung transplantation on 
quality of life, such limitations including missing data, selection bias, small sample sizes, and 
the exclusion of patients who either had died or were too unwell to participate. Relatively few 
studies assessed HRQoL and psychological outcomes longitudinally within the same study 
sample. On the other hand, studies consistently identified significant post-transplant 
improvements in both mental health and HRQoL.  
 
Empirical work 2: Psychological distress and quality of life in lung transplant recipients. A 
six months observational study 
The overall purpose of this study was to evaluate outcome trajectories in lung transplant 
patients with respect to psychological distress and quality of life within the first six months 
post transplant, to identify patients with poor postoperative trajectories, and to determine 
potential predictors of psychological distress and poor HRQoL six months after 
transplantation. Hierarchical cluster analysis revealed three patient clusters, discriminating 
between transplant recipients with optimal (35%), good (42%) and poor (23%) postoperative 
trajectories. Patients with poor postoperative trajectories tended to be older, to have suffered 
from more severe lung disease, to have more co-morbid conditions, and to have had a more 
prolonged ICU and/or hospital stay. We also found disease severity, length of hospital stay, 
and self-reported HRQoL two weeks post transplant to be significant predictors of 
psychological distress and HRQoL at six months of follow-up. 
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Empirical work 3: Early postoperative adjustment to lung transplantation. A longitudinal 
qualitative study 
By qualitative data analysis, we aimed to explore patients’ experiences with their transplant 
and adjustment to normal life within the first six months after surgery. More specifically, 
semi-structured interviews were conducted to investigate patients’ thoughts, feelings and 
attitudes with respect to the transplantation process, their new lungs, the organ donor, and 
their medication regimens two weeks, three months and six months postoperatively. Via 
content analysis, we identified ‘physical benefits’, ‘fear of rejection’, ‘gratitude’ and 
‘medication side effects’ as the issues most frequently mentioned over those first six 
postoperative months. Out of 22 coding categories of responses identified, only three 
changed significantly, in terms of frequency of mention, over that time. While comments 
about ‘ICU delirium’ and ‘worries regarding donated organ quality’ significantly decreased 
over those six months, those regarding ‘restrictions in everyday life’ increased. Only 
marginal differences in frequency of the coding categories were noted between the genders. 
 
7.2 Discussion of the results 
The systematic review of 63 studies identified important outcome measures and 
methodological approaches that have been utilized previously to evaluate psychological 
outcomes and HRQoL after lung transplantation. Most importantly, the literature consistently 
confirmed meaningful improvements in HRQoL following lung transplants, those 
improvements primarily reflected as enhanced physical function, increased vitality, more 
energy, less pain and discomfort, and fewer restrictions in social and leisure activities. 
Furthermore, the most important improvements in HRQoL were observed within the first 
year post transplant and remained stable for up to five years. Although a body of research 
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already existed on psychological outcomes and HRQoL after lung transplantation, our review 
of the literature revealed noticeable methodological limitations that might affect the 
interpretation of those prior results. Consistent with findings from another review, by Yusen 
et al. (2009, 2011), previous study limitations included small sample sizes, missing data, 
selection bias, loss of subjects to follow-up due to deterioration of health status or exclusion 
of deaths. Furthermore, longitudinal studies, which are important to survey the degree and 
stability of improvements following lung transplantation, were conducted only by a relatively 
small number of investigators (13 different first authors). In addition, a great number of 
different outcome measures were applied in the absence of any guidelines, which limits the 
comparability of these results. Finally, transplant-specific outcome measures were rarely 
used, despite being critical to identifying transplant-specific issues like the adverse effects of 
immunosuppressant medication, pain or adherence to medication regimen. Better outcome 
instruments are required that more adequately picture the effectiveness of lung 
transplantation and improvements in post-transplant HRQoL. Furthermore, the use of 
standardized test instruments is essential to reduce heterogeneity and to facilitate 
comparability of results among different studies.  
To date, studies on psychosocial outcomes following transplantation have primarily 
compared postoperative trajectories combining patients with a variety of solid organ 
transplants. Interestingly, most investigations focused on the average value of HRQoL and 
did not distinguish between favorable and poor postoperative outcome trajectories. To 
broaden the scope of HRQoL research in the field of transplant medicine, the second study in 
this thesis sought to assess post-transplant HRQoL and psychological distress in terms of 
trajectories, rather than just considering outcomes at discrete time points. To achieve this 
objective, HRQoL and psychological outcomes were investigated in 40 lung transplant 
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recipients over the first six months since surgery. It is important to note that our results are in 
line with the broad body of literature in demonstrating significantly improved HRQoL over 
the first six postoperative months. Consistent with our hypothesis, most patients experienced 
either a good or optimal postoperative trajectory. However, a quarter of patients had a poor 
postoperative trajectory, suffering from elevated distress and substantially impaired quality of 
life, with no significant improvement over time. Hence, a considerable proportion of patients 
might not benefit from transplantation, from a quality of life perspective. This result is 
alarming, given that depression and psychological distress appear to significantly increase the 
risk of mortality after transplantation (Havik et al., 2007; Sirri et al., 2010). Risk factors for 
poor postoperative outcomes after lung transplantation are not well described in the literature. 
Analyzing our three different cluster groups - optimal, good and poor outcome - for medical 
and sociodemographic differences, we found that patients with a poor postoperative 
trajectory tended to be older, more likely to suffer from more severe pre-operative lung 
disease and more co-morbid conditions, and more likely to have prolonged ICU and hospital 
stays. These results are in accordance with those of other studies that identified older age 
(Inci et al., 2015; Vasiliadis et al., 2006; Vermeulen et al., 2007) and the presence of co-
morbid conditions (Kugler et al., 2005; Vermeulen et al., 2003) as independent risk factors 
for diminished outcomes after lung transplantation. Similar to Inci et al. (2015), gender, time 
on the waiting list and underlying diagnosis failed to predict mortality. Improving health-
related quality of life is an important goal of lung transplantation. However, predictors of 
HRQoL outcomes are also not well understood. Addressing this knowledge gap, our study 
found that pre-operative lung disease severity, length of hospital stay, and self-reported 
HRQoL two weeks post-transplant were the strongest predictors of both high-level 
psychological distress and impaired HRQoL at the time of the six-month postoperative 
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evaluation. Our results emphasize the need for new pre-transplant predictors of poor early 
post-transplant outcomes that can help to identify candidates with high risk for severe 
complications, reduced quality of life and mortality after lung transplantation. Furthermore, 
the effect of exercise training, education and psychosocial support in patients with poor 
postoperative HRQoL-trajectories should be further explored.   
The qualitative study provided novel insights into how patients experience lung 
transplants and adjust to normal life over their first six postoperative months. The most-
frequently mentioned themes within the categories ‘transplantation process’, ‘new lungs’, 
‘the donor’ and ‘medication regimen were ‘physical benefits’, ‘fear of rejection’, ‘gratitude 
towards the donor’, and ‘side effects’, respectively. Contrary to our expectations, most 
themes that concerned patients immediately after surgery remained unchanged in the 
prominence over time. One possible explanation for the relative absence of change over time 
is the lengthy process required for recovery and adjustment to transplantation, which 
typically spans several years. At six months post-transplant, patients are only starting to 
resume their normal daily routines (Rosenberger, Dew, DiMartini, et al., 2012). Although 
seemingly inconsistent with findings in the current literature demonstrating gender 
differences in HRQoL after lung transplantation (Kugler et al., 2007; Rodrigue & Baz, 2006), 
our results revealed only marginal gender differences, suggesting that gender does not play a 
major role in how patients process the transplant experience. Consistent with quantitative 
studies on HRQoL outcomes post lung transplant (Finlen Copeland et al., 2013; Kugler et al., 
2007; Smeritschnig et al., 2005), we found that improvements in physical function during the 
early postoperative phase were offset by clinical complications, fear of rejection, medication 
side effects, and restrictions in everyday life. Even though these aspects might be well-known 
to practitioners, this study extends prior work by presenting narratives that comprehensively 
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depict patient experiences. Analyzing these narratives, it becomes evident that lung 
transplantation is a life-changing event that affects many physiological, psychological, social 
and behavioral aspects of a person’s life. The themes related to lung transplant identified in 
this study have direct clinical implications and should increase healthcare-givers awareness 
of the many challenges transplant recipients must confront within the first six months after 
their surgery. Postoperative recovery and returning to normalcy is a demanding process that 
requires considerable time and energy. To facilitate this journey to relative normalcy, 
healthcare providers must act as both mediators and providers of information and support. 
The number of authors who have employed qualitative methods to explore psychological 
outcomes after lung transplantation is still few even though qualitative research is an 
important prerequisite for providing important insights of psychological adjustment to lung 
transplantation (Singer & Singer, 2013). Further longitudinal qualitative research is required 
to investigate the patients’ well-being and experience with their transplant 2 or 3 years after 
transplantation. 
 
7.3 Limitations 
Despite the significant contributions mentioned above, there are several limitations that 
should be considered when interpreting our data. Specific limitations have already been 
discussed in the discussion section of each paper, and I will refrain from reiterating them 
here. Rather, I will make some cautionary remarks about the limitations of this thesis in its 
entirety.  
First, the small number of patients included in our studies limited our ability to 
perform subgroup analysis, as we did to compare the three cluster groups, and was therefore 
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under-powered. Results from the cluster analysis are therefore exploratory in nature and need 
to be confirmed in bigger subject samples. 
Second, data were collected over a short postoperative observation period. The early 
post-transplant period is predominantly characterized by rehabilitation, close monitoring of 
health status, the introduction of new medications with potential side effects, and the distinct 
possibility of early re-hospitalization. Six months after transplantation may be too short for 
patients to have achieved optimal pulmonary recovery. As such, longer follow-up times may 
be required to more accurately document HRQoL outcomes, including the risks and benefits 
of lung transplantation. Additionally, relative to cross-sectional studies, prospective 
longitudinal studies remain few in number when reviewing the current medical literature and 
definitely constitute a niche for further research.  
Third, no pre-operative reference values were considered during study design, even 
though such information would have been important as an aid to predicting postoperative 
outcomes.  
Fourthly, data were extracted from a single medical center, which inherently limits the 
generalizability of our results to other contexts, since the community or health center itself 
might have biased patient responses to some extent. 
Other important methodological limitations resulted from our inability to control for 
confounding variables like the underlying diagnosis, and the presence of co-morbid pre- and 
post-transplant medical conditions. Also, selection bias is inherent when interviewing only 
surviving patients or patients who are fit enough to participate in a study (e.g., including only 
those patients with completed data sets might have resulted in a better HRQoL estimates than 
actually characterized by our patients overall). Lastly, the loss of subjects during the course 
of follow-up – for reasons like psychological distress, fatigue and other health complications 
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– is a common problem when conducting prospective longitudinal studies in lung transplant 
recipients.  
 
7.4 Future research  
To determine the overall outcomes of lung transplantation, future research should include 
pre- versus post-transplant assessments, embedded within a prospective longitudinal study 
with patient samples large enough to allow for more extensive empirical analysis. Most 
suitable would be to implement some sort of standard assessment, investigating patients from 
the time of entry into the transplant system until death or other removal from the transplant 
system.  
A further huge opportunity for future research lies in the development of guidelines to 
aid in the selection of outcome measures to assess psychological outcomes after lung 
transplantation. The use of consistent outcome measures in transplant medicine would reduce 
heterogeneity and facilitate comparisons between different studies. Adopting transplant 
specific HRQoL-measures is also highly recommended, such as measures that screen for 
physical symptoms like the potential adverse effects of immunosuppressants but also quantify 
the degree of disability, in terms of activities of daily living and self-care.  
The identification of powerful pre-transplant predictors for poor postoperative 
outcomes in terms of reduced HRQoL and mortality are important to improve overall 
outcomes of lung transplantation and to avoid futile transplantation.  
Although HRQoL outcomes have been researched extensively in transplant medicine, 
the question of whether the benefits of lung transplantation outweigh its potential harm 
remains largely unacknowledged. Better tools are required for measuring post-transplant 
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HRQoL. Addressing this issue, Yusen (2011) suggested integrating outcome instruments that 
assess both survival and quality of life. By considering the risks and benefits of lung 
transplantation, including longevity, symptom experiences, everyday function, and other 
components of HRQoL, a quality-adjusted survival value could be computed that more 
adequately demonstrates the effectiveness of this treatment. 
The use of subgroup analysis rather than considering outcomes at discrete time points 
are highly recommended to detect those patients who did not experienced any improvements 
in HRQoL after lung transplantation.  
Finally, only a small number of investigators have investigated mental health among 
lung transplant recipients. The reasons for ongoing psychological difficulties in lung 
transplant recipients are not completely understood and warrant further study. Even though 
the physical health of lung transplant recipients has improved significantly, the 
unpredictability of outcomes and patient feelings of lack of control may continue to adversely 
influence emotional health and raise levels of anxiety (Dew et al., 2012). Employing 
qualitative data analysis could yield a deeper understanding of the transplant experience, as 
well as the concerns, symptoms and emotional difficulties associated with this procedure.  
 
7.5 Conclusion 
The over-riding purpose of this thesis was to comprehensively investigate patients’ 
psychological adjustment to lung transplantation, in terms of psychological outcomes and 
HRQoL. The present results are important given the growing body of scientific literature 
demonstrating that lung transplantation confers clinically meaningful and statistically 
significant improvements in HRQoL in patients suffering from end-stage pulmonary disease 
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(Finlen Copeland et al., 2013; Santana et al., 2012; Singer & Singer, 2013). HRQoL 
improvements essentially concern physical domains and largely transpire within the first six 
months post transplant (Kugler et al., 2010). In contrast, beyond the first year after 
transplantation, HRQoL outcomes become less predictable. Larger longitudinal studies with 
large enough subject samples are required to better assess the long-term effects of 
transplantation on HRQoL.  
Given the scarcity of available donor organs, it has become increasingly important to 
determine factors that are predictive of who is most likely to benefit from lung 
transplantation in terms of extended survival and improved HRQoL (Evon et al., 2010). 
Although lung transplant candidates are selected according to relative and absolute 
contraindications, approximately 20% of lung transplant patients die within the first year after 
transplantation (Inci et al., 2013). Therefore, new factors need to be identified that more 
powerful can predict the risk for severe early post-transplant complications (Hook & Lederer, 
2012). 
To date, many conceptual and methodological limitations persist in the scientific 
literature that render comparisons between studies difficult and weaken the ability to draw 
conclusions concerning the effects of lung transplantation on HRQoL. These limitations 
include survivorship bias, losses to follow-up, predominant use of cross-sectional study 
designs, and small sample sizes.  
The findings of this thesis underscore the need to develop guidelines for outcome 
instrument selection and thereby reduce study heterogeneity. Once a special transplant 
interest group has identified those instruments that best measure HRQoL outcomes in lung 
transplant recipients, these instruments could be used to integrate HRQoL data by default into 
existing registries, as is currently being done to some degree within the Swiss Transplant 
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Cohort Study (STCS) (De Geest et al., 2013). Doing so could help to reduce sample size 
limitations and biases that result from single-center studies. Such a standardized assessment 
could also improve efforts to quantify the impact of lung transplantation on HRQoL (Yusen, 
2011).  
Although lung transplantation dramatically improves most patients’ physical function 
and quality of life, they remain confronted by a variety of health problems, including the risk 
of organ rejection, side effects of immunosuppressants, various medical co-morbidities, and 
mental health problems like anxiety and depression (Lanuza et al., 2012). Adjusting to life as 
a transplant recipient requires acceptance of ongoing medical illness and continued reliance 
on caregivers. To identify those patients with clinically significant distress and impaired 
HRQoL post-transplant, healthcare providers ought to conduct early, comprehensive 
diagnostics as part of their routine clinical practice, so mental distress symptoms can be 
treated rapidly and HRQoL improved. Support groups and psychosocial interventions are 
critical to sustaining and increasing gains related to transplantation, to optimizing adherence 
with medical regimens, and to decreasing patients’ symptom experiences (Rosenberger et al., 
2012).  
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